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Abstract 
The use of proteins as therapeutics is one of the fastest growing sectors of the 
pharmaceutical industry, particularly monoclonal antibodies. However, a 
significant challenge in the development of such protein-based medicines is to 
counter aggregation of the proteins in solution (as these drugs are typically 
administered by injection). In solution form, aggregation of the normally 
monomeric protein ingredient affects therapeutic efficiency and reduces shelf life. 
Moreover, the rapid formation of aggregates in patients during the administration 
of therapeutic proteins can lead to immunological reactions which could be fatal. 
Hence, the long term storage of proteins in solution is discouraged. 
Lyophilization (vacuum drying) is considered to be an effective route for 
ensuring longer shelf life and better stability of protein therapeutics. However, 
aggregation can still occur, because the driving forces for aggregation (covalent 
as well as non-covalent interactions such as hydrogen bonds, van der Waals 
forces and hydrophobic interactions) are influenced by lyophilization induced 
changes in the pH, temperature, exposure to interfaces, and dehydration stress. 
Lyoprotectants such as sugars can counter the undesirable consequences of 
lyophilization depending upon their nature and potential. Several mechanisms 
have been proposed for the role of the lyoprotectants. The comprehensive 
investigation into the inherent nature and influence of lyoprotectants on a protein 
therapeutic during lyophilization is hence important. In this project an attempt has 
been made to develop a novel nanoscale screening methodology for the detection, 
Mudasir Ahmad Lone Abstract 
quantification, characterization and prevention of protein aggregation. Initially, 
ferritin and then a polyclonal IgG (antiglucose-6-phospate dehydrogenase 
antibody) antibody have been used as model proteins for these studies. The effect 
of lyophilization on the level of aggregation of IgG was studied and compared to 
reports in the literature. IgG was exposed to seven cycles of lyophilization, where 
each cycle of lyophilization was followed by reconstitution and characterization. 
IgG was also lyophilized with different excipients (sucrose and mannitol, alone 
and in combination) in different molar ratios. In the liquid state, the formulations 
were characterized on the basis of particle size and antigen binding activity, 
whereas in the dry powdered form, the formulations were characterized by 
studying morphology, thermal stability, and secondary structural alterations in 
order to establish a relationship amongst the indicated properties. Atomic force 
microscopy (AFM), dynamic light scattering (DLS) and single particle tracking 
(Nanosight) were used to study particle size. The identification of different 
components at the nanoscale and general morphology were screened by AFM and 
scanning electron microscopy (SEM). Subsequently, the thermal properties and 
structural alterations respectively were analysed by differential scanning 
calorimetry (DSC) and infra read spectroscopy (ATR-FTIR) spectroscopy. The 
antigen binding activity was investigated by performing an indirect ELISA assay 
on the lyophilized formulations. 
Lyophilization of ferritin and IgG caused a significant decrease in the proportion 
of monomeric species was confirmed by AFM, DLS and Nanosight. Dimeric, 
11 
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lower-multimeric and larger aggregates existed in variable proportions for both 
ferritin and IgG. Powdered lyophilized ferritin formulations showed aggregation, 
increased crystallinity (concomitant decrease in amorphicity), porosity and 
flakiness which in case of IgG increased with repeated lyophilization. A 
consistent increase in the extent of aggregation (unfolding of Fabs and Fc) was 
detected by DSC and an increase in the ~ ~ - sheet structure coupled with structural 
re-arrangement within the components by ATR-FfIR. The presence of sucrose in 
IgG formulations resulted in reduced aggregation and enhanced porosity. The 
inclusion of Mannitol promoted crystallinity, decreased porosity when used 
alone, however, improved the efficiency of sucrose in combined formulations. 
The nature of crystals formed by mannitol during lyophilization was shown by 
SEM and confirmed by AFM. The data obtained from DLS, NT A, AFM, DSC, 
A TR, and SEM was consistent with by ELISA results which indicated a 
significant fall in IgG activity upon repeated lyophilization, and improvement in 
the activity when IgG was formulated with sucrose, which significantly enhanced 
in combination with mannitol. The benchmark provided by this work would serve 
as a precursor for developing a novel screening standard for optimizing and 
improving the therapeutic efficiency of other proteins besides furnishing a 
detailed account of the disparity in correlating the data from multiple novel 
techniques. The findings of our work can be directly translated to biotech and 
biopharm industries for the enhancement of protein based therapeutics. 
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Chapter 1 
Introduction to aggregation in 
protein therapeutics 
1.1 Biopharmaceuticais 
Pharmaceutical products form the backbone of modern medicinal therapy [I, 2, 
3]. The majority of pharmaceuticals remain low molecular mass organic 
substances, and are manufactured by direct chemical synthesis. Direct chemical 
synthesis is now employed even for the manufacture of drugs (such as aspirin) 
which were originally obtained from natural sources. The term 'bio-
pharmaceutical' refers to products of a biological origin or from biotechnological 
endeavour. This includes vaccines, enzymes, hematopoietic growth factors [such 
as granulocyte colony-stimulating factor (G - CSF), macrophage colony-
stimulating factor (M - CSF), erythropoietin (EPO) - which stimulates red blood 
cell formation], interferons [suth as interferon alfa - 2a and interferon alfa - 2b 
(IFN - a 2a, IFN - a 2b] and interleukins [such as recombinant human 
interleukin-I P] which regulate immune response, monoclonal antibodies, 
hormones, antibiotics and plant metabolites [such as angiotensin - I - converting 
enzyme obtained from tabacco/tomato treats hypertension]. The advent of 
recombinant proteins and monoclonal antibodies in the 1980s, and their 
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subsequent use in therapeutics and vaccines have profited humans globally. The 
US Food and Drug Administration (FDA) have permitted 30 antibody based 
drugs until 2011 [4] and presently 418 protein based drugs are under 
developmental process [5]. The first biopharmaceutical product to come on the 
market was recombinant human insulin, produced in Escherichia coli. This 
product (trade name Humulin) was granted a marketing licence by the Food and 
Drug Administration (FDA) in 1982 [3]. The significance and urgency of 
developing proteins based drugs stems from their natural origin, direct extraction 
from biological source, considerably better bioavailibity and lesser side effects 
compared to synthetic drugs and more astonishingly biopharmaceutical 
companies are developing such 73 medicines and vaccines, which are 
concentrated on enhancement of treatment regimes, more effective therapies and 
encouraging novel deterrent answers for AIDS and patients affected with cancer 
[5, 6]. The development of such biopharmaceuticals is anticipated to become 
increasingly important and is generally agreed to be urgently required in the 21 sl 
centenary for the prevention and treatment of diseases such as different forms of 
cancer, hepatitis, multiple sclerosis, strokes, diabetes, Parkinson's and 
Alzheimer's [7]. 
While highly effective as therapeutics, proteins are challenging to formulate as 
stable preparations. Proteins are intricate molecules possessed of abundant 
reactive chemical moieties and a subtle three-dimensional structure organized 
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into primary, secondary, tertiary and quaternary structural components [6]. This 
intricacy renders proteins with significant and new stability problems compared 
to traditional small molecular weight drugs. Hence protein based drugs can be 
exposed to several physicochemical changes during purification, formulation, 
handling and storage [7]. A slight alteration in protein structure can have a 
significant impact on protein activity and/or can therefore cause immunogenicity 
[8]. Therefore, the challenge of stabilizing proteins in the course of processing, 
formulation, storage and handling is growing. Another important aspect is 
protein instability, reduced bioavailibity if administered via non-invasive routes 
due to the larger size and highly hydrophilic propensity of the protein molecules. 
Therefore, predominantly protein therapeutic compels parenteral administration. 
The protein formulation in the solution state is usually a favoured mode due to 
the avoidance of issues associated with change in tertiary structure, degredation 
and difficulties in adsorption across mucosal membranes, which inturn improves 
therapeutic efficacy and bioavailbility. However, the development of stable 
protein formulations in the solution state is challenging because denaturation and 
aggregation can be induced by several influences to which protein in solution 
state is sensitive, such as agitation, freezing, heating and exposure to interfaces 
[9-12]. Furthermore, protein molecules can undergo chemical alterations 
(hydrolysis and de-amidation facilitated by water) in the suspension state. Dried 
suspension formulations in a solid form have been used effectively to improve 
physico-chemical stability and long term storage of protein based drugs. One 
such widely employed and preferred method of drying is lyophilization [13, 14]. 
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However, despite drying by using the effective method of lyophilization, 
aggregation can still occur and therefore, currently one of the major challenges 
for pharmaceutical companies is to prevent aggregation in bio-pharmaceutical 
products, particularly those based on proteins/peptides, such as IgG antibodies 
and Insulin [15, 11]. Protein based bio-pharmaceutical products when exposed to 
conditions different from their native environment can result in physical and 
chemical changes in protein structure as stated earlier, which can trigger 
aggregation or precipitation during drug formulation processes. As a 
consequence both drug dosage and biological activity of a therapeutic protein 
product can be adversely affected. The most concerning problem is that 
aggregates can trigger a severe immune response, which could even prove to be 
fatal [16]. Moreover, there is often a need for very high concentrations to achieve 
an effective and potential therapeutic dose, and hence this increases issues 
related to aggregation [16]. A related problem is the need to increase the shelf 
life of bio-pharmaceutical formulations, because increased shelf life provides the 
liberty to store the drugs for longer time while keeping their therapeutic 
efficiency intact. This in turn prevents the loss of millions of pounds each year 
caused by the limited shelf life of bio-pharmaceuticals [17]. Therefore, an 
effective formulation strategy/technique which would enable us to overcome the 
problem of aggregation in bio-pharmaceutical formulations for the preservation 
of their chemical and physical stability would be a welcome in the bio-
pharmaceutical industry. 
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1.2 Aggregation in proteins 
Aggregation of proteins is an important phenomenon and can have both positive 
as well as negative consequences. Most naturally occurring protein aggregation 
is productive, because it governs normal functioning of many biological 
processes. For example: fibrillation reaction of (G - actin - globular) --+ (F-actin-
fibrillar)n, regulates the normal shape and mobility of cells in humans [18,19]. 
Neurodegenerative diseases such as Alzheimer's [20], Huntington's [21], and 
Parkinson's [22], the amyloidoses, and prion diseases are hypothesized to be the 
negative consequences of aggregation in p - amyloid, polyglutamine and a -
synuclein respectively [23]. 
Aggregation involves nonspecific assemblage, association or polymerisation of 
two or more proteins/-polypeptides (either denatured or not) [24, 25]. 
Aggregation can be described as the formation of larger assemblies from 
completely or partially folded proteins/polypeptides. 
The aggregation is considered to be normal when the starting reactant (monomer) 
is in its native form (natural). However, in cases of abnormal aggregation, there 
is a concern whether the starting reactant (monomer) begins in its native form, or 
in denatured state (more active). It is generally believed that the association of 
proteins in a non-native state is responsible for their abnormal aggregation. The 
driving force for the aggregation emanates from the interactions between 
inappropriately solvent exposed hydrophobic surfaces that are normal to the 
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protein's interior. Hydrophobic surfaces which are highly exposed upon 
denaturation act as sticky spots and interact with whatever they can during forces 
of interaction. In an aggregated protein solution, since an individual protein 
molecule can exist either in native (folded), partially folded or unfolded form, 
therefore, the nature of the constituents of different types of aggregates becomes 
highly unpredictable. Moreover, there is a general consensus that different 
species of aggregates produced in protein solution may exist in dynamic 
equilibrium with each other, which could be influenced by number of factors 
such as pH, ionic strength, buffer composition, surfactant concentration, besides 
thermaVmechanical stress, lyophilization, thawing, quenching, and exposure to 
interfaces or denaturing chemicals [13, 24]. It has been reported that any protein 
has a tendency to form aggregates when exposed to a suitable external 
environment both in vivo and in vitro and can be broadly categorized into an 
ordered [amyloid fibrils] and disordered aggregates [26, 27]. Amyloid fibrils are 
predominantly composed of highly organized ~ ~ - sheet structures stabilized by 
hydrogen bonds. Each amyloid fibril is around 10 nm in diameter and composed 
of 2 - 6 cross ~ ~ - structured proto - fibrils with ~ ~ - sheets running perpendicular 
to the fibril [26, 27]. Although the aggregation depends on the characteristics of 
the amino acid sequence, the inter-peptide chain interactions may also cause 
conformational changes which would make it difficult to predict aggregation. In 
vivo examples of disordered aggregates (inclusion bodies) are those formed due 
to re-aggregation during renaturation of insoluble non-ordered protein. On the 
other hand, the in vitro disordered counterparts are those produced in the course 
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of the refolding of denatured (unfolded protein). These are usually produced at 
much larger concentrations of protein. These are classified as folding aggregates 
and are produced in near native environments when concentration exceeds a 
critical level. The natively folded proteins may aggregate in a way different from 
those folded non-natively. It has been reported that the former precipitate at an 
isoelectric point of protein. Since at an isoelectric point, there occurs no net 
charge on the surface of protein, pH of the solution reaches to equilibrium at the 
hydrophobic surface of the protein with considerable decrease in the formation of 
dipoles, van der Waals, or hydrogen bonds by water molecules on the protein's 
exterior. Therefore, water molecules diffuse away, thereby decreasing the 
volume occupied by the water molecules at the protein surface. In this fashion, 
protein-protein interactions become predominant and let protein to fall and 
precipitate. The precipitates of native protein show instant solubility in buffer 
environment identical to native. The reason is due to the induction of salt into the 
protein-solvent system (salting in); salt ions interact with the hydrophilic 
residues stationed on the protein's exterior surface. Consequently, the number of 
water molecules required to interact with hydrophilic amino-acid residues on the 
external surface of protein reduces whereas the amount of free water molecules 
for protein solvation increases. However, in contrast, the influence of increased 
salt concentration causes several water molecules to get attracted by salt ions 
which in effect decreases the proportion of water molecules available to interact 
with the charged part (hydrophilic) of the protein. Hence, protein solvation 
decreases, which consequently imparts greater strength to inter-protein 
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interactions than protein-water interactions. Eventually, the protein molecules 
precipitate by forming hydrophobic interactions and interactions between 
oppositely charged patches on the proteins's external surface (salting out). 
However the precise concentration instigating precipitation differs from protein 
to protein, thereby consenting separation of different proteins at different points. 
The dissociation of insoluble aggregates (non-natively folded and disordered) 
aggregates in contrast, occurs only in presence of high concentrations of 
denaturant or detergent [26, 27]. It is also believed that proteins with several 
short amino-acid sequences containing hydrophobic residues show an inclination 
towards ~ ~ - sheet formation and likely demonstrate a greater tendency to form 
aggregates and/or amyloid fibrils [26, 27]. In contrast, the surrounding polar 
amino-acid sequences are considered responsible for improving the protein 
solubility. This is because solvation is favoured with increase in the number of 
hydrophilic amino acid residues on the protein's exterior surface and is expedited 
by electrostatic interactions between charged (positive or negative) hydrophilic 
amino acid residues and a - positive or a - negative dipoles induced in water [26, 
27]. 
Despite various attempts in the last couple of decades to explain aggregation and 
its potential effects, some of the fundamental questions associated with 
aggregation are not yet fully understood. For an example: What is the nature of 
the species (starting reactants and intermediates) responsible for aggregation? 
What is the most detailed mechanism that could be accountable to explain 
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aggregation and the core kinetics involved in such a process? What would be the 
morphological and chemical structure of aggregates? What sort of specific 
intermolecular associations govern aggregation of a particular type of protein? 
Why some protein forms are ordered (amyloid) and sometimes disordered such 
as inclusion bodies, folding and amorphous aggregates? How do environmental 
factors affect aggregation and why are different proteins affected differently? 
Finally, how can we develop such methodologies that would enable us prevent, 
minimise and overcome aggregation fully? The following text will describe 
known mechanisms of protein aggregation. 
1.2.1 Mechanisms of Aggregation 
Several mechanisms have been proposed to protein aggregation such as by 
Goldberg et al. for the enzyme tryptophanase [28], King et al on the tailspike 
protein endorhamnosidase [29] and Wetzel et al on mammalian amyloid [30, 31]. 
According to Goldberg and his colleagues, aggregation proceeds via the 
formation of an intermediate and that under reasonable denaturant (denatured 
protein) concentration that aggregated, the addition of other folded proteins did 
not disturb the quantity of aggregated tryptophanase. This view that partially 
folded intermediates might be responsible for aggregation has been also 
describes molecular interactions between hydrophobic surfaces of subunits in an 
advocated by the descriptions given by King et al and Wetzel et al. Moreover, 
intermediates the aggregation of several proteins [32, 201]. 
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Figure 1.1 The standard model that gives a simplified account for protein 
aggregation. The partially unfolded intermediate could be produced either from a 
native or unfolded protein and has tremendous susceptibi lity to aggregate. The formation 
of ordered amorphous aggregates is governed by specific mechanisms such as an 
exchange of structural components [ESC]; sideways association [SW A]; ~ ~ - sheet 
piling [BSP]; association of individual protein chains [APe]. Non-specific self-
association of both and non-natively folded protein leads to the formation of disordered 
aggregates [29]. 
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Figure 1.1 demonstrates standard representation of the proposed model having 
generalized consensus on the phenomenon of aggregation [29-31, 32]. The 
indicated model aggregate composed of partially folded protein molecules. 
According to the proposed model indicated in Figure 1.1, aggregation or protein 
folding proceeds with the formation of intermediates, where each given 
intermediate is composed of several sub-types which are nearly identical. The 
sub-types generally display characteristic secondary structure with a high 
probability of having relatively native-like structure in the common core. 
However, the rest of the polypeptide chain has high probability to be in a state of 
disorder or in an unstable structural configuration. The native state is designed 
by the ordered interaction of sub-structural components (sub-domains), which 
could be stable or metastable in an individual state, but become stabilized by 
interactions with other sub-structural components [26]. The native state is 
designed by the intra-molecular interaction of the hydrophobic surfaces of sub-
structural components Figure 1.2 [section A]. The specificity of such an 
interaction is influenced by several factors such as geometric shape and length 
of the hydrophobic area besides the attendance of other sub-structural 
components. Such specific interaction of the hydrophobic surfaces in an 
intermolecular fashion results in aggregation Figure 1.2 [section B]. This 
demonstrates that the commencement of aggregation involves interactions 
between the specific surface portions of the sub-structural components of two 
11 
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A. Pathway that leads to fonnation of nonnal ensembling 
of sub-structural components 
1 1 ! 
• Unfolded Intelmediates Native 1 B. Pathway that leads to aggregation due to abuOImal 
H) drophobic 
Aggreoates 
........ ~ ~
Figure 1.2 Schematic of the most probable folding mechanism of the sub-structural 
components of a given protein. [A] Repre ent normal folding pathway and is a 
con equence of intra-molecular whereas [B] leads to an aggregation and is a result of 
intermolecular interaction of hydrophobic surfaces (shown by orange faces) stationed on 
the sub-structural components. The folding, both in the native state and structure 
involved in aggregation tart off from the partially folded intermediate. All the 
intermediates involved would be compo ed of conjoint sub- tructural components [26]. 
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molecules. To begin with, the aggregates formed are either dimers, trimers, 
tetramers and other lower multimeric forms would be soluble, but in due course 
their size surpasses proliferation of inter-molecular interactions. 
The intermediates are more susceptible to aggregate further due to high 
probability of the presence of substantial number of solvent exposed 
hydrophobic surfaces. The unfolded native state results from the intra-molecular 
interaction of the hydrophobic faces of sub-structural components. Therefore, in 
an unfolded state, the lesser tendency to aggregate stems from the fact that the 
hydrophobic side-chain residues are not exposed for intermolecular contact. This 
is in contrast to the high propensity for aggregation in partially folded 
intermediates due to greater chances of the inter-molecular hydrophobic surfaces 
to come in to contact. Furthermore, amongst the several proposed mechanisms of 
protein aggregation [26, 28, 29, 32]. Figure 1.3 gives the most detailed account 
of the mechanism of aggregate formation that proceeds with the formation of 
amyloid fibrils in case of native (non-denatured) and non-native (denatured) 
starting reactants (monomers) [33]. Amyloid fibrils are predominantly composed 
of highly organized p - sheet structures stabilized by hydrogen bonds [Figure 
1.4]. Each amyloid fibril is around 10 nm in diameter and composed of 2 - 6 
cross p - structured proto - fibrils with P - sheets running perpendicular to the 
fibril. Although the aggregation depends on the characteristics of the amino acid 
sequence, the inter-peptide chain interactions may also cause conformational un-
13 
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Figure 1.3 [A] and [B] respectively highlight the multiple stages of aggregation in 
non-native and native aggregation respectively . There eem to be a consensus that 
protein aggregation occur via a mechanism that involves nucleation both in the case of 
native and non-native polymeri ation (from [25]) 
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desirable changes. This makes it difficult to predict the aggregation pathways. 
Aggregation can also be influenced by the intrinsic properties of the proteins 
such as charge, hydrophobic/hydrophilic patterns and secondary structure 
propensities [25]. It has been considered that non-native aggregation is a process 
which is typically initiated when the secondary structure [Figure 1.4] of the 
starting reactant significantly differs from that in the native state. Consequently, 
these structures highly affect the size, morphology and toxicity of resulting 
aggregates. 
Figure 1.3 [A] highlights the association steps between the partially misfolded 
monomers in step I (as designated in Figure 3). Steps I and II are reversible. Step 
III describes a cooperative realignmentlmisfolding of two or more non-native 
polypeptide chains. This is what is currently thought to create the smallest 
irreversible aggregate, and is designated nucleation stage. Irreversibility of the 
nucleation step likely results from the large number of stabilizing inter-peptide 
chain contacts such as hydrogen bonding and hydrophobic interactions. Step IV 
is a growth step and involves further irreversible addition of single or multiple 
monomers to the aggregate formed in the nucleation stage. It is important to 
mention that not all aggregates undergo significant growth after nucleation. Most 
studies have confirmed that the polymers/filaments observed in stage IV are 
generally linear and are predominantly composed of ~ ~ - sheet structures. 
However, this does not necessarily apply for all polymers. Step V shows that 
15 
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sometimes condensation takes place where aggregates associate with each other 
by means of cross linking to from gels, or form fibrils by way of bundling or 
lateral association and even separate out as precipitates. The native state that 
yields proper function is considered to be a low energy stable conformation of a 
protein. An inter-chain contact with other parts of that protein or with other 
protein moieties produces energetically more favourable conformation than the 
native state of that protein, which consequently result in aggregation. Figure 1.3 
[8] describes a native protein aggregation pathway which doesn't account for the 
conformational changes in step I. 
The model shown in Figure 1.3 is considered to be more reasonable for natively 
folded proteins/polypeptides. The nucleation (III) and polymerisation (IV) steps 
are implicitly irreversible, and will occur if stage V is omitted. It has been 
observed that in some cases the reversible nature of step II corresponds to the 
predominant formation of P - sheet structures [Figure 1.4] [25]. 
16 
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Figure 1.4 Three dimensional representation of the molecular secondary structure 
of a protein [Top panel] [34] ; The bottom panel is ball and stick model representation 
of p - pleated heet tructure of an amyloid fibril which i formed as a result of an inter-
chain hydrogen bonding (----) protein chains. The side chains run up and down the heet 
and alter in the arrangement of aminoacid alongside the chain [35]. 
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1.2.2 Kinetics of Aggregation 
There occurs a kinetic struggle at the beginning of an aggregation process 
between folding and all other aggregates (ordered and disordered) made from the 
partially folded intermediate [36]. The aggregation of a partially folded 
intermediate, that is structurally different from the native state of the protein, 
takes place by three parallel directions [Figure 1.1]. In any given pathway, the 
partially folded intermediate can undergo chain polymerization and self-
association or both. Protein aggregation predominantly displays first order 
kinetics [even in the growth of amyloid fibrils, and other amorphous aggregates] 
and is defined by the expression: 
Rn-I+G-Rn 
- R is the aggregation sensitive state (partially folded intermediate) 
- G is either the unfolded state (Ve), or the native state (Ns) of the monomer. 
It has been reported that both in vivo and in vitro aggregation involves the 
formation of the same partially folded intermediate as precursor [25,26, 27, 29, 
30, 31 and 32]. The extent of formation of partially folded intermediates in itself 
and the rate of the aggregation depends upon the nature of the protein amino acid 
sequence and as such is influenced by several environmental (solution) factors 
such the pH, temperature, ionic strength, the concentration of the protein and the 
occurrence of other solutes. The disparity in the stability of the native state to the 
18 
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partially folded intermediate stems from the influences of the ingredients that 
constitute the solution environment. For instance, protein concentration has a 
substantial impact on the degree and rate of intermolecular interaction. The 
nature of the precursor that starts aggregation is intricate and affects the 
equilibrium between the native state and the partially folded intermediate. The 
equilibrium of the partially folded intermediate with native state always makes 
the partially folded intermediate precursor for aggregation [25, 26, 29]. The 
instability of the native state increases the amount of a partially folded 
intermediate and aggregation will be amplified. Longer lifetime of partially 
folded intermediates ensures enhanced inter-molecular interaction and therefore, 
favours aggregation. 
1.2.3 Significance of aggregation in protein based therapeutics 
The control and understanding of the abnormal aggregation is highly significant 
to biotech and pharmaceutical industries for keeping protein based drugs in a 
non-aggregated state in order to ensure their safety, efficacy and a longer shelf 
life. Otherwise, aggregation not only reduces the drug efficacy and shelf life, but 
can also lead to toxicity and evoke an immunological reaction [37]. From a 
pharmaceutical perspective, it is generally believed that protein based 
formulations usually experience aggregation during the early or final stages of 
developmental process, where they are most often difficult to detect [38]. The 
aggregates formed in protein based formulations show a high degree of 
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variability in their size, solubility, morphology and the nature of interactions 
which hold them together [39]. On the basis of their solubility, aggregates are 
broadly classified as: 
A. Soluble aggregates 
These are invisible particles to the naked eye and it is difficult to separate them 
from the protein formulation. 
B. Insoluble aggregates 
These are easily detectable, visible to the human eye and can be removed by 
filtering. The insoluble aggregates may be considered pathological in nature. 
This must not be confused with insolubility of the native state due to protein 
concentrations above the solubility limit (precipitating out). It must be realized 
that in many such cases of pathological aggregation the starting oligomer formed 
may be comprised of soluble aggregates, but become insoluble when they exceed 
a certain size. 
Both soluble and insoluble aggregates create problems in the development of a 
protein based biopharmaceutical. Consumption of such a formulation can 
stimulate immunogenic response which can prove fatal. Aggregation of insoluble 
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aggregates in general is considered irreversible under native-like environments. 
[25 - 27]. However, it does not mean that aggregation cannot be reversed. For 
example in vivo reversal of aggregated amyloids has been reported [25 - 30]. 
Several studies have shown that an addition of protein fragment could inhibit 
aggregation by disrupting specific interactions and that enhanced hydrophobicity 
of the interface of sub - structural components could amplify the drive for an 
aggregation. This has been best evidenced by the investigations conducted by 
Brems et ai., [40] on bovine growth hormone (BGH). On the basis of the nature 
of interactions between the monomers, aggregation is of two types: 
!: Irreversible aggregation 
This type of aggregation can occur due to covalent bond formation between 
multiple monomers of a given protein/polypeptide or due to simple protein-
protein interactions. Disulphide bond formation of free thiols is one of the most 
common pathways for the formation of covalent aggregates. Formation of 
bityrosine crosslinks due to the enzymatic oxidation of tyrosine residues is often 
believed to promote covalent aggregation in proteins. It has been proposed that in 
the presence of peroxidase and hydrogenperoxide at basic pH results in tyrosine 
is oxidized to form a tyrosyl radical cation which upon loss of proton forms 
neutral a radical [Figure 1.5]. Therefore, the formation of bityrosine is 
materialized by the oxidative phenolic coupling of two tyrosyl radicals followed 
by tautomerization [8, 12, 13, 14, 15,41,42]. 
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Figure 1.5 Representation of the sequence of steps involved in the form ation of 
bityrosine: oxidative phenolic coupling of two tyrosyl radicals coupling is succeeded by 
tautomerization [42,280] . 
b. Reversible aggregation 
This lUnd of aggregation takes place due to the weaker interactions such a 
hydrogen bonding, dipole-dipole and van der Waal interactions between the 
reacting monomer. However, the reversibility of the e protein aggregates could 
be influenced by the alteration in pH, salt concentration and concentration of 
protein it elf (explained in ection 1.2.4) [13,14,15,41] . 
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1.2.4 Factors influencing protein aggregation 
1.2.4.1 Solution pH 
Chapter 1 
The pH of the solution plays an important role in protein stability. Proteins have 
ability to retain their stability in solution only over a certain pH range, which is 
characteristic of a particular protein. Therefore, any change in the stable pH 
range may cause a protein to aggregate. It is because solution pH regulates the 
charge density and nature of charge (positive or negative) on the surface of the 
protein. Consequently, this affects the protein conformation and the nature of 
electrostatic (protein-protein; protein-water; protein-ion, and ion-water) 
interactions. Typically, at pH far distant from the isoelectric point (pI) of the 
protein, the fundamental electrostatic interactions that destabilize protein are 
nonspecific repulsions that emanate from the charged groups of hydrophilic 
amino acid residues on the external surface of a highly charged protein. In 
addition, any increase in the acidity or basicity of the solution builds up the 
number of charged groups on the surface of protein. Therefore, there occurs an 
increase in the charge repulsions within the protein which disrupts the folded 
protein conformation. The pH induced protein unfolding is facilitated due to an 
increase in the charge density on the folded protein (native) in order to attain a 
conformation of lower electrostatic free energy. Furthermore, specific charge 
interactions by way of ion pairing can also affect protein conformation [24, 31, 
43]. Other than the change in conformation; in case of proteins with anisotropic 
charge distribution on the protein surface, the charges on protein molecules also 
give rise to the attractive forces between neighbouring protein molecules stem 
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from dipole interactions which are formed as a result of electrostatic interactions 
between an acidic amino acid residue of one protein and basic amino acid residue 
of other. Such protein-protein interactions are highly attractive and result in 
energetically favourable aggregation. However, the dominance of attractive 
forces is opposed by the formation of repulsive electrostatic interaction forces 
between protein molecules; and also favours protein dissolution. The repulsive 
electrostatic forces are formed as a consequence of the movement of oppositely 
charged ions (present in buffer solution) towards charged amino acid residues 
situated on the surface of protein. 
1.2.4.2 Effect of salt 
The effect of the presence of an electrolyte (salt) on protein in solution is an 
intricate process to understand. It is because ions in solution can destabilize the 
physical structure by altering protein conformation; interfere with solubility (e.g., 
salting-in and salting-out) and influence the tendency of the proteins to form 
non-native aggregates. The ions released from salt in a solution bind to proteins 
by interacting with unpaired charged side. chains (hydrophilic amino acid 
residues) on the protein surface. The cross-linking of the hydrophilic amino-acid 
residues via multivalent ions stabilizes the native state of protein. However, in 
case of non-native state of protein, the salt ions initiate the destabilization of the 
protein by binding to peptide bonds which carry dipole moment which arises 
from partial positive charge on the amino group and partial negative charge on 
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the carbonyl oxygen. The electrostatic interactions (attraction and repulsion) 
between the charged species both within the protein and between protein 
molecules are regulated by electrolyte (salt) in the solution. The conformational 
stability is influenced by intra-molecular electrostatic interactions. On the other 
hand, solubility equilibrium and the rate of aggregate formation are governed by 
inter-protein electrostatic interactions. The ion-induced dipoles in water 
molecules at low concentration of salt shields surface charge, which reduces 
electrostatic (both intra and inter-protein) interactions by improving solvation. 
However, at high concentration of salt, in addition to charge-shielding effects, 
supplementary ions of the salt guard protein surface with multi-ion charges, 
which trigger decrease in thermodynamic stability of the native conformation 
besides rendering proteins lower degree of solubility in solution. The reason is 
layer of salt ions forms firm background on the surface of protein; all hydrophilic 
amino-acid residues on the protein's external surface become unavailable for 
interaction with water molecules [24, 31,43]. 
Therefore, available salt ions interact with water molecules, which increase the 
proportion of water molecules to solvate salt ions. Consequently, decrease in 
amount of free water molecules results in inter-protein interactions (between 
oppositely charged patches on the external surface of two proteins and 
hydrophobic interactions). The precise concentration causing in precipitation 
differs from protein to protein, consenting separation of different proteins at 
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different points. The resultant effect of salt on protein stability in solution is 
therefore multidimensional, as there are multiple ways by which salt ions interact 
with protein molecules which affect electrostatic interactions (intra - protein; 
inter - protein, protein - water; water - ion; ion - protein, ion - ion). 
1.2.4.3 Effect of temperature 
The biological functionls of protein is determined by its specific globular 
conformation which is thermodynamically stable and least energetic with free 
energy of the order of 5 - 20 kcaUmole. The free energy obligatory for the 
formation of the folded conformer is expedited by energy drawn from inter-
peptide interactions, hydrophobic interactions, hydrogen bonding, van der Waals 
forces and electrostatic forces (charge repulsion or ion pairing). However, the 
conformational entropy acts as a contradictory force to protein folding. With an 
increase in temperature, the thermal kinetic energy for activated protein 
molecules increases, therefore, the conformational entropy of the protein 
observes an increase in the degrees of freedom both on molecular level 
(translational, rotational, and vibrational degrees of freedom) as well as on the 
level of chain configuration. The change in temperature, pH, or salt 
concentration of the protein-solvent system can create alterations in the protein's 
native conformation, which in turn can initiate unfolding and destabilization of 
the structure of the protein. Generally, proteins experience thermal denaturation 
at temperatures slightly above their stability temperature. However, the 
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denaturation lead aggregation can initiate at temperatures well beneath the 
equilibrium melting temperature of the protein, which advocates for the 
aggregates that are not made from completely unfolded molecules but from 
partially unfolded protein species. The aggregation kinetics is strongly 
influenced by temeperature and rate of aggregation increases exponentially with 
temperature [24, 31, 43]. 
1.3 Lyophilization process 
General methods of drying of bio-pharmaceutical products (such as antibodies, 
proteins/peptides, hormones etc) always cause loss in their activity or some other 
damage, because such products are very delicate and heat sensitive. Therefore, 
an improved and more complex form of drying called lyophilization (freeze 
drying), is now widely employed, because it significantly minimises the extent 
of damage caused by general drying [12, 13, 14, 43]. Figure 1.6 shows a 
schematic phase diagram of lyophilization process. The process of removal of 
solvent directly from solution while in the frozen state is called is called 
lyophilization. However, this process can promote the inactivation of some 
proteins. However, this process can promote the inactivation of some proteins. 
Therefore, specific cryo - protectants in the form of carbohydrates (such as 
glucose and sucrose), proteins (such as albumin; and amino acids such as lysine, 
arginine or glutamic acid) are added to the specific product in order to minimise 
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such inactivation. Some alcohols and polyols have also been used as cryo-
protectants [L 2, 44] . 
p 
T 
Figure 1.6 Lyophilization: (blue arrow) brings the system around the triple point, 
in order to avoid the direction liquid - gas transition observed in case of general drying 
(green arrow). 
Lyophilization involves in two stages pnmary and secondary drying. The 
detailed description of the indicated stages is given in the following text. 
1.3.1 Primary drying 
This is initiated by placing the material in a freeze - drying flask and rotating the 
flask in a bath, called a hell freezer, which is cooled by mechanical 
refrigeration, dry ice, methanol or liquid nitrogen. In this step, it is important to 
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cool the material below its triple point, i.e; the lowest temperature at which the 
solid and liquid phases of the material can coexist. This ensures that sublimation 
rather than melting will occur during secondary stage of drying. Usually, the 
freezing temperatures are between - 50°C and - 80 0c. Ice crystal formation and 
their growth are promoted by a decrease in the temperature, as a consequence, 
the effective solute concentration of all solutes (protein and excipients) present in 
the solution phase increases. This increase in the effective solute concentration 
can speed up chemical reactions which could damage the protein. Moreover, due 
to the increase in effective protein concentration, the intimacy of protein 
molecules increases, which in turn promotes protein-protein interactions, and 
therefore aggregation. Further, reduction in temperature causes crystallization of 
solutes, and they are effectively removed from solution. Crystallization of 
individual buffer constituents at different ten:tperatures, may lead to change in pH 
values of the remaining solution, due to which aggregation can be induced [1, 11, 
13]. As the temperature is further lowered, the viscosity of unfrozen solution 
increases dramatically until molecular mobility effectively ceases. This unfrozen 
solution will contain protein as well as the excipients, and at most 50% water. As 
molecular mobility effectively ceases, chemical reactivity also ceases. The 
consistency of this 'solution' is that of a glass, and the temperature at which this 
is attained is called glass transition temperature (T g). For most protein solutions, 
T g values reside between - 40°C and - 60 0c. The primary objective of the initial 
stages of lyophilization usually is to decrease product temperature below the Tg 
as quickly as possible [1,11,13,45]. 
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1.3.2 Secondary drying 
The second step in the lyophilization process involves the application of a 
vacuum to the system usually at temperatures slightly in excess of 0 dc. This 
results in the sublimation of the crystalline water, leaving behind a powdered 
material. The removal of water from any bio-pharmaceutical product yields a 
powdered product, usually displaying low water content of the order of 3 % [11]. 
Lyophilization gives the opportunity to avoid denaturation caused by heating the 
product, by maintaining it frozen throughout drying. This is the most obvious 
advantage over liquid - phase drying. Moreover, liquid - phase drying triggers 
an undesirable shrinkage and concentration of active constituents which causes 
damages protein as well as a movement of these constituents to the surface of 
evaporation, where they form a dense, impermeable skin that inhibits drying, and 
later, rehydration. Lyophilization ensures greater reduction in the chemical 
biological-mediated inactivation of the biopharmaceutical and an improved shelf 
life of the product. Therefore, lyophilization is often considered to be a valuable 
tool for preserving many bio-pharmaceutical products [45]. Advantages of freeze 
drying are the minimum damage and loss of activity in proteins. Rapid and 
completeness of rehydration, leaves product porous and friable, and effectively 
cleans products. The main disadvantage of this technique is its high capital cost. 
It also usually takes long time, for example 24 hours per cycle. So far several 
studies have investigated the impact of lyophilization on the level of aggregation 
in other proteins and IgG [15, 43 - 60]. A brief introduction of these studies is 
given in the following sections: 
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1.4 Effect of the lyophilization on IgG and other proteins 
As mentioned earlier in the section 1.1, protein based formulations show an 
inherent propensity to form aggregates in solution, therefore, pharmaceutical 
industries often use dry powdered preparations for increased stability and shelf 
life. For this purpose, one of the most widely employed methods of drying is 
freeze drying (lyophilization). Mostly lyophilization of protein based 
formulations is accompanied by some level of structure collapse which may or 
may not be associated with activity loss. Several studies have investigated the 
impact of lyophilization on proteins such as ~ ~ - galactosidase, catalase [57], and 
lactate dehydrogenase (LDH) [15,58]. Studies have shown that ~ ~ - galactosidase 
(150 kDa monomer) loses most of its activity after lyophilization in the absence 
of lyoprotectants. This loss in activity has been assigned to partial unfolding 
followed by the formation of insoluble aggregates after lyophilization. Other 
proteins such as catalase retain 40 % activity after freezing, while after 
lyophillization only 13 % activity had been reported [15, 56, 58]. Some others 
have reported that catalase retains 80 % of its initial activity after freeze thawing, 
but only 30 % after lyophillization [15]. The partial dissociation of catalase into 
monomers and dimers during lyophilization has been found to be the likely 
reason of inactivity [15, 56, 58]. The loss in the activity of the lactate 
dehydrogenase has been seen to be concentration dependent and increase in its 
activity at higher concentrations after lyophilization had been found significantly 
greater than after freezing [15, 58]. However, the addition of a lyoprotectant has 
been shown to prevent inactivation of most of the studied proteins during and 
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after lyophilization [15, 57, 58]. It has also been observed that the recovery of the 
activity in all proteins follows the same pattern after lyophilization and appears 
to be concentration dependent [46, 59, 60, 61]. Similarly other proteins such as 
glutamate (GDH) in 20 mM potassium phosphate buffer have been found to 
retain 65 % of their activity after lyophilization [62]. Although, the recovery of 
protein activity varies with the nature of protein, the higher recovery had been 
reported at higher concentration. However, in the context of IgG, due to the 
availability of the limited literature published on its aggregation response to 
freeze drying, variation in the immunoglobulin concentration, buffer 
composition, added salts and specific freezing and drying (lyophilization) 
conditions makes the formulation of general conclusions regarding the relative 
impact of these variables on aggregate formation uncertain. Investigations of the 
effect of multiple cycles of lyophilization by different researchers have observed 
that IgG has a strong propensity to form insoluble aggregates (42 %) when 
dissolved in 0.05 M PBS and 0.5 N NaCI at neutral pH (42 %) [46,47]. 
Size exclusion chromatography (SEC) studies have shown that the multiple 
cycles of lyophilization of L6 mouse - human monoclonal IgG, antibody 
(dissolved in 0.5 M PBS and 0.5 N NaCl), promotes the formation of stable 
dimers (2.5 - 16 %) at the expense of monomers [48]. Studies have shown the 
formation of IgG dimers increases with buffer concentration during 
lyophilization. Moreover, the effect of concentration in the range of 1 - 10 
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mg/mL was reported not to have significant impact on the level of aggregation 
[49]. The decrease in monomers coupled with an increase in the formation of 
insoluble aggregates of IgG (at 1 mg/mL in 0.01 M PBS containing 0.22 N 
NaCl) after lyophilization and reconstitution, following both fast and slow 
cooling has also been reported [49]. Moreover, the addition of NaCI to a highly 
concentrated solution of IgG (50 mg/ml) results in the dissolution of larger 
aggregates into homogenous solution with particle size under 10 nm [41]. Rapid 
cooling of IgG dissolved in 0.05 M phosphate buffer and 0.5 N NaCI at pH 7 
during lyophilization has been reported to change the the average particle size of 
IgG from 400 nm (for slow cooling) to 1 !-tm. The reason for the difference in 
average particle size has not been explained [48]. It has also been reported that 
rapid cooling consistently results in higher levels of aggregates protein in a 
buffer containing 0.01 M PBS at pH = 7.1 with 0.22 N NaCI [49]. These studies 
suggested that rapid cooling could be detrimental to protein integrity. 
It has also been reported that the level of insoluble aggregate formation is 
directly related to the freezing rate over the range of 0.5 °C to 50 °C/min when 
human growth hormone was subjected to cooling after lyophilization [61]. 
Moreover, the biological activity of the proteins is lost because of freezing, due 
to partial unfolding or complete denaturation of proteins after adsorption to the 
ice surface, which results in aggregate formation upon reconstitution [50]. 
Scanning electron microscopy (SEM) studies showed that annealing after fast 
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freezing reduces the percentage of aggregates in the reconstituted solids from 32 
% to about 12 % [49]. These studies have also confirmed that denaturation of 
proteins becomes irreversible after lyophilization. 
The effect of concentration on the level of aggregation in solutions of IgG after 
lyophilization has also been studied. It has been reported that the aggregate level 
formed in human IgG after multiple cycles of lyophilization decreased with 
increasing IgG concentration until, at 50 mg/rnl IgG, no aggregation took place 
[47,61]. An increase in the protein concentration on the level of aggregation was 
also studied in other antibody formulations, for example an increase in the 
concentration of interleukulin-1 receptor antagonist from 1 to 100 mg/ml, 
diminished the level of aggregates from 50 % to 0.01 % [51]. The, cause of this 
decrease, however, was not explained. Although, from these studies, it is clear 
that an increase in the protein concentration reduced aggregation, some studies 
have also shown a 20 fold increase in concentration results in a 50% increase in 
the aggregation of IgG [52]. It has been also observed that higher protein 
concentration inhibits crystallization of buffer salts. This is due to an increase in 
intermolecular protein interactions at higher concentration; as a consequence, 
protein crystallizes, and occupies water (30 - 70 %) and/or buffer in its big 
cavities which are formed as a result of inter-protein interaction between two or 
more than monomers [52,61]. Most of the water remains disordered within the 
crystal). Moreover, it has also been reported that the quantity of aggregates in 
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IgG formulations decreased significantly with a concentration increase from 4 
mglml - 8 mg/ml [18, 53]. However, it has been also reported that pH changes 
during freezing do not appear to be a likely explanation for the concentration 
effect. 
Studies of the impact of buffer composition on the level of aggregation in IgG 
formulations have revealed that at constant buffer concentration, potassium salts 
(at 0.01 M) consistently result in a significantly lower level of aggregates relative 
to sodium phosphate (at 0.01 M). However, adding either NaCI (0.22 N) or KCl 
(0.22 N) results in increased aggregation compared to buffer alone. In addition; 
relative to buffer alone, the NaCl resulted in more aggregation than KCl at the 
same concentration (0.22 N) [49]. The reduced aggregation with KCl has been 
correlated to significantly lesser surface area of lyophilized solids from solutions 
compared to that of NaCI. The other reason behind increased stabilizing effect of 
KCI has been attributed tohigher stability of KCl glass which potentially 
increases the stability of proteins during the freezing stage of lyophillization 
[49]. 
Surfactants are commonly used in formulations to prevent protein adsorption to 
surfaces and to minimise interfacial denaturation by preferentially adsorbing to 
hydrophobic surfaces and to hydrophobic regions of proteins. The use of 
surfactant, either in the reconstitution medium or in the formulation has been 
found to significantly decrease, but not eliminate aggregation. For example the 
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incorporation of polysorbate in the reconstituted solution of interleukin-l 
receptor antagonist reduced the aggregate level by about 27 % [51]. 
The detection and quantification of IgG aggregates following lyophilization, for 
example using SEC (1 mg/mL of IgG in 0.01 M potassium phosphate buffer 
containing 0.22 N NaCl) [49] and DLS (1 mglml IgG in 100 mM phosphate pH 
7.2) [63] has confirmed the presence of monomeric and dimeric IgG species. 
This has been proved by comparing their hydrodynamic radii with calculated 
sizes of IgG (subunits or whole molecules) from the protein data bank [49]. DLS 
studies have shown that the hydrodynamic radius of IgG monomer ranges from 5 
nm - 6 nm and that of a dimer (9.75 nm - 11.38 nm) [49], whereas differential 
mobility analysis (DMA *) studies have shown particles 8 nm - 9 nm in size are 
monomers and particles lOnm-I1.6nm in size as dimers [52]. Moreover, DMA 
studies have also confirmed that the lengths of Fab and Fc, subunits as 8.9 nm 
and 7.7nm respectively. The width of each subunit confirmed by DMA studies is 
4nm [52]. The average size for Y shaped IgG molecule from protein data bank is 
7.3 nm (112 molecule), 9.3 nm (monomer; single molecule), 11.7 nm (dimer; 2 
molecules), 13.3 nm (trimer; 3 molecules), 14.4 (tetramer; 4 molecules), 15.2 
(pentamer; 5 molecules), 15.9 (hexamer; 6 molecules). This size range has also 
been reported and complimented in the previous studies on IgG aggregation [52]. 
[*DMA is a method for measuring low-order soluble protein aggregates in solution. Protein 
solutions are electrosprayed and different aerosolized populations are separated according to 
their electrophoretic mobility using a differential mobility analyzer. Particles in the size range of 
3nm-250nm can be separated]. 
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1.5 AFM for mapping IgG aggregation 
In this thesis, novel technique AFM wa employed for the characterization of 
IgG aggregation. Therefore, it became essential to shed some light on the 
relevant studies of IgG previously performed with AFM. It was the study of 
antibody/antigen interaction by AFM for example by Allen et al [64] and many 
others [65, 66] which stimulated the intere t of imaging of bio-molecules and 
their aggregation state. 
Figure 1.7 A tapping mode image (obtained in the attractive interaction regime) of 
everal antibodie having four distinct morphologie according to the orientation of 
domain with respect to the ub trate urface [67] . 
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High resolution imaging of antibodies with AFM in air and fluid is a challenge. 
However the tapping mode imaging in air has revealed the sub-molecular details 
of isolated IgG antibodies on flat surfaces such as mica [66]. It has been shown 
that by controlling the forces between tip and sample, sub molecular resolution 
of IgG can be obtained [66]. Tapping mode AFM images (obtained in the 
attractive interaction regime) of IgG antibodies incubated onto mica surfaces 
have confirmed that their three dimensional structure resembles a Y - shaped 
conformation [66] . The observed AFM image of an IgG sample dried onto mica 
substrate (concentration 1 Ilg/mL, 20 ilL) showed random orientations, because 
of the non-specific nature of adsorption of the antibodies on the surface of 
substrate a shown in Figure 1.7. Although antibodies were observed to have 
random orientation on the surface, four basic morphologies which were reported 
are pre ented in Table 1.1 
~ ~ Description of Morphology 
1 Single domain with a lateral size (longest axis) of - 18 nm 
2 Molecules with two roughly equivalent domains of - 10 nm acros 
3 Antibodie with two domains, one large ( - 11 nm) 
4 Some molecule with three roughly equivalent domains of - 8 nm across 
Table 1.1 Different morphologies of IgG domains and their dim ensions repor ted in 
AFM studies [66, 67] . 
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Feature with morphology type four had an overall morphology that resembles 
the characteristic Y -shaped conformation of the IgG antibody molecule. 
However, it ha been reported , that even though these four classe of orientation 
were dominant, variation in orientation from one molecule to the next were still 
apparent. The features A, B, and C in Figure 1.7 were reported to be three IgG 
molecules with flat orientation, where three 50 kDa subunit (2 Fab and Fe) were 
re olved. Two of the e molecules (A and B) consist of one subunit which was 
significantly higher than the other showing that they have subtle differences in 
orientation. These studies also revealed that the height of individual antibody 
subunits and ubunit separation varied from one molecule to another. The 
difference in the orientation of subunits with re pect to the substrate surface and 
with respect to each other wa proposed to be the most probable reason for the 
variation in ize. There i only a small variability from molecule to molecule due 
to flexibility in the hinge region connecting Fab with the Fc domain. Table 1.2 
and Table 1.3 re pectively present the confirmed average heights of Fab and Fc 
subunit and the average eparation between ubunit with a mea ured error of 
0.1 nm tudie [66 - 69] . 
Domains 
Fab t 
Fab2 
Fe 
Inter-subunit distance between two 25 kDa 
IgG sub - units 
A verage Heights 
1.56 nm 
1.36 nm 
I.40nm 
3.30 nm 
Table 1.2 Average heights of IgG domains measured by AFM [66.67.68] . 
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Domains 
Fabt and Fab2 
Fabt and Fe 
Fe 
A verage Separation 
7.30 run 
6.80 nm 
7.70 nm 
Chapter 1 
Table 1.3 Average separations between IgG domains measured by AFM [67] . 
This AFM based study therefore confirmed that mean separation between IgG 
subunit was around 7.56 nm which is comparable with X - ray crystallography 
measurement [67]. The possible reasons for small difference between AFM and 
X - ray data were attributed to the fact that the AFM measurements are made as 
2D projection and the X - ray as 3D [66] . 
1.6 Protein Therapeutics 
Insulin, Blood Factor (VIll, IX, vn, Protein C, Antithrombin), Erythropoietin, Interferons, 
Enzymes, Bovine Pancreatic Trypsin Inhibitor (AprotininIBPTI), Growth Harmones 
(Nutropin, Nutropin Depot and Protropin). Please visit chapter 7 for more details. 
1.7 Immunoglobulins (Antibodies) 
Immunoglobulin are glycoprotein molecule produced by plasma cells in 
respon e to an immunogen (antigen), and which function as antibodies. The 
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immunoglobulins derive their name from the binding, which makes them they 
migrate with globular proteins when an antibody containing serum is placed in 
an electrical field. Five classes of immunoglobulins have been characterised: 
IgM, IgO, IgA, IgD and IgE. Human IgO can be subdivided into IgO l , Ig02, 
Ig03, Ig04• Murine IgO can be subdivided into IgO l , Ig02a, Ig02b, and Ig03 [I, 
3,631 
1.7.1 Basic structure of Immunoglobulin G 
Immunoglobulins of all classes display a similar basic four-chain structure 
consisting of two identical light (L) chains and two heavy (H) chains. All IgOs 
are monomers. The subclasses differ in the number of disulphide bonds and 
length of the hinge region. IgOs are one class of immunoglobulins of about 150 
kDa in mass and consist of three subunits (two Fab and one Fc). Figure 1.8 
shows a schematic representation of an (lgO) molecule and the description of its 
different parts are as under: 
ill Heavy (Blue) and Light chains (Green) 
The heavy chains are almost twice the length and mass of light chains, being 
about 50 kDa, while the light chains are 25 kDa. Both chains fold locally into 
characteristic p - sandwich domains, with three strands on one side and four on 
the other. This motif is known as the immunoglobulin fold. The light chain has 
two of these domains and the heavy chain has four (i.e; 12 in total, each being 
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about 12.5 kDa). There are four folds or domains in each of the 50 kDa subunits. 
In the Fab subunits, the folds from the light and the heavy chains crossover each 
other to from two smaller subunits each of about 25 kDa mass. However, in the 
Fc subunit, only one of the e subunits is formed by crossover of two immuno -
VH 
VL 
Fab 
CL 
Fc 
Hinge 
region Subunits of 
(- 25 kDa) 
Disulphide bonds 
Immunoglobulin 
folds (- 25 kDa) 
Figure 1.8 The tertiary structure of IgG molecule. Each rectangle represents a 12.5 
kDa fold of an immunoglobulin . Blue and green rectangles respectively represent 
heavy and light polypeptide chains. Solid black lines indicate di-sulphide linkages 
between light and heavy chain . The overlapped folds form domains each - 25 kDa in 
molecular mass (Adapted from [67]). 
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immnoglobulin domains of the heavy chain, while· the two nearest to the hinge 
region remain separated. The overall structure is held together by disulphide 
linkages and non - covalent interactions [67, 70]. 
!ill Disulphide bonds 
Interchain disulphide bonds 
The heavy and light chains and the two heavy chains are held together by inter-
chain disulphide bonds and by non-covalent interactions. The number of inter-
chain disulphide bonds varies among different immunoglobulin molecules. 
Intrachain disulphide bonds 
Within each of the polypeptide chains there are also intra-chain disulphide 
bonds. 
(iii) Variable (V) and constant regions (e) 
In their native conformation each immunoglobulin is seen to be composed of 
discrete domain structures, stabilised by intra-chain disulphide linkages. Each 
domain contains approximately 110 aminoacid residues. Hand L chains contain 
both variable (V) and constant (C) domains. VL and VH contain 110 amino-acid 
residues each, but CL (110 aminoacids) and CH (330 - 440 aminoacids) differ in 
the number of aminoacid residues. The variable regions house the actual antigen 
binding site of the antibody. Variable regions of antibodies displaying different 
(antigen binding) specificities differ in amino acid sequence. Constant regions 
(within anyone antibody class/subclass) do not. Light chains contain one 
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variable (Vd and one constant (Cd domain. Heavy chains contain one variable 
(VH) and three constant (CHI. CH2 and CH3) domains. 
(iv) Hinge region 
This is the region at which the arms of the antibody molecule form the classic Y 
shape. The flexible hinge (H) region (in fact heavy chains display a short 
sequence joining CHI and CH2, which contains several proline residues). The 
flexibility of an antibody molecule results from this region. 
!!.l Oligosaccharides 
As mentioned earlier immunoglobulins are glycoproteins. Carbohydrates are 
attached to the CH2 domain in most immunoglobulins via an N - linked 
glycosidic bond. However, in some cases carbohydrates may also be attached at 
other positions. Elimination of the carbohydrate moiety has no influence upon 
antigen binding; however, it does disturb several antibody effector roles and 
modifies its serum half - life [67, 71]. 
1.7.2 Proteolytic cleavage of IgG 
Immunoglobulin molecules on treatment with proteolytic enzymes (such as 
papain) cleave at their hinge regions, yielding two separate antigen binding 
F(ab), and one constant (Fc) fragments. Each F(ab) fragment contains the light 
chain and the VH and CHI domains of the heavy chain. However, 
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immunoglobulin incubation with other proteases (e.g; pepsin) results in antibody 
fragmentation immediately below the hinge region. This leaves intact two inter-
chain disulphide linkages towards the C - terminus of the hinge region. This 
holds the two antigen binding fragments together. The products of this 
fragmentation are donated F (ab,)2 and Fc. 
ill F(ab) fragments 
The F(ab) fragments are termed because they contain the antigen binding sites of 
the antibody. Each F(ab) fragment is monovalent, and hence the IgG is divalent. 
The antigen binding site of the antibody is created by both the V H and V L. An 
antibody is able to bind a particular antigenic determinant because it has a 
particular combination of V H and V L. Different combinations of V H and V L result 
in antibodies and can bind different antigenic determinants. The F(ab) subunits 
are identical in sequence to each other, giving symmetry to the molecule. 
!ill Fe fragment 
Digestion with papain also produces a fragment that contains the remainder of 
the two heavy chains CH2 and CH3 domain. This fragment was called Fc because 
it was easily crystallized. The effector functions are mediated by this part of the 
immunoglobulin molecule. Different functions are mediated by the different 
domains in this fragment. 
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(iii) F(ab,)2 
F (ab,)2 because of its bivalent nature retains the ability to precipitate antigen in 
vitro. The Fc region of the molecule is digested into small peptides by pepsin. 
The F (ab,)2 can bind an antigen, but it does not mediate the effector roles of the 
whole antibodies [67,71]. 
1.7.3 Structure of the variable region 
The variability of the amino-acid sequence in the variable domains of the 
antibody is responsible for generating the antigen binding sites. The comparisons 
of the amino - acid sequences of the variable regions of the immunoglobulin 
show that most of the variability resides in three regions called hyper-variable 
regions or the complementarity determining regions (CDRs). CDR's are found in 
both the H and the L chains [70]. 
1.7.4 The iso - electric point (pI) of IgG 
Monoclonal antibodies such as IgG have no unique isoelectric point. The 
antibodies have variable regions which contain charged residues. It has been 
reported IgG molecules have an isolectric point varying from 4.35 to 9.95 
between pH 7 and 9.95, and are most basic isotype of the immunoglobulin [72, 
73]. The average pI values of different types of IgG with standard deviations are 
presented in Table 1.4. 
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. ~ ~ Average (pI) SD 
IgG l 7 -9.5 0.4 
IgG2 7 -9.5 0.6 
IgG3 8 - 9.0 0.8 
IgG4 5.5 -6.0 0.8 
Table 1.4 Average p(l) values reported for various IgGs 
1. 7.5 Crystallographic structure of IgG 
X-ray crystallographic studies have confirmed the three dimensional structure of 
human IgG, with average distances of almost 6.6 nm between Fc - F(ab)\, Fc -
F(abh = 9.2 nm, F(ab) \ - F(abh = 7.5 nm. Moreover, the resolution of the x- ray 
derived structure is around 2.7 A. [74]. 
1.7.6 Extinction co-efficient of IgG 
It has been shown that most mammalian antibodies (IgG) have protein 
extinction coefficient in the range of 12 - 15. For a typical IgG with a molecular 
weight = 150 kDa, this value corresponds to a molar extinction coefficient (€:) 
equal to 210,000 M-l cm-I [75, 76] . 
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1.8 Conventional particle size characterization techniques 
The characterization of protein aggregates has been investigated by using 
conventional analytical techniques such as analytical ultracentrifugation (AVC) 
[77] , field flow fractionation (FFF) [78] , size exclusion chromatography (SEC) 
[79, 80], static and dynamic light cattering (SLS and DLS) [81] . Each of these 
techniques has certain merits and problems which are described in Table 1.5. To 
a lesser extent atomic force microscopy (AFM) been employed to characterise 
aggregates in protein ba ed bio-pharmaceutical formulations such as IgG [67,82, 
83,84] . 
Method Merits 
Quantifiable, potential for 
measuring aggregate distributions 
AVC in formulation buffer, no matrix 
interactions 
Widely used in biotech industry, 
SEC Fast ( < 1 h) 
Fast ( < 1 h), high sensitivity for 
DLS large aggregate distributions in 
formulation buffer, no 
matrix interactions 
Demerits 
Slow (- day) obtaining aggregate size 
distributions requires fitting of the 
sedimentation proftles 
Interactions with matrix can alter the 
aggregate distributions, complicate 
quantitation and sizing, mobile phase 
usually different from formulation 
buffer 
Difficult to resolve small aggregates, 
from monomer obtaining size distribution 
requires fitting of correlation, highly 
concentrated solution leads to loss of 
scattering intensity 
Table 1.5 Comparative out-look of conventional techniques. 
A brief introduction of AVC and SEC is given in the following section 
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1.8.1 Analytical ultra-centrifugation (AVC) 
Ave was developed by Svedberg III the 1920's, and is used for the 
characterisation of purified proteins III dilute solutions and has played a 
significant role in understanding of the colloidal systems, especially 
macromolecular systems [85]. AVe consists of the application of a centrifugal 
force with the simultaneous real-time observation of the resulting redistribution 
of the macromolecule. AVe uses a conventional ultracentrifuge equipped with 
an optical system for the observation of the protein redistribution in real time 
during the centrifugation. Analytical rotors take in 10 - 400 fAL of sample 
between windows that are optically transparent and perpendicular to the plane of 
rotation. The optical detection system is synchronised with the rotor revolution, 
such that data are acquired only when the sample is in the path of the light as 
shown in Figure 1.9. 
Light source ) 
Sample 
I 
Movable Imaging System ~ : :
I 
I 
I 
I 
Detector ) 
Figure 1.9 Schematics of a typical analytical ultracentrifugation technique [85] . 
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The optical detection system usually dual beam VV spectrophotometer equipped 
with a mono-chromator and a highly sensitive interferometer records the 
refractive index gradients. For the study of protein interactions, proteins 
complexes which sediment faster in solution, are transported through the 
solution, as a consequence of this reversibly formed complexes that dissociate 
can readily re-associate during the experiment [63, 86]. Thus, permitting hydro-
dynamic and thermodynamic characterisation of even the weak and transient 
interactions. AVC of non-interacting proteins can reveal the gross shape, molar 
mass and the heterogeneity of the sample. The heterogeneity of the sample 
includes even the detection of traces of oligomers and aggregates, which can be 
of interest for pharmaceutical, biotechnological and bio-sensor applications. The 
sedimentation process is governed by three factors: the gravitational force, the 
buoyancy and the hydrodynamic friction. These three forces help us in deriving 
Svedberg equation given below: 
S = M (1- V ~ ) / R T T
D 
1.2 
where M is molar protein mass, R - gas constant, p - density. 
The amount of the material used is typically of the order of few 100 ~ g . . Typical 
concentrations used are 0.5 - 1 mg/ml at a detection wavelength 280 nm. 
Concentration gradients are established during centrifugation, a 10 - 1000 fold 
increase in concentration is observed in a single cell. Interacting components 
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may have size ranging from peptides to very large macro-protein complexes. In 
general, affinities in the range of 104 - 108 M-1 can be determined and kinetic 
dissociation rate constants of the order of - 10-5 - 10-2 can be distinguished [17, 
87]. 
1.8.2 Size exclusion chromatography (SEC) 
SEC is also called gel filtration chromatography and is widely used for the 
characterisation and purification of biological polymers such as proteins, 
carbohydrates, and nucleic acids in solution based on their size (hydrodynamic 
volume) [86, 88]. High- performance SEC is a simple method for molecular 
mass estimation and is therefore widely employed for the characterisation of 
biopolymers [89]. In this technique, an apparatus called a size exclusion column 
consists of a hollow tube packed with minute beads designed to have pores of 
variable size (Figure 1.10). 
This technique uses beads (porous particles) to separate molecules of different 
sizes, and determines their molecular weights and molecular weight distributions. 
Molecules that are smaller than the pore size can enter the beads and therefore, 
have a longer path and longer transit time than larger molecules/aggregates that 
cannot enter beads. Particles larger than the pore size cannot enter the pores and 
elute together as the first peak in the chromatogram. This condition is called total 
exclusion. Molecules that can enter pores will have an average retention time in 
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beads that depends on the molecular size and shape. Different molecules 
therefore, have different total transit/retention times through the size exclusion 
column. This portion of a chromatogram constitutes the selective permeation 
region. Molecules that are smaller than pore size can enter all pores, and have the 
longest residence time on the column and elute together as the last peak in the 
chromatogram. This last peak in the chromatogram determines the total 
permeation limit. 
Porous 
particles 
Small 
molecule 
Large 
molecule 
Column 
Figure 1.10 Schematic of a size - exclusion chromatography column. 
One of the limitations of this technique is that it does not measure mass or 
hydrodynamic volume of particles in solution, because it is not able to determine 
how much space a particular molecule takes up when it is in solution. Use of this 
52 
Mudasir Ahmad Lone Chapter 1 
technique, however, derives from an exact relationship between hydrodynamic 
radius and molecular mass which could be employed for all polymers. This 
method also suffers from a few restrictions that prevent correct estimation of 
molecular mass. Retention difference is caused by different diffusivities of the 
proteins into pores, besides electrostatic interaction and hydrophobic interaction 
with the matrix, which may give rise to aberrant retention. In addition, SEC may 
influence aggregate composition, since aggregation is highly concentration 
dependent. All of these, factors could affect the accuracy of the calculated 
molecular mass [88]. 
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1.9 Aims and Objectives 
As described in the introduction, in liquid state biopharmaceuticals, the 
complete/partial loss in activity and a reduced shelf life are the potential 
consequences of protein aggregation. Loss in protein activity is possibly induced 
due to the subtle or massive changes in the protein environment such as changes 
in pH, temperature, and ionic strength. Therefore, there is a growing demand to 
find an effective formulation strategy which would enable us to better predict or 
overcome the problem of aggregation. 
Presently, in order to avoid the potential consequences of aggregation in solution, 
pharmaceutical companies often prepare powdered (dry) preparations, and 
lyophilization is one of the most widely employed methods for this purpose. 
Although, lyophilization is considered to be a viable option for the manufacture 
of dry protein formulations, it is still not the best option for completely stopping 
aggregation, because formation of insoluble aggregates and loss of monomers 
has been reported in many protein solutions, reconstituted from their respective 
lyophilized powders. The detection limit for some of the conventionally used 
techniques for aggregate detection lies within the micrometer range and 
therefore, they can fail to detect much finer structures such as fragments, and 
monomers etc. So far the effect of lyophilization in minimising aggregation in 
biopharmaceutical formulations including IgG, using conventional techniques 
has been found to be dependent on the nature of protein itself and the precise 
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lyophilization conditions employed. Very little work has been done to investigate 
the effect of multiple cycles on proteins such as IgO using novel techniques such 
as AFM, whose detection limits are much more penetrative (can detect - 1 nm) 
and can therefore, account for much interested species such as fragments and 
monomers in more detail. 
The main aim of this study was to explore the effects of the process of 
lyophilization on the fundamental characteristics required of any protein (such as 
IgO) from therapeutic considerations. Our idea was to test the inherent ability of 
IgO to resist aggregation (due to change/s in its native state), when exposed to 
multiple cycles of lyophilization. Both conventional and novel analytical 
methods were employed to map the effects of the lyophilization process, number 
of cycles of lyohilization, sugar-protein concentration, temperature and humidity 
(in absence and presence of lyoprotectants) on therapeutically significant 
parameters of IgO such as particle size, secondary structure, thermal stability, 
morphology, porositylflakiness and antigen binding activity. Size analysis was 
performed using both conventional and new particle characterisation techniques 
(DLS), such as Nanosight (single particle tracking based upon light scattering) 
[90] and AFM. Results from Nanosight, DLS and AFM experiments were useful 
for comparative analysis. Scanning electron microscopy (SEM) [91] and AFM 
were employed for morphological studies; ATR-Infrared spectroscopy [92] and 
differential scanning calorimetry (DSC) [93] were used for the investigation of 
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secondary structure and thermal stability respectively. The activity determination 
was carried with enzyme linked immunosorbant assay (ELISA) [94]. Therefore, 
an attempt was made to identify critical formulation and processing variables 
affecting aggregation of IgG during multiple cycles of lyophilization. The 
parameters examined were, the effect of IgG concentration, the number of cycles 
of lyophilization, particle size, secondary structure, thermal stability, 
morphology, antigen binding activity, and effect of lyoprotectants (sucrose and 
mannitol) alone and in combination. Preliminary studies focused on the particle 
size characterization of ferritin and pure polyclonal IgG molecules. 
The new hypothesis is presented to explain the significance of nanoscale 
investigation and other major factors that need to be optimized for the 
therapeutic stability and efficiency of protein based biopharmaceuticals such as 
IgG during lyophilization. It has been proposed that upon exposure to multiple 
cycles of lyophilization, an IgG antibody forms a range of aggregates of variable 
size, both in absence and presence of lyoprotectants. The propensity of IgG 
molecules to aggregate is associated with decrease in the proportion of 
monomers and growth of crystalline material besides decline in the 
porositylflakiness, alterations in the secondary structure, reduced binding 
activity, and dip in the thermal unfolding resistance. The formation of different 
crystalline structures at nanoscale reveals a strong connection between 
aggregation and alterations in the secondary structure. IgG lyophilized with 
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sucrose (when used separately) and in combination (with mannitol), prove 
beneficial in maintaining the required therapeutic characteristics of an IgG 
antibody during multiple cycles of lyophilization. This hypothesis is based upon 
the size measurement results of the aggregates determined by complimentary 
techniques. Moreoever, the proposed hypothesis finds more strength from the 
other analyses such as as the study of morphology, spectroscopic, thermal 
stability and binding activity of the lyophilized formulations of IgG. 
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Chapter 2 
Materials and methods for sample 
preparation; Conventional and 
unconventional techniques 
employed for characterization 
2 Materials and Methods 
1bis chapter summarises the methods and materials used in the preparation and 
lyophilization of protein formulations and their characterization using a range of 
analytical techniques. 
2.1 Materials 
The batch numbers of all the materials which were used in this work are listed in 
Appendix 1. All proteins used in this study were supplied as lyophilized 
powders: - Ferritin (horse spleen ferritin in o. 15 M NaCl), IgG (anti - glucose -
6 - phopshate dehydrogenase (G - 6 - PDH) antibody produced in rabbit (IgG 
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fraction of antiserum in 0.01 M PBS); and (glucose-6-phosphate dehydrogenase 
from baker's yeast (S. cerevisiae). The resconstitution of lyophilized protein 
powders was performed in filtered water to desired stock concentrations. D -
sucrose (99 %); D - mannitol (98 %); D - sorbitol (98 %) were obtained from 
Sigma Aldrich. Secondary antibody (HRP - linked anti - Rabit IgO) was 
supplied by Bioscience UK Ltd. 0 - (+) - trehalose dehydrate (99.5 %) was 
obtained from Fluka. The phosphate buffered saline (PBS) tablets; bovine serum 
albumin (BSA) ELISA block; TWEEN 20 washing solution; 6. 3, 3', 5, 5'-
tetramethylbenzidine (TMB) liquid substrate system were all supplied by Sigma 
Aldrich. 
Two types of silicon nitride AFM cantilevers used, termed -'DNP-S' and 'SNL', 
were both obtained from Nanoprobes (BrukerNano) CA. Phosphorous doped Si 
(RTESPA) cantilevers with nominal spring constant of 20 - 80 N/m were used 
for AFM imaging of lyophilized powders. All cantilevers were rinsed with 
de ionised water and dried in a stream of nitrogen prior to imaging. Mica (0 250 
- 1, 3"x 1") was obtained from Agar Scientific. Sterile 0.2 !!m Ministart filters 
from Anachem were employed for the filtration of deionised water and PBS 
solution. Nitrile gloves were worn at all times in order to avoid contamination. 
Double sided adhesive tape was used to stick clean mica to magnetic sample 
stubs, their surfaces following cleaving to expose a fresh surface were then 
incubated with a 10 - 20 III of sample solution prior to imaging with AFM in 
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liquid. Polypropylene plates (Immuno 96 MicroWeUTM) were obtained from 
Sigma for the determination of activity with ELISA experiments. Specimen 
supports for SEM (12.5 mm aluminum pin stubs; Agar Scientific, cat. no. 0301) 
covered with black carbon discs were gold coated for imaging with SEM; T A 
hermetic lids and pans for DSC experiments and clean glass slides were used in 
ATR-FfIR experiments. 
2.2 Preparation of protein stock solution 
2.2.1 Ferritin stock solution 
10 !-ll aliquots of ferritin solution (50 mg/ml in 0.15 M NaCl) were diluted with 
filtered deionised water to a concentration of 0.1 ng/ml. This was stored in five 1 
ml aliquots in a refrigerator to be used for the preparation of samples for 
conducting AFM imaging experiments. 
2.2.2 IgG stock solution 
For the preparation of the IgO stock solution, 200 ml of 0.01 M PBS solution 
was prepared by dissolving one PBS tablet in deionised water. The O.OIM PBS 
solution was then filtered through sterile 0.2 !-lm filters from Anachem. The 
lyophilized powder of IgO (0 - 6 - PDH) antibody was first reconstituted in 2 
ml of filtered deionised water to give 2 ml in PBS as per manufacturer's 
instructions. This resulted in approximately 2 ml solution of IgO with a 
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concentration of 90 mg/ml in PBS. Thi wa followed by diluting the 2 ml 
solution of IgG (concentration 90 mglml) to a concentration of 2 mg/ml by 
adding 88 ml of filtered 0.01 M PBS by applying the equation: 
2.1 
Thi proce resulted in 90 rnl of 2 mg/ml olution of IgG, which was then 
ub equently to red in a number of aliquot. The detai ls of volumetric 
breakdown into aliquot are given in Table 2.1 
Serial Number of Volume in Total 
No. aliquots each aliquot volume 
1. 50 Iml 50 rnl 
2. 51 0.5 m! 25.5 rnl 
3. 50 0.2m! 10 ml 
4. 50 0.1 mJ 4rnl 
5. 50 0.01 rnl 0.5 mJ 
Table 2.1 The breakdown of IgG protein solution obtained after reconstitution into 
diffe rent volume aJiquots. 
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2.3 Concentration determination 
The protein concentration of IgG solution was determined by UV absorption at 
280 nm u ing a molar extinction co - efficient (MEC) of 210,000 M-I em-I. This 
value of MEC i typical for an IgG with molecular weight equivalent to 150000 
Dalton . UV ab orption wa performed at 0.5 mg/mI, 0.6 mg/mI, 0 .7 mg/mI, 0.8 
mg/ml, 1 mg/mI, 1.5 mg/ml and 2 mg/mI using UV photo spectrometer. UV 
ab orbance plot of the indicated concentrations is shown in Figure 2.1. 
0.3 Colorimetric Assay 
0.25 
cu 0.2 u 
c: 
~ ~
0.15 ~ ~
1-0 
0 
r.Il 
~ ~
< 
0.1 1 
0.05 y = 0.1026x + 0.041 
0 I 
0 0.4 0.8 1.2 1.6 2 
Concentration (mg/ml) 
Figure 2.1 UV absorption plot for a range of concentrations of IgG, which 
were recorded at 280 nm. 
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2.4 Storage of liquid protein solutions 
The long tenn storage of liquid IgG protein stock solutions filled in various aliquots 
was ensured by freezing at - 4 0c. However, the lyophilized powdered fonnulations 
of IgG (in glass vials) were stored in a desiccator at room temperature in order to 
make sure that the fonnulations were moisture free. 
2.5 Lyophilizer and lyophilization of samples 
A typical Modulyo Lyophilizer [S.W. Jennings and Company Ltd, Scientech 
House, East Bridgford, Nottingham, UK] with Edwards Pump (Crawley, West 
Sussex, UK) as shown in Figure 2.2, was employed for the lyophilization process. 
Lyophilization was accomplished in two steps as is typical. In the fIrst step. the freezing of 
all the protein formulations was performed in liquid nitrogen (for I - 2 minutes, 
freezing temperature - - 50 to - 80°C). In the second step, the application of a 
vacuum to the frozen protein formulations at a temperature slightly in excess of 0 
°C was applied. This resulted in the sublimation of the crystalline water, leaving 
behind a powdered protein material. The removal of water from a bio-
pharmaceutical product yields a powdered product. usually displaying low water 
content on the order of 3 %. This temperature was held for 8 - 12 hours at a 
pressure of 60 mT. 
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Figure 2.2 Image of an Edwards's lyophilizer, type Modulyo K4 equipped with 
vacuum chamber. Technical specification : 220 V. 50 Hz. Temperature range - 50 °c 
up to ambient. 
2.5.1 Lyophilization of ferritin samples 
Two (0.5 ml and 1 ml) aliquots of ferritin solution (0.1 ng/ml in 0.15 M NaCl) 
were eparately poured into two clean gla s vials with the help of pipette and 
then the vial covered with parafilm. The vials were first frozen in liquid 
nitrogen for a couple of minutes. The parafilm covering the mouth of glass vials 
wa perforated with a clean needle 0 that all the moisture would be removed 
during lyophilization (vacuum drying) . The pre-lyophilized ferritin samples were 
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then mounted in the lyophiliser, and left to dry at a suction pressure of 0.1 mbar 
at a temperature of 25°C for 8 - 12 hours. This resulted in the formation of 
powdered ferritin which was then reconstituted in filtered deionised water prior 
to AFM imaging. 
2.5.2 Lyophilization of IgG samples 
Seven aliquots of JgG solution were stored in a freezer (0.5 ml each, 
concentration 2 mg/ml each) were allowed to defrost for 10 - 15 minutes before 
use. From aliquots, the solutions were poured into clean glass vials with the help 
of a pipette. The vials were then covered with parafilm. The vials were then 
frozen in liquid nitrogen as above, and subjected to the lyophilization process as 
described in section 2.5.1. However, in the case of JgG, after the end of the first 
cycle, one sample was taken out and stored in a fridge as shown in Figure 2.3. 
The remaining six samples were reconstituted in filtered water and then again 
subjected to the lyophilization process as above. After the end of the second 
cycle, another sample was taken out and stored in a fridge. The remaining five 
samples which had been lyophilised twice were reconstituted in 0.5 ml of filtered 
water again as in the step 2. The same procedure (take one out after each cycle, 
reconstitute rest in filtered water and lyophilise rest) was adopted in steps 3, 4, 5, 
6, and 7, so that after the end of each cycle of lyophilization process. In this 
way, as shown in Figure 2.3, seven samples of IgG exposed to 1,2,3,4,5,6, and 
7 cycles of lyophilization were prepared. 
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~ ~ Cycle 3; No. of vials left = 5 
~ ~ Cycle 4; No. of ials left = 4 
~ ~ Cycle 5; No. of vial lef1 = 3 
Chapter 2 
After Cycle I 
• One vial taken out 
for storage 
After Cycle 2 
One vial taken out 
for storage 
After Cycle 3 
One vial taken out 
for storage 
After Cycle 4 
One vial taken out 
for to rage 
After Cycle 5 
One vial taken out 
for storage 
After ycle 6 
One vial taken oul 
for storage 
After Cycle 7 
One vial taken out 
for torage 
• 
• 
• 
• 
• 
• 
Figure 2.3 chematic overview of the methodology adopted during the mUltiple 
cycle (even) of lyophilization of IgG. After the end of each cycle one ample is taken 
out for torage and re tare recon tituted and expo ed to next cycle and 0 on. 
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2.6 Techniques employed for the investigation of protein 
aggregation 
As described in Chapter 1, the therapeutic efficacy/viability/potential of an 
antibody formulation is determined on the basis of various parameters/attributes 
such as particle size, shape, morphology, amorphicity, activity, structural and 
thermal stability [67]. Each specific attribute mentioned was investigated by 
more than one analytical technique. The following text provides a basic 
description of the techniques employed in this work. 
2.6.1 Atomic Force Microscopy (AFM) 
The atomic force microscopy technique allows mapping of the surface 
characteristics in three dimensional images with nanoscale resolution. AFM has 
the ability to provide both qualitative and quantitative information on 
nanomechanical and other fundamental properties of the sample surfaces such as 
particle size, surface texture, morphology, roughness, interfacial forces, 
adhesive forceslligand-receptor interactions, with theoretical force sensitivity of 
10- 15 N [17, 95]. This technique was invented by the Binnig, Quate and Gerber 
in 1986 in order to overcome the sample type limitations of the scanning 
tunnelling microscope (STM) in imaging nonconductive samples [17,96]. 
However, the possibility of modifying the surface, manipulating individual 
molecules, and single molecule force measurement has made AFM an ideal tool 
for biological applications [97]. One important advantage of this technique is the 
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Figure 2.4 Schematic overview of the working of an AFM instrument showing a 
beam bounce reflection method of detection using a laser and an appropriately 
positioned sensitive photo detector. Interaction between the atoms of the AFM tip and 
sample urface produce deflection in the cantilever and are monitored by a detector 
(u ing feedback electronics) to generate the map of the urface characteristics in the 
form of images. IBM NANO i a typical AFM image howing oxide line of about 20 
nm wide silicon dioxide pattern on a silicon wafer [98] . 
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often simple and rapid sample preparation that can be employed. Another 
important feature of AFM is the ability to conduct measurements on samples 
under a variety of environment, including ambient and near-physiological 
conditions [99]. It has been widely used to image biomolecules such as proteins, 
membranes, nucleic acids. Figure 2.4 demonstrates a schematic overview of the 
working and basic concept of an AFM technique. 
The fundamental principle of AFM is that it measures forces between a sharp tip 
« 10 nm in radius) attached to the free end of a flexible cantilever onto which a 
laser beam is focused and the sample surface as revealed in Figure 2.4 [100, 
101]. 
The vertical and lateral motion of the sample with respect to cantilever is 
achieved by a piezo-cerarnic stage holding the sample. The vertical motion of the 
cantilever is controlled by piezoelectric actuators affording sub-nanometer 
resolution [97,102]. The piezo-ceramic stage has the property to expand or 
contract in the presence of voltage gradient. By rastering the tip in the x - y 
direction over the surface of a sample, forces (attractive or repulsive) resulting 
from the interactions between the tip and the surface cause bending (positive or 
negative) of the cantilever can be monitored. This bending is typically detected 
by the deflection (At) produced in the laser reflected from the back of cantilever 
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and is directly proportional to the force (F) acting on the tip in accordance with 
the Hooke's Law:-
F = - klJx 2.2 
where k is spring constant of the cantilever, 
~ ~ is the deflection produced in the cantilever. 
If the spring constant of the cantilever (typically - 0.1 - 1 N/m) is less than 
surface the cantilever bends and the deflection is monitored. Finally, the 
deflection produced in the laser is collected by a photodiode for image 
generation [103]. The deflection produced in the laser as a consequence of 
cantilever bending as demonstrated in Figure 2.5 which shows a force-distance 
profile of an interaction between AFM probe and sample surface in greater 
detail. The AFM probe sample interaction curve demonstrates an approach cycle 
and a retract cycle [104]. The approach cycle (O*CA) initiates at the free level 
region (0*) where no deflection is produced in the signal, as no forces act on the 
probe because probe is at a detachment from the surface. This stage is manifested 
by green line (O*C) of the curve, in Figure 2.5. 
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Figure 2.5 Schematic of force as a function of AFM probe-sample interaction. 
The short dip (blue) in the same curve corresponds to an attractive jump to 
contact the surface. As the probe approaches the surface, the attractive forces 
begin to operate on the probe and just at a particular distance; the strength of 
attractive forces conquer the tiffness of the cantilever and the probe hops (C) in 
contact with urface. The purple line (CA) of the curve communicates to the 
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probe being pushed onto the surface of the substrate awaiting a set loading force 
is attained. The amount of this loading force is given by the difference in 
deflections produced in the signal from the free level (O*C) to the contact region 
of approach cycle (CA). The point (A) denotes the finishing of an approach cycle 
and the commencement of the retract cycle (ADO*). The adhesion force 
commences to act between probe and the sample surface and bend cantilever in 
the opposite direction. This stage is demonstrated by region (AC*) of the retract 
cycle. During the retract cycle way, the elastic forces within the cantilever kick 
off, and at a specific bending (D), the elastic forces within the cantilever surpass 
the probe-sample adhesion force (Fadh ) and split probe away from the surface 
(DE). Later, the additional pull out of the piezo from the surface brings the 
cantilever back to the original position or free level (EO*). Hooke's Law 
described in the earlier text can be employed to work out adhesion force (Fadh) 
from the displacement region (DE = OB). The area under the loop (CC*DE) 
gives the energy of the adhesion (ElIdh). 
2.6.1.1 Strength and weakness of measuring particle size with AFM 
Strengths: 
(a) AFM can characterize size of the particles in a wide variety of environments 
including an ambient and near physiological conditions. (b) Single 
molecules/individual particles and groups of particles can be resolved with AFM. 
Physical properties for each particle within a set of particles can be examined to 
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generate a statistical distribution for the entire set of particles. (c) The diameter 
of the particle in the x - y plane determines the particle diameter with 
SEM.However, with AFM over other techniques such as SEM, is the maximum 
height of the particle that defines particle size and is independent of tip diameter, 
because the laser bearp/probe quality does not influence particle height 
measurement. Moreover, with AFM, size information for individual particles can 
be measured in terms of (length, width, height and volume). (d) AFM has the 
ability to characterize particle size in height from 1 nm to 5 !lm and in two 
dimensions can scan up to 80 !lm x 80 !lm. (e) The statistical significance of the 
data generated from ensemble particle size characterization techniques, has 
always been a point of concern. However, in case of AFM, it is easy to achieve 
superior statistical significance by combining data from several scans to acquire 
information on the larger population of particles. (f) AFM image analysis and 
data processing permits to measure statistics on groups of particles. Mass 
distribution can be worked out with information of the density of material. 
Weakness and limits of resolution: 
(a) AFM takes more time in scanning a sample surface compared to SEM. (b) 
The particle size characterization with AFM is predominantly limited by probe 
geometry. Generally, AFM instruments enjoy horizontal (X-Y) resolution of 
around 1 nm. However, the diameter of tip employed for scanning limits the 
horizontal resolution (X-Y-axis). On the other hand, the vertical resolution (less 
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than 0.1 nm) along Z-axis is limited by the vibration environment of the 
instrument (such as noise associated with floor, thermal noise etc). 
2.6.1.2 AFM imaging modes 
AFM operates in three basic data acquisition modes: 
(i) Contact mode (static) 
In this mode, the AFM tip is allowed to continuously contact the surface and 
hence the tip-sample interaction is dominated by short range repulsive forces. 
This mode provides the highest possible resolution but can be difficult to use on 
soft samples which can deform under the load applied by the AFM probe or may 
be damaged by the lateral forces generated during scanning. This mode is 
typically operated in a constant force setting whereby the cantilever deflection is 
maintained at a constant value by adjusting the height of the sample in response 
to any changes in the measured force [97, 105]. 
(ii) Non-contact mode 
Non-contact mode minimizes tip-sample interaction, as the tip-sample separation 
of (0.5 - 2 nm) 'ensures a reduced interaction of the tip and sample within the 
longer range attractive force region [67, 105, 106]. The attractive forces from the 
sample are substantially weaker than the forces used by contact mode. 
Considering the fact that very small forces (attractive Van der Waals forces) are 
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acting between the tip and sample surface, a small oscillation is given to the tip 
in order to ensure the detection of these small forces for the collection of images. 
This mode involves the use of a silicon probe having a high spring constant of 
the order of 20 - 100 N/m, so that it does not stick to the sample surface at lower 
amplitudes. The limitation of non-contact mode is that it produces images with 
lower spatial resolution due to reduced force gradient that is being sampled. In 
addition because of contaminant layers in ambient environments can interfere 
with the oscillation it typically requires operation in ultra-high vacuum for better 
resolution [97,105]. 
(iii) Dynamic mode (Tapping mode) 
Dynamic AFM mode, also known as tapping mode (TM) AFM, was developed 
to improve lateral resolution and minimise sample distortion or damage, because 
it eliminates a large part of the permanent shearing forces experienced in contact 
mode [44, 45]. In tapping mode AFM (an amplitude modulation technique) the 
tip intermittently contacts the surface in a normal direction and the tip sample 
separation varies between approximately 0.1 - 10 nm [67, 97,105, 106]. The 
contact time depends on the mechanical properties of the sample and the set 
point used in imaging. The cantilever oscillates close to its resonant (natural) 
frequency and the feedback loop maintains constant pre-set amplitude of 
oscillation (or frequency, or phase), so that tip-sample interaction is maintained 
during scanning. 
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2.6.1.3 AFM probe-sample interaction forces 
AFM has two distinct force interaction regimes, attractive and repulsive as 
shown in Figure 2.5. In the attractive regime a net attractive force dominates the 
amplitude of oscillation, while in the repulsive interaction regime a net repulsive 
force controls the cantilever dynamics. The long-range attractive [(electrostatic 
and capillary forces (due to the water layer often present in an ambient 
environment)] and short-range repulsive forces (van der Waals forces) control 
the cantilever motion in repulsive and attractive interaction regimes respectively 
[67,97, 104]. The former dominates AFM tip scans at large distances (non-
contact mode) from the sample surface whereas latter operates when tip is in 
contact with the surface (contact mode). The forces acting between the sample 
and the tip cause a change in the amplitude of oscillation, as a consequence 
produce change in resonant frequency and phase of the cantilever [97, 100, 106]. 
The change in the amplitude of oscillation is used as a feedback signal and 
vertical adjustments of the piezoscanner are recorded to measure topographic 
(height) variations of the sample. The phase change of the cantilever maps 
different components of the sample which exhibit different adhesive, viscoelastic 
and mechanical properties. TM AFM enables simultaneously mapping of 
topography, phase contrast and hence an element of compositional analysis [67, 
68, 97, 107]. 
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The liquid AFM topography imaging experiments reported in this thesis were 
performed using Nanoscope lila MultiMode II (BrukerNano) using DNP-S' and 
'SNL' silicon nitride cantilevers in contact mode. However, AFM imaging 
(topography and phase) of multiple times lyophilized powdered samples of IgG 
(lgG on its own and in combination with excipients) was performed using 
Nanoscope lila MultiMode, e-Nanoscope with a humidity controller 
(BrukerNano) and Dimension 3000 (BrukerNano) using RTESPA cantilevers in 
tapping mode (TM) AFM. A scan rate of 1 Hz over a 1 J..lm x 1 J..lm scan size and 
an amplitude set point of one volt were typically used. Set point is quantity of the 
force applied by the tip on to the sample surface. This force is constantly 
maintained by feedback electronics and could be either a certain deflection of the 
cantilever (in contact mode) or a certain amount an oscillation of the cantilever (in 
tapping mode), which regulates the force with which the tip taps on the sample 
surface. Set point is the characteristic of the nature of the AFM tip. These 
measurements were conducted at room temperature. Using the same scanning 
parameters, the images were also recorded at a range of different humidity (10 
%, 20 %, 40 %, and 60 %) to investigate the impact of moisture on protein 
aggregation. For each sample, more than 50 images (topography and phase) 
were taken using three different types of probes described in the materials 
section. The imaging data were analyzed using scanning probe image processor 
(SPIP) TM V 4. 
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2.6.1.4 Scanning probe image processor 
Scanning probe image processor (SPIP) ™ V4 contains many generic analytical 
and visualization tools that can be applied on various types of images and curve 
data. SPIP is provided with a grain analysis tool. The grain analysis menu is used 
for the detection and quantification of grains or other regions for which 
boundaries can be defined, based on height or slope conditions. Grain analysis 
was used for the measurement of the size of aggregates and individual protein 
molecules. Grains are the islands left when the image landscape is flooded to a 
threshold level. The threshold is a limit chosen (or horizontal line), to impose a 
binary condition, so that only a part of the signal above the threshold is 
considered a segment or grain while the rest is omitted. Therefore, the parts 
under the threshold level can be regarded as grains to be detected. The grain 
anal ysis module is able to detect grains/segments and calculate a large number of 
properties for individual segments in the image. Statistics for the whole set of 
segment properties (such as width, volume, length area etc) are calculated and 
results can be directed to the screen and files. The grain analysis module also 
performs automated detection and reporting to text files besides creating HTML 
reports containing combined numerical and graphical results. A graphic 
explanation of grain analysis is given in Figure 2.6. SPIP generates area, length, 
width and volume histograms of all the individual particles produced from each 
image. In order to study trends based on more data points, all the values of 
length, area, width and volume of all individual nano-particles collected from 
SPIP generated text files of more than 50 images for each of zero cycled and one 
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time lyophilized ferritin (at 0.1 ng/ml) and IgG (at l!!g/ml, 0.75 !!g/ml) were 
compiled together in an excel file. 
Surface 
B 
Figure 2.6 Schematic of the grain analysis performed by SPIP software on a 
particle immobilized on the surface of substrate. [A] Shows the side view of the 
particle and gives a measure of the height from the surface; represented by purple arrow 
(h). Thre hold (Th) value shown by orange arrow is used for generating area, length, 
width and volume histograms. [B] Shows the top view: Blue and red arrows represent 
the width and length of the particle respectively. 
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2.6.2 Scanning electron microscopy (SEM) 
SEM enables high resolution visualization in terms of morphology, topography, 
chemical composition in solid materials [108]. SEM analyses a surface by 
scanning the surface with a focussed electron beam and measuring reflected 
electrons. SEM has been widely employed to investigate biological samples and 
has an enormous potential in a wide spectrum of research fields in life sciences, 
including developmental biology, pathology, microstructural anatomy and the 
assessment ofthe integration of new bioconstructs in regenerative medicine [109, 
110]. A typical SEM instrument, showing the electron column, sample chamber, 
EDS detector, electronics console, and visual display monitors is shown in 
Figure 2.7 and a schematic diagram of an SEM. 
The fundamental principle of SEM is that it involves an interaction of a highly 
focused electronic beam of large kinetic energy with the sample of interest. The 
electron-sample interaction generates a wide variety of signals such as the 
secondary electrons (SE), back scattered electrons (BSE), diffracted back 
scattered electrons (DBSE), X-rays and heat [109,111]. Images obtained from 
each signal provide specific information about the sample. For example; images 
from the secondary electrons (SE) typically provide morphological and 
topographical data, whereas back scattered electrons (BSE) illustrate rapid phase 
contrast in multiple phase samples [112]. 
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Figure 2.7 Schematic overview of the working of an SEM instrument. 
81 
Mudasir Ahmad Lone Chapter 2 
DBSEs are primarily used to determine crystallinity and orientation of the 
contents in the sample. The X - rays provide description about elemental 
composition and are characteristically produced for an each individual element 
by an inelastic collision of the incident electrons with electrons in discrete shells 
of atoms in the sample. SEM typically allows data collection in the form of two 
dimensional scans (l cm to 5 microns) of the sample surface having 
magnification ranging from 20X to approximately 30,000 X, with spatial 
resolution of 10 - 100 nm. 
In all the SEM experiments reported in this thesis, the morphology and porosity 
were analysed using a JEOL JSM - 6060 V (JEOL (UK) Ltd., Welwyn Garden 
City, UK) at various magnifications. The one time lyophilized powdered samples 
of proteins (ferritin and IgG) and multiple times lyophilized samples of IgG on 
its own and in combination with several excipients (sucrose, mannitol, sorbitol 
and trehalose) were mounted onto carbon stubs and then sputter coated with a 
thin layer of gold in an argon atmosphere (50 Pa) at 30 rnA for 2 min for SEM 
analysis. SEM images were taken in order to determine whether any 
morphological changes occur after lyophilization of IgG on its own and in 
combination with various excipients. 
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2.6.3 Dynamic light scattering 
Dynamic light scattering (DLS) is a rapid, non-invasive and a well-established 
technique widely employed for the sizing of nanoparticles of different materials 
(proteins, polymers, micelles, carbohydrates, colloidal dispersions, emulsions, 
microemulsions) in suspension. The technique is also known as photon 
correlation spectroscopy (peS) and quasi elastic light scattering (QELS). DLS is 
typically used to measure hydrodynamic sizes, polydispersities (distribution of 
size) and the presence of aggregates in protein samples [81, 113, 114]. DLS can 
measure size of particles lower down to 1 nm [114, 115]. 
The basic principle behind this technique is that it measures the variation in light 
scattered by the solute particles in a suspension within very short time periods 
(one tenth of a millisecond/microsecond) at a fixed scattering angle, typically 90° 
and correlates the data to produce a diffusion coefficient (D). 
In a typical DLS as shown schematically in DLS Figure 2.8, a laser beam from a 
laser diode is allowed to illuminate a solution in which particles are undergoing 
Brownian motion. The light is scattered in different directions, and the intensity 
of the scattered light fluctuates at a rate which is dependent upon the size of 
particles. The fluctuations result in a time varying signal which is monitored by a 
high sensitivity detector. It is essential that enough light is scattered to achieve 
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Figure 2.8 Schematic diagram of a conventional, 90° dynamic light 
scattering instrument. 
sufficient tati tical accuracy of the correlation function. The wave vector 
determines the length scale over which molecular motions (Brownian motions) 
are detected and it is given by the equation 
q 21tll sin ( ~ ) ) A 2.3 
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where 1'/ is the refractive index of the buffer, 
l is the wavelength of the radiation, and the scattering angle. 
The measurement of the variation/fluctuation in the scattered light intensity with 
time I (t) caused by the diffusion of solute particles under Brownian motion 
produces correlation function as follows: 
G(r) f l(t)l(t+r) d [I (t)]2 t 2.4 
Under ideal conditions (for a monodisperse suspension), analysis of the time 
dependence of the intensity fluctuation, one would expect single exponential 
decay as follows: 
2.5 
where T is delay time, Dq2 is the decay rate, 
D is diffusion coefficient and the fitting parameter ~ ~ - ratio of coherent signal to 
incoherent noise. 
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The diffusion co-efficient, defines the Brownian motion of solute particles in the 
suspension, and therefore, can be used to calculate the hydrodynamic radius of 
the particles in solution using Stokes - Einstein equation as follows: 
D 2.6 
where K B is Boltzmann constant, T is absolute temperature, .., is viscosity of the 
solvent, D is diffusion co-efficient and Rh is the hydrodynamic radius [39]. 
The hydrodynamic diameter measured in DLS is a value that refers to how a 
particle diffuses within a fluid. The diameter that is obtained by this technique is 
the hydrodynamic diameter of a sphere that has the same translational diffusion 
coefficient as the particle. The translational diffusion coefficient depends on the 
number of factors such as the size of the particle core, its surface structure, 
concentration and the type of ions in the solution. Ionic strength of the medium 
also highly influences the diffusion speed by changing the thickness of electrical 
double layer around the particle. The change in the thickness of dissolved 
particle alters its diffusion speed which in tum affects the determined 
hydrodynamic diameter. The hydrodynamic diameter of any particle in a solution 
of low ionic strength would hence be apparently larger than its true diameter due 
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to the formation an extra layer of ions which surround the particle. The reverse 
would be the case in case of high conductivity medium. An altered surface 
structure of polymer particles due to changes in the ionic strength or due the 
change in molecular conformations of the polymer would also affect its motion 
and hence, can affect the measurement of the size by several nm. In addition the 
change in the shape of the particles may not affect the diffusion speed. For 
example in case of a rod shaped particle, only a change in its length will affect its 
diffusivity in solution which will affect the size measured, however, the 
diffusivity would hardly be affected due to any change in its diameter. That is 
why, in the case of proteins, only conformational changes which are generally 
dependent on the nature of the dispersing medium, can affect the diffusion speed 
are detected by DLS [116]. 
2.6.3.1 DLS data production 
The raw data from a DLS experiment is an intensity distribution related to 
particle size. However, the intensity distribution can be misleading, in that a 
small amount of aggregation or the presence of larger particles can dominate the 
distribution and in this way can mask the presence of smaller aggregates and/or 
monomers. Therefore, using the concept of Mie theory [117], DLS software 
automatically processes an intensity distribution into mass, number and volume 
distributions and are best for describing the relative proportion of multiple 
components in the same sample based on their mass, number or volume. The 
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number, mass, volume distributions respectively give the relative total number, 
mass and volume of particles in the solution. The disparity stuck between 
intensity, volume (rna ) and number distributions can be under tood by taking 
into account, a total of 12 pherical particle of four different diameters to DLS 
a hown in Figure 2.9. 
1 nm 2nm 3nm 5 nm 
Figure 2.9 Twelve spherical particles in total with variable hydrodynamic 
diameter: 3x 1 nm, 3x 2 nm, 3x3 nm and 3x5 nm particle . 
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The intensity of light scattering is directly proportional to 6th power of radius of 
the particle, I a r 6 ) has been stated [116, 118]. Therefore, intensity distribution 
of these particles would generate a result as shown in DLS Figure 2.10. The 
intensity of the light scattered predominantly corresponds to the 5 nm particles 
(95 %), whereas only 4.5 % and 0.38 % light scattered accounts for 3 nm, and 2 
nm particles respectively. The contribution from 1 nm particles towards light 
scattering is almost negligible. Knowing that volume of the sphere is given 
by ~ 1 l T 3 3 (here it is assumed that particles are spherical), therefore, alteration of 
3 
the intensity distribution into volume distribution would produce the result as 
revealed in DLS Figure 2.10. Once again, larger particles dominate the volume 
distribution, as 85 % the total volume is occupied by 5 nm particles. The 
contribution from 3 nm and 2 nm particle species is 18 % and 5.5 % respectively. 
Consequently, it becomes understandable, that mainstream of the particle mass 
or volume emanates from 5 nm particles. This proves that larger particles 
dominate the data in both DLS intensity and volume distributions. However, the 
alteration of data into number distribution would create the result as shown in 
DLS Figure 2.10 [C] where each particle size accounts for one fourth of the total. 
The number distribution homogeneously accounts for the attendance of all 
particles of all sizes in the solution and eliminates the dominating effect of larger 
particles in a distribution. The data alteration is highly important and 
recommended when there are multiple modes and peaks. However, alteration is 
useless, if intensity distribution is a fairly single smooth peak. 
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Figure 2.10 [A], [B], and [C] respectively represent a typical intensity, volume and 
number distributions: of a total of twelve particles of four different sizes: - 1 nm (red 
bars), 2 om (blue bars), 3 nm (green bars), and 5 nm (purple bars) in a hypothetical 
nanoparticle solution. Number di tribution equi vocall y demonstrate the presence of 
particle of al l ize. Thi is contra t to intensity and volume distributions, where 
particles larger in ize dominate the distribution. Hence, the attendance of smaller 
species remain rna ked. 
90 
Mudasir Ahmad Lone Chapter 2 
2.6.3.2 DLS measurements 
Dynamic light scattering measurements reported in this thesis were conducted 
using a Viskotek DLS (Malvern Instruments Ltd., Worcestershire, UK) equipped 
with a He - Ne laser operating at a wavelength of 630 nm. Approximately 60-80 
Jll of sample solution was injected into the 80 JlL quartz cuvette to determine 
particle size. The lyophilized and subsequently re-suspended protein (lgG) 
formulations varied in concentration from 0.25 - 2 mg/ml. Each sample was first 
equilibrated for 30 minutes at 25 DC prior to the first measurement. Count rate or 
photon count rate (PCR) (photons detected per second) was set above 300 
kcounts, so that enough signals reach the detector for analysis. PCR determines 
sample quality and monitors sample stability as a function of time. Data 
(correlation functions/scattering intensities) were collected in an automatic mode 
by taking 40 acquisitions for each measurement. A special flow mode operating 
procedure on the software allows continuous acquisitions for a single 
measurement. The resulting data were analyzed using OmniSIZE 300295 
software (Malvern Instruments Ltd., Malvern, UK). All the DLS results reported 
in this thesis were interpreted on the basis of number distributions. Standard 
deviations are the means and were determined from the results obtained from 
repeated measurements. 
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2.6.4 NanosightlNanoparticle tracking analysis (NT A) 
In comparsion to DLS, Nanoparticle tracking analysis is a relatively newer 
system for characterization of particles and generally measures particle size from 
30 - 1000 nm, with the lower recognition limit down to 10 nm being reliant upon 
the refractive index of the nanoparticle material [119, 120]. NTA enables 
direct/real time visualization, detection, counting, and measurement of 
concentration. Like DLS, the particle size is determined from the fluctuations in 
scattered light intensity due to the Brownian motion of the particles [119, 120, 
121]. However, unlike DLS, NTA technique compensates the masking effect of 
larger particles, because in this technique, laser light scattering microscopy is 
conjoined with a charge-coupled device (CCD) camera, which facilitates the 
visualization and recording of motion of individual nanoparticles in solution. 
Figure 2.11 shows the basic set-up. NT A enables size characterization of both 
monodisperse and polydisperse samples with fine peak resolution. Regarles of 
having potential advantages over DLS, NT A is known to have several limitations 
such as NT A measurements are time consuming and essentially require a skilled 
operator for software adjustments. In addition, the shear caused to the sample 
during administration into the cell and the stress experienced by sample (when 
comes in contact with glass, stainless steel, and 0 - ring of the chamber) is more 
aggressi ve than D LS operation [120]. 
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The fundamental principle of this technique is that it allows the tracking of the 
Brownian motion of individual nanoparticles in solution. A finely focused laser 
beam (640 nm) is passed through a prism edged optical flat refracts at the 
interface between the flat and the thin layer of suspension placed above it. The 
refracted laser beam produces an illumination region across the thin liquid film 
in which nanoparticles can be visualized, with the help of magnification 
micro cope objective, as shown in Figure 2.12. A CCD camera is lIsed to capture 
a video field of view of approximately 100 !-tm x 80 !-tm. 
Martin camera 
Nanosight camera adapter - 11------..... 
Oculars - - -+-___ _ _ _ ~ ~
Top illumination light source 
Intensity adjusting/alignment controls 
X20 objective 
LM I 0 unit mounted on 
modified microscope stage 
Microscope coarse and fme adjust ,/ 
-
Top illumination on/off switch _ _ - ~ : : : I I I I _ . .
Power control ......... , 
Figure 2.11 Schematic and labelled overview of the Nanosight instrument (LM 10). 
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In NTA the Brownian motion of the particles in a uspension is analysed by a 
video. A video of the movement of each particle is analysed on a frame-by-frame 
basis and the particle's size is established from an analysis of the average speed 
of movement. The NT A , inbuilt software is then proficient to spot and follow 
individual nanoparticles moving under Brownian motion. The individual 
positional changes are tracked in two dimesnions, and the average distance each 
Heat 
Particles 
scattering 
the beam 
Size (nm) 
Glass 
Metallized 
surface 
Width 
Figure 2.12 Nanosight laser (red) illuminations in optical flat (left). The analytical 
breakdown of the proces which take place in the optical flat during laser illumination 
i shown toward right. Particles in the liquid scatter the light and one can observe 
Brownian motion of the cattered nanopartic\es through microscope fitted on the top of 
the optical flat (Figure from Nanosight Ltd). 
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particle moves in x and y directions in the image are automatically calculated 
from which particle diffusion coefficient is determined. Subsequently, this 
diffusion coefficient related to the motion to a particle diameter according 
Stokes-Einstein equation as described earlier in DLS section. 
2.6.4.1 NTA data production 
Figure 2.13 demonstrates an example of data produced by NT A for a lyophilized 
sample of IgG exhibiting aggregation. Like DLS, the NTA also displays data as 
an intensity distribution of particle size, however, in case of NTA, as the size of 
each particle is measured individually; therefore, the measurement of relative 
light scattering intensity by populations of different sizes at the same time 
becomes possible (Figure 2.13 [CD. In this way, the resulting estimate of the 
particle size and particle size distribution overcomes the disadvantage of being 
an intensity biased distribution where larger particles dominate the mean as in 
DLS. The simultaneous measurement of particle size and light scattering 
intensity makes NTA an ideal technique for the characterization of poly-disperse 
samples Figure 2.13. Furthermore, NT A also enables measurement of 
concentration directly from the particle size distribution in the form of a direct 
number/frequency distribution, Figure 2.13 [B]. The emergence of various peaks 
up to 100 nm is an indicative of a sample with diverse populations of smaller 
aggregates (Figure 2.13 [BD. It is important to have sufficient number of 
particles to be analysed within an acceptable time period (e.g; < 60 seconds for 
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the production of tatistically meanmg and reproducible particle SIze 
distribution) . This is typically en ured when a given sample at least contain 
between 107 and 109 particle IInl. 
Figure 2.13 Typical example of a sample report produced by nanoparticie tracking 
analysis (NTA) software for one time lyophilized solution (0.25 mg/ml) of an IgG 
exhibiting aggregation. [A]: video frame image of nanoparticle tracks, the white dot 
like structure represent scatters of the IgG nanoparticles particles under Brownian 
motion, [B]: show particle size distribution profile, [C]: plot of particle size against 
relative inten ity, [D]: 3D plot of particle size against relative intensity. 
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2.6.4.2 NTA measurements 
Particles sizes and size distributions reported in this thesis were measured using a 
NanoSight LMlO (NanoSight Ltd., Amesbury Wiltshire, UK) enabled with laser 
output of 40 mW at 640 nm. 10 - 30 III sample solution was injected into the 
sample chamber using a syringe. At least three measurements were performed 
following each injection. The image analysis (tracking of individual particles and 
their size measurement) was carried out by using the Nanosight software. The 
displayed frequency size distribution histograms by software were output to a 
spreadsheet for comparative analysis with DLS results. 
2.6.5 Differential scanning calorimetry (DSC) 
DSC is a thermal analysis technique widely employed for investigating the phase 
behaviour (thermal transitions) which occur within samples under the influence 
of a regulated increase or decrease in temperature [122]. The basic principle of 
DSC is that it determines the temperature and heat flow in and out of sample 
which is associated with material transitions (melting points, glass transition 
temperature, crystallinity, polymorphism, and decomposition) of polymers in 
solid, liquid or in mixed phases (e.g; suspensions) as a function of time and 
temperature. These measurements provide quantitative and qualitative 
information about the physical and chemical changes that involve endothermic or 
exothermic processes. Distinctively, in case of proteins; DSC measures the 
enthalpy ( ~ H ) ) of unfolding due to heat denaturation. Under the influence of 
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applied heat, equilibrium between the native (folded) conformation and its 
denatured (unfolded) state is sustained. The higher the thermal transition 
midpoint (T m), when 50 % of the protein molecules are unfolded, the more stable 
the molecule. DSC is also used to determine the change in heat capacity ( ~ C p ) )
of denaturation. Heat capacity changes associated with protein unfolding are 
primarily due to changes in the hydration of side chains that were buried in the 
native state, but become solvent exposed in the denatured state. By studying the 
thermal transitions occurring within the material, information is acquired on the 
nature of the polymer in the context of thermal strength [122]. 
A typical DSC instrument as shown in Figure 2.14 measures heat into or out of 
sample relative to a reference with a linear temperature ramp. The sample 
material is enclosed in a pan and empty reference pan are placed on a 
thermoelectric disk surrounded by a furnace. The furnace which is subjected to a 
linear heating rate, allows the heat to be transferred to the sample pan and 
reference pan through thermoelectric disk, in order to raise the temperature of 
both pans identically over time. The difference in the specific heat capacity (Cp) 
of the sample and the reference pan is measured by the area of thermocouples, 
and the consequent heat flow is measured by the area of thermocouples, and the 
consequent heat flow is determined by the following equation:-
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Figure 2.14 DSC instrument on top (blue) and underlying schematic of a 
typical DSC cell. 
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Chapter 2 
2.7 
where Q is heat flow through the sample, !1T is the temperature difference 
between sample and reference, RE is the resistance of the thermoelectric disk. 
Specific heat capacity (Cp) is the amount of heat required to ralse the 
temperature of one gram of a particular material by one Kelvin (units of JIg K). 
Specific heat capacity (heat flow) is given by the equation: 
~ H H - C p ~ T T 2.8 
In differential state; 
dH C dT + th l .. 
- = p - erma transltlOns dt dt 2.9 
where Cp = specific heat (JIg °C), T = temperature (OC), H = heat (J), dWdt = 
heat flow (J/min), dT/dt = heating rate (Oe/min). 
Owing to the difference in the specific heat capacities of the pan loaded with the 
sample and the reference pain, the amount of heat required to ensure the 
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temperature of the sample is the same to that of the reference is the amount of 
excess heat absorbed (endothermic transition) or released (exothermic transition) 
by the molecules in the sample. Figure 2.15 provides a brief description of how 
this excess heat changes as a function of temperature. 
DSC has the capability to elucidate various underlying factors that affect the 
folding and stability of polymeric biomolecules. These include van der Waals, 
hydrophobic, and electrostatic interactions, hydrogen bonds, hydration of the 
exposed residues, conformational entropy, and the physical environment (such as 
pH, buffer, and excipients). The difference in the specific heat capacity (Cp) 
emanate from changes in the alignment and strength of the above indicated 
bonds/interactions responsible for stabilizing protein structure. DSC is highly 
sensitive technique able to pick up structural change produced in the molecule, 
because changes in the conformation affect the position, sharpness, and shape of 
thermal transition( s). Figure 2.16 shows a typical DSC trace revealing glass 
transition, crystallization, cross linking and melting events, polymer can undergo 
when subjected to heat. The sudden downward shift observed in the DSC trace is 
indicative of a polymer having undergone a glass transition (Tg). At Tg more 
heat flows through the polymer and indicates an increase in the heat capacity 
(Cp). The Tg is characteristic of polymers and its larger value is indicative of 
increased thermal stability. 
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Figure 2.15 Graphical representation of heat flown through a reference cell (qs) 
and a sample cell (q ). The amount of exces heat absorbed by the sample cell is 
equivalent to the heat absorbed by the molecule in the sample. The subtraction of the 
DSC scans (sample - reference) shows how this excess heat changes ( ~ q ) ) as a function 
of temperature; ~ H - c o r r e s p o n d s s to change in enthalpy, ~ C P P represents change in the 
heat capacity (Cp), Tm - Melting point [122] . 
102 
Mudasir Ahmad Lone Chapter 2 
The con equent movement of the polymer molecules can lead to crystallization 
with the evolution of heat as shown by inverted peak in the Figure 16. Heating 
the polymer past the temperature of crystallization (Tc) eventually leads to 
melting. The melting corresponds to a single molecular transition, where Cp is 
equal to zero. Integrating any given transition peak to a temperature expresses 
the enthalpy ~ H H for that transition, and the corresponding Cp are obtained via the 
difference between pre-transition and post-transition baselines. 
... 
I 
~ ~
-o 
E 
-~ ~
~ ~ Transition 
c.. 
U 
Crystallization Cross-Linking (Cure) 
Temperature, T(k) 
Oxidation 
Figure 2.16 Typical DSC thermal transitions under the influence of applied heat 
[123]. 
2.6.5.1 DSC Measurements 
DSC experiments reported in this thesis were carried out using a Q - 2000, 
differential canning calorimeter (TA Instruments Ltd, Fleming Centre, 
Manor, Crawley, West Sus ex, UK) with a con tant 10 °C min- I heating rate, 
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from 0 °C to 200 °C in a dry nitrogen atmosphere. Dry powdered samples (2 - 5 
mg) were analyzed in crimped hermetically sealed aluminium pans. Samples 
were heated from 0 °C - 200°C at a scan rate of 10 °C/min. The 
thermograms obtained for the DSC results were analysed using TA universal 
analysis-NT software. The melting point of the IgG antibody lyophilized 
multiple times on its own and the T glmelting point of the sugar-containing 
antibody formulations were obtained as the midpoint of the corresponding 
transition by integrating the slope of the DSC curve. 
2.6.6 Fourier-transform infrared spectroscopy (FTIR) 
Ff-IR is a highly sensitive physico-chemical diagnostic technique, capable of 
elucidating structural details of any given sample by exposing them in the 
infrared region of electromagnetic spectrum [124]. This technique measures the 
absorptions of the IR-radiations by a sample (solid, liquid or a gas), to produce 
an IR spectrum that can be used to identify functional groups and molecular 
structure of the sample. A particular molecular entity exhibiting a unique 
chemical structure when subjected to Ff -IR spectroscopic examination, the 
characteristic Ff -IR spectrum displayed corresponds to the structural fingerprint 
of the examined molecule. Therefore, any shift in the native structure of the 
interested molecule will be observed in the Ff-IR spectrum. In this way, 
alteration from the original structure observed in the Ff-IR spectrum of the 
exposed molecule discloses structural/molecular deformation/discrepancies that 
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have occurred under given conditions. The biomolecular species such as 
protein, lipid, carbohydrates and vitamins etc have been widely and 
succe fully. characterized by FT-IR [125,126,127, 128]. 
Fixed Mirror 
Movable Mirror 
Polychromatic IR beam ---+ 
Sample 
~ - - - - - . . C h o p p e r r _ 
! 
Recombined Beam + I 
__ I 
i 
_ IRSource Reference 
IR-Detector 
Figure 2.17 Basic set up of the process of working of an FT-IR spectrometer. A 
polychromatic IR beam split at the beam splitter. Recombined polychromatic IR-beam 
hit the sample/and reference on its way to detector for the generation of an infrared 
pectrum of the sample under ob ervation with the help of software installed on the 
computer. 
FT-IR spectroscopic technique exercises the phenomenon of interference and 
Fourier tran formation for its swiftnes and sensitivity. Unlike conventional 
spectro copy, Ff -IR spectro copy irradiates the sample of interest with aJJ 
wavelength imuJtaneou ly in the infrared region of electromagnetic spectrum 
and the quantity of light ab orbed by the sample i determined by tailoring 
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different frequencies in the reflected beam. This process is repeated numerous 
times. Finally, all the data collected is processed by an inbuilt software 
programme 10 the computer to calculate the amount of absorption at each 
wavelength. 
Figure 2.17 illustrates basic working of a typical FT -IR spectrometer. A 
polychromatic IR- beam directed onto a beam splitter sends the beam onto two 
mirrors at right angles to each other. The movable mirror as moves in a direction 
perpendicular to its axis in such a way so that the recombination of reflecting 
beams ( .. ~ ) ) at the beam splitter (_ ) results in the introduction of path 
difference which produces interference. This recombined wave (output signal) 
interact with the sample before it way to a detector for the production of an 
interferogram (sum of the sine waves of all frequencies present). Fourier 
transformation of the interferogram produces the resultant spectrum. The 
polychromatic nature of the IR- beam makes it non- attenuated and therefore the 
signal to noise ratio of the resultant spectrum is very much high, which is 
necessary for improving the quality of spectrum to be obtained. 
2.6.6.1 FT-IR modes of analysis 
FT-IR pectroscopy can be performed in three modes depending on the property 
of sample: 
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Incident IR beam ---/----P-..... ~ ~ - _ + . . Transmitted beam 
Absorbed beam 
I Reflected beam 
Sample 
Figure 2.18 Transmitted, absorbed and reflected portions of an incident 
polychromatic IR-beam after hitting the sample. The measurement/detection of a 
specific portion determines the mode of Fr-IR analysis. 
(iv) Transmission mode 
In this mode of operation, the recombined IR beam passes through the sample 
and the amount of infra-red energy that gets transmitted is measured (Figure 
2.18). Both solid and liquid samples can be examined in this mode of analysis. 
The intensity of the IR-spectrum is determined by the .sample thickness and 
should be typically in the range of tens of few microns (0.1 - 15 !lm) [129] . The 
micron thickness is ensured by introducing a small quantity of sample onto a 
diamond window of a micro compression cell to flatten and thin. Solid samples 
are usually compressed in a pellet and one of the most commonly employed 
methods for the examination of solid samples in the transmission mode is 
pressing in a pellet (alkali halide such as such as NaCl, KBr or CaF2) . This 
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involves grinding of the solid material to a fine powder and dispersing it in a 
matrix usually KEr, then transporting the mixture to a compression die (Figure 
19 [AD. The mixture is subjected to high pressure until the mixture forms a pellet 
that is transparent to infrared light. This makes the sample ready to be introduced 
in the spectrometer for transmission analysis. In case of liquid samples, micro 
compression cell comprises of two IR-transparent windows (Figure 2.19 [B]). 
The film thickness considered necessary and path length for quantitative analysis 
is ensured by introducing a spacer usually made of Teflon or Lead [129]. 
(v) Reflectance mode 
It involves reflecting the light off the sample and detects the infra-red energy that 
is reflected from the sample. The infra-red radiation reflected off from the 
surface can be either specular (directly reflected from surface without any 
absorption by sample) or diffuse (where IR-energy penetrates into sample 
surface a short depth and bounces back after reflecting internal portions of the 
sample). The specular reflection is non-invasive and does not require any sample 
preparation. However, a small quantity of sample (in case of hard polymers) that 
clings to the surface of silicon carbide disc is needed during diffuse reflection. 
The spectra in general are collected from the sample under reflectance mode with 
clean gold surface as background. 
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A B 
Figure 2.19 [A] KBr die for IR analysis: This set includes evacuable die body, base, 
plunger, two 13 mm polished steel pellets, O-ring vacuum seals, and knock-out ring for 
sample disc extraction . [B] Liquid cells: Each cell has precise path length which is 
standardized by making use of the interference blueprint produced by an empty cell in 
the IR-beam. These cells utilize a spacer which is merged with the window material. 
The specular reflection is non-invasive and does not require any sample 
preparation. However, a small quantity of sample (in case of hard polymers) that 
clings to the surface of silicon carbide disc is needed during diffuse reflection. 
The spectra in general are collected from the sample under reflectance mode with 
clean gold surface as background. 
(vi) Attenuated total reflection mode 
This mode i highly recommended when samples are strongly absorbing. 
Attenuated total reflection mode (a type of reflection mode) operates by 
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measuring the changes that occur in a totally internally reflected, infra-red beam 
comes into contact with the sample as shown in Figure 2.20. 
IR beam 
Sample surface in contact with evanescent wave 
t 
1 
Detector 
i 
Evanescent wave ATR crystal 
Figure 2.20 IR - beam observes the phenomenon of total internal reflection within 
the A TR crystal, hence produces an evanescent effect. A thin sample is mounted on 
to the vertical face of the crystal with upper surface exposed. 
An IR beam is directed onto an optically dense crystal with a high refractive 
index at a certain angle of incidence experiences the phenomenon of total 
internal reflection inside the crystal. Multiple internal reflections (usually 
between 5 and 10) occur, however their number within the crystal depends on the 
angle of incidence, length and thickness of the crystal. The consequence of total 
internal reflection produces an evanescent wave (a bubble of infrared 
immobilized on the surface) that extends beyond the surface of the crystal into 
the sample held in contact with the crystal. This evanescent wave protrudes only 
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a few microns (0.5 - 5 !lm) beyond the sample surface and into the sample. This 
penetration demands a better contact between the sample and the crystal surface. 
Regions of the IR-spectrum where evanescent wave would be attenuated or 
altered correspond to the energy absorbed by the sample. The attenuated energy 
from each evanescent wave is transferred back to the IR-beam, which then exits 
at the opposite end of the crystal before finding its way to a detector fixed in IR-
spectrometer for producing the spectrum of the sample. 
This technique, in recent times has revolutionised solid and liquid sample 
analyses by IR-spectroscopy, because it conveniently prevails over the most 
imperative challenges of IR-spectroscopy which are the sample preparation and 
the spectral reproducibility [130]. This is for the reason that A TR works by way 
of an evanescent effect which ensures least possible damage to the sample 
compared to that when the sample is irradiated by a non-attenuated IR beam. 
However, the two important requirements for the success of this technique are: 
tight contact between crystal and sample, and significantly higher refractive 
index of the crystal than the sample. This is due to the fact, that for the 
phenomenon of total internal reflection to occur, the refractive index of the ATR 
crystal should be significantly greater than that of the sample; otherwise the 
incident IR-beam will be transmitted in the crystal. Typically refractive index 
values of ATR crystals lies in between 2.38 and 4.00 at 2000 cm- I with an 
effective penetration depth of almost I !lm [129]. Zinc Selenide (ZnSe), 
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Germanium (Ge) and diamond are by far the generally employed materials which 
are used as ATR crystals. While expensive, diamond is by far the best ATR 
crystal material, because of its robustness and durability. 
2.6.6.2 FT -IR measurements 
Ff -IR experiments described in this thesis were performed using a Nicolet Ff-
IR-spectrometer using diamond crystal. The recorded spectra were obtained for 
the determination of changes in the secondary structure of IgG lyophilized on its 
own as well in combination with different excipents. Sample powder (2 - 3 mg) 
was placed on a clean glass slide and then mounted on the sample stage. The 
spectra for each sample were recorded from 4000 cm- I to 650 cm- I in ATR mode 
at room temperature. Each measurement was an average of 200 scans, at a scan 
speed of 0.15 cm- I and the resolution of 2 cm- I . The optical bench was purged 
with dry nitrogen to avoid interference from water vapour infrared absorption. 
Each spectrum was background corrected for the glass slide. The amide I (1720 
cm- I - 1600 cm- I ) and amide II (1575 cm-I - 1480 cm- I ) regions were used to 
analyze changes in the secondary structure of protein [129, 130]. 
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2.7 T - test for statistical analysis 
T -test involves statistical inspection of two mean values of data produced from 
two samples in order to determine whether or not the difference between two 
means reflects a true change. Generally, t-test is employed when the variances of 
two normal distributions are not known. The test statistic in the t-test is known as 
the t-statistic or (t value) and is given by the formula given below: 
tStat = 
where: 
Xt-XZ 
s Z s Z ~ + ~ ~
Nt Nz 
2.10 
Xl and S1 2 denote the mean and standard deviation of the data set from sample 1 
Xl and S1 2 represent the mean and standard deviation of data set from sample 2 
Nl and N2 signify number of data entries in the sample 1 and 2 respectively. 
The t - test takes into an account the following important factors: 
(i) t - Statistic is the calculated t value using the formula given above. 
(ii) t - Critical: is a cut-off value to which the value of the test statistic is 
compared in order to decide whether or not the null hypothesis is 
rejected. The t-critical is governed by level of alpha and whether the test 
is one-tailed or two-tailed. 
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(iii) Degrees of freedom (df): correspond to the number (N) of values that are 
there in the data and are given by N - 1 for one-sample and paired-
samples t-tests. 
(iv) Significance level alpha (a): is a threshold value which represents an 
acceptable probability in a statistical test. The value of a could range 
from any where between 0 - 1. However, the frequently used values for 
alpha are 0.01, 0.05, and 0.1. Mostly the standard for alpha is 0.05. 
(v) P-value: represents the probability of the existence of the result obtained 
alone in comparison with the recognized distribution of conceivable 
findings, even if the null hypothesis is right and no true difference exists 
between two samples. 
The t-test results are deemed statistically significant by two ways: one is when t-
statistic value exceeds t-critical value and the other is when the P - value does not 
exceed the chosen significance level of alpha. The statistical significance of data 
reported in this thesis was determined using t - test using an excel spread sheet. 
Table 2.2 shows an example of one such analysis in cycle 0 and cycle 1 times 
lyophilized ferritin particles (- 4 - 12 nm in width). The t-statistic (- 12) is larger 
than t-critical (1.86) and P- value is much smaller than the significance level at 
threshhold (a = 0.05). This suggests the significant difference in the proportion 
of the measured particles in the two indicated samples of ferritin. 
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Width 
Size Range 4.0-12 (nm) 
Measurement J 
Measurement 2 
Measurement 3 
Measurement 4 
Measurement 5 
Mean 
Variance 
Observation 
Hypothesized Mean Difference 
df 
t Stat 
t Critical two-tail 
Chapter 2 
Cycle 0 Cyclet 
Number of Particles Number of Particles 
70 
69 
74 
76 
72 
oal Variances 
Variable 1 
72.2 
8.2 
5 
o 
8 
11.813606 
0.000001 
2.306004 
53 
51 
48 
55 
50 
Variable 2 
51.4 
7.3 
5 
Table 2.2 T -test report of the number of ferritin (- 4 - 12 run in width) particles in 
cycle 0 and cycle 1 times lyophilized ferritin performed on excel spreadheet. 
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Chapter 3 
Nanoscale characterization of the 
effect of lyophilization on the 
propensity of ferritin aggregation 
3.1 Introduction 
This chapter describes the effect of the lyophilization on the aggregation of ferritin. 
In the preliminary studies, ferritin was employed as a study material. The idea of 
the utilization of ferritin was endorsed for various reasons such as its relatively 
lower cost; availability of significant studies reported in literature; adsorbs easily on 
the hydrophilic surfaces, making it easy and quick to prepare samples; its high 
stability and its attributes for easy characterisation makes it convenient for studying 
protein adsorption onto solid substrates [131-133]. The other fundamental objective 
of this study was also to get myself familiarized with AFM technique in order to 
gain experience of imaging proteins in air and liquid while using not much 
expensive proteins. As described in the Chapter 1, in liquid state 
biopharmaceuticals, the complete/partial loss in activity and a reduced shelf life 
are the potential consequences of protein aggregation. Loss in protein activity is 
possibly induced due to the subtle or massive changes in the protein 
environment such as changes in pH, temperature, and ionic strength. Therefore, 
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there is a growing demand to find out an effective formulation strategy which 
would enable us to better predict or overcome the problem of aggregation. 
Presently, in order to avoid the potential consequences of aggregation in 
solution, pharmaceutical companies often prepare powdered (dry) preparations, 
and lyophilization is one of the most widely employed methods for this purpose. 
Although, lyophilization is considered to be a viable option for the manufacture 
of dry protein formulations, it is still not the best option for completely stopping 
aggregation, because formation of insoluble aggregates (described in chapter 1) 
and loss of monomers has been reported in many protein solutions which were 
reconstituted from their respective lyophilized powders. The detection limit for 
some of the conventionally used techniques (such as SEC, AVC) for aggregate 
detection lies within the micrometer range and therefore, they can fail to detect 
much finer structures such as fragments, and monomers etc. So far the effect of 
lyophilization in minimising aggregation in biopharmaceutical formulations 
such as antibodies, using conventional techniques has been found to be 
dependent on the nature of protein itself and the optimum lyophilization 
conditions employed. Very little work has been done to investigate the effect of 
lyophilization on proteins using unconventional techniques such as AFM, which 
has relatively much higher resolution (can detect - 1 nm) and can therefore, 
easily account for much interested species such as fragments and monomers in 
more detail. The identification of critical formulation is determined by the 
optimization of processing variables such as effect of concentration, 
lyophilization, pH change., sugar lyoprotectants, buffer concentration, counter 
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ion (Na+ versus K+ phosphate), added salts, cooling rate, residual moisture 
level, and presence of a surfactant [134, 135]. However, the parameters 
examined in these preliminary studies were the effect of protein concentration 
and the number of cycles of lyophilization. AFM studies were focused on 
evaluating the effect of lyophilization on the aggregation of ferritin molecules on 
the basis of their size and morphology. A brief introduction of ferritin, its 
structure, and the AFM studies conducted on ferritin is described in the 
following sections:-
3.1.1 Ferritin; its tertiary and quaternary structure 
Ferritin can be described as a nano-particle and consists of an organic protein 
coat (apoferritin) surrounding an 8 nm sized cavity, that can be fully or partially 
occupied by a hydrated iron (III) oxide known as mineral ferrihydrite 
[FeO(OH)]s [FeO(H2P04)] as shown in Figure 3.1 [A]. The iron oxide core 
inside the sphere can store up to 4,500 iron atoms which are stored as 
nanoparticles inside the ferritin [137, 138]. The apo-ferritin shell offers great 
possibilities for incorporating diverse functionalities. It prevents metallic core 
agglomeration and causes the particles to be water soluble. Ferritin is water 
soluble and an iron storage intracellular protein with a molecular weight of 450 
kDa [136, 137]. 
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Apo-ferritin (Protein coat) V 
Iron core 
Iron releasing channel 
I II III IV 
Figure 3.1 Structure of ferritin: [A] Simplified structure of a ferritin molecule: - A 
typical cross section structure of ferritin molecule with an iron core surrounded by an 
organic protein coat (apo-ferritin), Iron releasing channels are extending out from the 
core. [B] Diagram of ferritin subunit: - (l - helices and ferroxidase centre side chains: 
helix I (green); helix II (light green); helix III (blue); helix IV (orange) and short helix 
V (red) . Pink dots in the middle represent Iron atom positions [C] Tertiary crystal 
structure: - of Pseudonitzschia multiseries ferritin [138, 145, 279]. 
Ferritin consi ts of 24 polypeptide subunits, which self-assemble to form a 
hollow and roughly spherical protein shell with octahedral symmetry [137,138] . 
Inner and outer shell diameters are - 8 nm and - 12 nm respectively. Each 
subunit is compo ed of four a-helical strand (1, II, III, IV) with a short fifth 
helix (small stretch V) toward top at the C - terminus (see Figure 3.1 [B]). 
Interactions amongst subunits result in the construction of three-fold and four-
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fold channels through the well-crowded protein shells (Figure 3.1 [C]). The 
three-fold channels are polar and are thought to serve as pathways to transport 
iron atoms into the cavity. In contrast, the four-fold channel is non-polar and 
serves in proton transport. The amino acid residues that line the channels 
determine the polarity of the channel. Ferritin stores iron and releases it through 
channels in a controlled fashion. When the Fe (III) in the crystalline mineral is 
reduced to Fe (II), the iron becomes solvated and ferritin releases the solvated 
iron [Fe (H20) 6], through the three fold polar channels. Hence, ferritin can 
control the amount of available iron in the body, preventing disorders like 
anaemia and iron over load. The three dimensional structure of ferritin is hence 
crucial to its function within the body [137, 138]. Ferritin is not readily required 
for cellular activity. The storage of iron when present in excess prevents from its 
auto-toxicity. Otherwise when free leads to the formation of oxygen free radicals 
(OHe) by catalysing the reaction between hydrogen peroxide and Fe (II). The 
production of such free radicals could strongly damage tissues and are found to 
be the main reason for the neurodegenerative diseases such as Alzheimer's. It 
has been reported that in Alzheimer's, the configuration of ferritin iron core 
alters significantly from that in normal state [137,139, 140]. The nature of the 
core which is predominantly ferrihydrite; Fe (III) oxide in physiological state, 
gets transformed partially into other ferric-ferrous oxides such as magnetite in a 
pathological state (Figure 3.2). It is the aggregation of ferritin that produces 
change in the normal oxidation state of iron within the ferritin core and which 
leads to abnormal functioning of the protein. Therefore, from the biomedical 
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point of view, it would be also useful to examine if there is any difference in the 
above stated aggregation behaviour of ferritin after lyophilization under near 
physiological conditions. 
Magnetite 
Apoferritin 
Ferrihydrite 
Figure 3.2 Schematic of state of iron core structure of Ferritin in Alzheimer's:-
The presence of magnetite and hematite indicate dysfunction in the physiological state 
of ferritin becau e the different phases do not coexist within the same core in the normal 
configuration [140,141] . 
3.1.2 AFM studies of ferritin 
AFM studie have shown that it can form an ordered monolayer in a hexagonal 
manner on flat surface uch a mica [136, 137, 138, 142]. The ordered 
monolayers of ferritin molecules had been imaged with high reproducibility. 
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AFM measurements have also confirmed that size of the individual ferritin 
nanoparticles ranges from 7 nm - 20 nm, which is close to its crystallographic 
size (8 - 12 nm) [137, 142, 143, 144]. The increase in size during AFM imaging 
has been attributed to several factors, such as distortion of sample by the tip 
during tapping, denaturation (due to changes in pH, ionic strength etc) during 
sample preparation. The assimilation of basic knowledge of model protein and 
its AFM studies was fundamental for me to perform imaging experiments. 
3.2 Aims and objectives 
The aim of this preliminary investigation was to characterise the effect of 
lyophilization on the aggregation ferritin. With plenty of lieratre available and 
being relatively cheaper than IgG, ferritin became an ideal choice to gain an 
initial experience in imaging proteins in air and liquid. Therefore, the plan of 
characterizing ferritin with SEM and AFM in particular in these investigations 
was to provide foundation for examining the behaviour of medically and 
therapeutically significant IgG antibody in the subsequent chapters that are 
reported in this thesis. 
3.3 Materials 
Horse spleen ferritin (50 mg/ml solution in 0.15 M NaCl), phosphate buffered 
saline (PBS) tablets, Mica (G250 - 1, 3"x I"), Deionised water of 18 M Ocm 
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resistivity was used for the preparation of ferritin samples, and as a medium for 
conducting measurements with AFM. Sterile 0.2 f.lm Ministart filters for 
filtration of deionized water. Silicon nitride AFM cantilevers (termed -'DNP-S' 
and 'SNL'), from Nanoprobes (Veeco) CA. SEM (12.5 mm aluminum pin stubs. 
The batch numbers of all the indicated materials are listed in the Appendix 1. 
3.4 Sample preparation methodology 
3.4.1 Preparation of ferritin solution 
10 f.ll of ferritin solution (50 mg/mI) was diluted in filtered deionised water to a 
concentration of 0.1 ng/mI. This was stored in five Iml aliquots in a refrigerator 
to be used for the preparation of samples for conducting AFM imaging 
experiments. 
3.4.2 Lyophilization of ferritin 
A Modulyo Lyophilizer [S.W. Jennings and Company Ltd, Scientech House, 
East Bridgford, Nottingham, UK] with Edwards Pump (Crawley, West 
Sussex, UK) was employed for the lyophilization process. Two (0.5 ml and 
1 ml) aliquots of ferritin solution with concentration of 0.1 ng/ml were 
separately poured into two clean glass vials with the help of pipette and then the 
vials covered with parafilm. The vials were first pre-freezed in liquid nitrogen 
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for a couple of minutes . The parafilm covering mouth of glass vials wa made 
perforated with a clean needle so that all the moisture would be sucked during 
freeze drying (vacuum drying). The pre-freezed ferritin samples were then 
mounted in the freeze drier, and left to dry at a suction pressure of 0.1 mbar at a 
temperature of 25°C for 8 hours. This resulted in the formation of powdered 
ferritin which was then reconstituted in deionised water prior to AFM imaging. 
3.4.3 Preparation of ferritin samples for AFM analysis 
Three types of samples with the same protein concentration were prepared, and 
are presented in Table 3.1 
Sample 
1. 
2. 
3. 
Preparation scheme 
20 !!l of zero cycled ferritin, (concentration 0.1 ng/rnl), was 
deposited onto a clean mica surface supported by a round 
steel disc, and allowed to dry for half an hour; this sample 
was imaged with AFM in air 
20!!1 of zero cycled ferritin , (concentration 0.1 ng/rnl),was 
deposited onto a clean mica surface supported by a round 
steel disc, and allowed to dry for half an hour; and then 
directly imaged with AFM in liquid (deionised water) 
20 !!l of lyophilized ferritin (concentration 0.1 ng/rnl), was 
deposited onto a clean mica urface supported by a round 
steel disc, and allowed to dry for half an hour; and then 
directly imaged with AFM in liquid (deionised water) 
Table 3.1 Scheme of the preparation of ferritin samples for AFM analysis 
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3.4.4 Preparation of ferritin samples for SEM analysis 
Powdered (1 !lg) ferritin from manufacturer and 1 !lg/ml solution of ferritin was 
lyophilized to its powdered form for SEM analysis 
3.5 Methods of analysis 
3.5.1 Atomic force microscopy 
Ferritin samples (1, 2 and 3) were imaged with Multimode AFM with 
Nanoscope V controller (Digital Instruments, Veeco, Santa Barbara, CA, USA) 
equipped with an E - scanner™ (approximately 14 !-tm X - Y scan range). 
Mechanical noise was minimised by placing the apparatus on an air table. 
"DNP" silicon nitride (ShN4) cantilevers with a nominal spring constants of 0.1 
N/m, were used at room temperature. Ferritin (mounted on double sided tape) 
was imaged in air as well as in deionised water. For imaging in liquid, deionised 
water was injected into a fluid cell around the sample in ferritin. This was done 
in order to avoid the aggregation of protein, which may be induced during of the 
sample prior to imaging. The images were obtained by scanning the sample 
surface in a tapping mode while keeping the oscillation amplitude constant. 
Tapping mode allows high resolution images of adsorbed molecules and avoids 
unfavourable tip sample interactions. The images were recorded at a scan rate of 
2 kHz (512 x 512 pixels). 
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3.5.1.1 AFM data analysis 
Scanning probe image processor (SPIP) ™ V 4 was employed for the processing 
(grain analysis) of AFM images as described in section 2.6.1.2. Threshold level 
of 3.1 nm was fitted to the plane. The values of length, area, width and volume 
of all individual nano-particles were respectively compiled together in an excel 
file in order to determine mean size. For each sample indicated, data collected 
from SPIP generated text files is from more than 50 images. 
3.5.2 Scanning electron microscopy 
The effect of lyophilization on the particle morphology and porosity was 
examined using a JEOL JSM-6060LV (lEOL (UK) Ltd., Welwyn Garden City, 
and UK) at various magnifications. The powdered samples of ferritin 
(lyophilized and non-lyophilized) were mounted onto carbon stub and gold 
coated at 30 rnA for 2 min in an argon atmosphere prior to SEM analysis. SEM 
analysis was conducted under high vacuum at a voltage 10 - 12 kV. Scan sizes 
were variable (1 - 5 Ilm). 
3.6 Results and discussion 
3.6.1 Imaging of ferritin samples in air 
AFM has been widely employed for studying the adsorption of ferritin onto 
various surfaces [136 - 147J. TM mode AFM analysis of both (zero and once 
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freeze dried) ferritin samples in air confirmed that deposits of ferritin of variable 
sizes were randomly distributed onto the hydrophilic surface of mica as shown 
in Figure 3.3 Generally it was observed from more than 20 AFM scans that the 
arrangement of the deposits of the ferritin molecules was denser in the case of 
non-lyophilized ferritin sample than in lyophilized sample. 
Figure 3.3 one micron TM AFM scans of: [A] Non-lyophilized and [B) Lyophilized 
ferritin samples in air. Z - scales were different: 9.8 nm for non - lyophilized and 6 nm 
for lyophilized ferritin sample. Concentration of both samples was 0.1 ng/ml . 
3.6.2 Imaging of ferritin samples in liquid 
TM AFM imaging of ferritin samples (both non-lyophilized and lyophilized) in 
liquid produced scans (Figure 3.4) containing fewer deposits of randomly 
ordered ferritin molecules. The hydrophilic nature of the substrate surface can 
result in unstable attachment of the molecules , which may lead to random and 
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less packed adsorption of ferritin onto the surface of substrate [136, 142 - 147]. 
Like in air, aggregates were detected both before and after lyophilization. 
Figure 3.4 one micron TM AFM scans of: [A] Non - lyophilized and [B] Lyophilized 
ferritin samples in liquid. Z - scales were different: 7 nm for non - lyophilized and 5 
nm for lyophilized ferritin sample. Concentration of both samples was 0.1 nglml . 
3.6.3 Particle size analysis 
The grain analysis of all individual TM AFM scans of ferritin (non-lyophilized 
and lyophilized) samples in air/liquid using SPIP software made it easy to 
scrutinize particle size. For each sample, numbers of particles measured per 
image were around - 50 - 100. Almost 2500 particles were examined after 
combining the data from 30 representative images. The particle size was 
demonstrated on the basis of area, length, width and volume of a particle. 
Histograms presented in Figures (3.5 and 3.6) represent normalized data 
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generated after SPIP testing. Normalisation of data was performed by dividing 
the number of particles of a particular size range by the total number particles in 
population. For an example, if we want to normalise a series data: 2, 5, 7, 9; then 
the proportion of each data set will be equal to that set divided by the sum of 
2+5+7+9 = 23, i.e; 2/23, 5/23, 7/23, and 9123 represent the normalised values of 
2, 5, 7, and 9 respectively in the total population of 23. The normalisation 
process enabled to find out the percentage proportion of features before and after 
lyophilization, which were then plotted in histograms. Figure 3.5 provides an 
account of the comparative analysis of size distribution of all the deposits of 
ferritin molecules in non - lyophilized and once lyophilized samples of ferritin 
when imaged in air. Figure 3.6 studies the same effect when imaging was 
performed in liquid. 
Size analysis in air (Figure 3.5) and in liquid (Figure 3.6) suggested the 
formation of a range of aggregates which were binned into various groups as 
follows: (20 - 30 nm2), (30 - 200 nm2), (200 - 300 nm2), (500 - 1000 nm2) and 
those (> 1000 nm2) on the basis of area (Figures 3.5 and 3.6 [A)); (8 - 12 nm), 
(13 - 25 nm), (25 - 40 nm), (40 - 100 nm) and those (> 100 nm) on the basis of 
length (Figures 3.5 and 3.6 [B)); (4 - 12 nm), (13 - 25 nm), (25 - 40 nm), (40-
100 nm) on the basis of width (Figures 3.5 and 3.6 [e]); and (4.5 - 12 nm\ 
(12 - 100 nm\ (100 - 500 nm\ (500 - 1000 nm\ (1000 - 2000 nm3) and 
those (> 2000 nm3) on the basis of their volume (Figures 3.5 and 3.6 [D]. 
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Figure 3.5 Effect of lyophilization on the relative particle size distribution in air: -
[A], [B], [C], and [D] respectively show the comparison of the area, length, width and 
volume of ferritin nano-particle at a scan ize of 1 !!m before and after lyophilization 
in air. In each set, blue and red bar represent data obtained form 30 AFM can (l Ilm 
each) before and after lyophilization. Each error bar represents a standard deviation in 
the percentage of given set of particle size in several repre entative AFM scans which 
were recorded at different locations of the sample. Relatively larger standard deviation 
po t lyophilization suggest non-homogeneous surface distribution of ferritin particles. 
However, it is important to note that due to hydration in liquid, there occurs an 
increa e in the size range of first group indicated in the area distribution (Figure 
3.6 [AD from (20 - 30 nm2) to (40 - 62 nm\ Both in air and liquid the presence 
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Figure 3.6 Effect of lyophilization on the relative particle size distribution in 
Iiquid:- [A], [B], [C], and [D] respectively show the comparison of the area, length, 
width and volume of ferritin deposits at a scan size of I fA.m before and after 
lyophilization in deioni ed water. In each set, blue and red bars represent data obtained 
form 30 AFM scans (I fA.m each) before and after lyophi lization. Standard deviation in 
the percentage of each set of particle size in many AFM images are highlighted by error 
bars .. The fairly lower standard deviations in liquid for sets of particle sizes after 
lyophilization advocate relatively homogeneous surface distribution of ferritin particles 
in liquid. 
of smallest sized aggregate (20 - 30 nm2) in air and (40 - 62 nm2) in liquid on 
the basis of area), (8 - 12 nm on the basis of length), (4 -12 nm on the basis of 
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width) and (4.5 - 12 nm3) in terms of volume equivocally demonstrated the 
presence of monomeric ferritin. The indicated aggregates in Figures 3.5 [A] and 
3.6 [A] are multiples of the 1tr2, where r is half of the diameter of 
individualferritin molecules, and could be anywhere in the range of (6 - 20 nm) 
because of the distortion. These findings are comparable to that reported in 
literature [142 - 147]. The size of the features measuring (8 - 12 nm) in length 
(Figures 3.5 [B] and 3.6 [B] roughly correspond to features measuring (4 - 8 
nm) in width (Figures 3.5 and 3.6) [C], and are more probably monomeric 
ferritin molecules, because this size is close to 12.5 nm reported in AFM and x-
ray crystallographic studies [136,142 - 147]. However, the deposits measuring 
between 13-25 nm (Figures 3.5 and 3.6 [B and C] could be considered either 
individual molecules of ferritin with larger amount of distortion or two 
molecules aggregated together and those between (25 - 40 nm) (Figures 3.5 and 
3.6 [B and C] could be more than two aggregated together or distorted. The most 
likely cause of the distortion could be due to the flattening of the protein by the 
AFM tip while scanning the substrate surface [142 - 147]. 
. The other probability could due to the spreading of the protein on to the solid 
surface during immobilization step, consequently exceeding x - y dimensions of 
the protein [136,142 - 147]. Moreover, most likely due to the stress induced 
during lyophilization. A stress results in the aggregation of protein by changing 
the conformation of the molecule has been reported [147, 148, 149]. In, addition, 
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trapping of moisture between the AFM tip and the substrate surface might have 
induced inter and intra-molecular hydrogen bonding, resulting in conformational 
changes, which might have induced an aggregation [147, 148, 149]. 
There occurred a significant decrease in the proportion of monomeric (likely) 
ferritin deposits after lyophilization. T - test described in chapter 2 (section 2.7) 
was employed to check statistical significance of our results. In air: - on the 
basis of area (26 % in 20 - 30 nm2), on the basis of length (8.3 % in 8 - 12 nm), 
on the basis of width (23 % in 4 - 12 nm and on the basis of volume (25 % in 
4.5 - 12 nm3)] distributions presented in Figure 3.5. Similar trend was observed 
in liquid (Figure 3.6]:- on the basis of area (36 % in 40 - 62 nm2), on the basis of 
length (18 % in 8 - 12 nm) and on the basis of width (22 % in 4 - 12 nm). In 
contrast in air, however, the proportion of (4.5 - 12 nm3) increased by 10 % 
after lyophilization (Figure 3.6 [D]). This could be explained due to the fact, that 
volume distribution takes height of the aggregate into account rather than radius, 
which could be reduced due to the flattening of the aggregate by intermittent 
taping of AFM tip in air (enhanced). Both in air and in liquid, the proportion of 
aggregates other than the first indicated group presented in Figures 3.5 and 3.6 
[A, B, C and D], showed a significant increase after lyophilization. T - test was 
used for significance check (see section 2.7 chapter 2). Table 3.2 (for air) and 
Table 3.3 (for liquid) summarize the percentage increase in the indicated group 
of aggregates after lyophilization on the basis of area, width, length and volume. 
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Table 3.2 Percentage increase in the proportion of 
ferritin aggregates after lyophilization in air 
AREA (Dm2) 
30- 200 4.5 % 
200- 300 8.67 % 
300-500 8.17 % 
500 - 1000 1.15 % 
~ ~ 10000 5.45 % 
WIDTH (om) 
13 - 25 18.5 % 
25-40 2.5 % 
40-100 2 % 
LENGTH (nm) Table 3.2 (Continued) 
13 - 25 4.9 % 
25-40 4.7 % 
40 - 100 6.6 % 
» 100 2.1 % 
VOLUME (Dm3) 
12 - 100 5.6 % 
100 - 500 5 % 
500 - 1000 9.13 % 
1000- 2000 0.97 % 
» 2000 3.77 % 
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Table 3.3 Percentage increase in the proportion of 
ferritin aggregates after lyophilization in liquid 
AREA (nm2) 
60- 200 - 2.6 % 
200-300 20.7 % 
300-500 4.65 % 
500 - 1000 8.86 % 
~ ~ 1000 3.59 % 
WIDTH (nm) 
13 -25 16 % 
25-40 5.3 % 
40-100 0.7 % 
LENGTH (nm) 
13 -25 15 % 
25 -40 10.2 % 
40-100 3 % 
~ ~ 100 3.5 % 
VOLUME (nm3) 
12 - 100 4 % 
100 - 500 4.5 % 
500 - 1000 3.9 % 
1000 -2000 0.9 % 
~ ~ 2000 -22.5 % 
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It is evident from the comparatively analysis of the data presented in Tables (3.2 
and 3.3) that increase in the proportion of indicated groups of aggregates 
following lyophilization of ferritin in liquid is significantly more than in air. 
This is likely due to the extensive hydration of ferritin molecules in liquid [150]. 
The adsorption of a protein onto a solid surface is a complex process [151]. The 
changes in surface structure due to changes in the interior of the protein core and 
inter-molecular bonding could be the other reasons for larger size in liquid 
[151]. Moreover, the effect of protein shell on the shape of ferritin molecule can 
result in a high surface area to volume ratio [146, 152]. This has been also 
supported by the fact that the reconstitution of dry proteins in liquid can 
restructure core (i.e., disordered) relative to the particle's exterior [153]. 
Moreover, most likely due to the stress induced during lyophilization. A stress 
results in the aggregation of protein by changing the conformation of the 
molecule has been reported [ 148, 154]. In, addition, trapping of moisture 
between the AFM tip and the substrate surface might have induced inter and 
intra-molecular hydrogen bonding, resulting in conformational changes, which 
might have induced an aggregation [149, 155]. This is probably due to fairly low 
salt concentration in the trapped moisture, the attractive electrostatic interactions 
between an acidic amino acid residue of one protein and basic amino acid 
residue of other, both within the molecule and between adjacent protein 
molecules would dominate the repulsive interaction interaction forces. 
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The measurement of the size of the ferritin deposits in terms of area, length 
width and volume histograms are consistent with each other in terms of overall 
trend. However, the measurement in terms of width as shown in Figures 3.5 [C], 
3.6 [C] shows 4-12 nm features, a size range which is more closer to the size of 
individual ferritin molecules reported in AFM and X - ray crystallographic 
studies [142, 144, 145, 147]. The width could be most likely considered 
diameter of the particle. Both in air and in liquid, the proportion of features 
measuring 4 - 12 nm (on the basis of width), demonstrated a similar, but 
significant decrease (23 %) after lyophilization Figures 3.5 [C] and 3.6 [CD. 
However, the proportion of features measuring 8-12 nm (on the basis of length) 
suggested more decrease in the liquid by about 10 % after lyophilization. This 
could be due to excessive hydration, which might have led to an increase in the 
size. The other likely cause of the more increase in y dimensions of the protein, 
probably caused by the distortion of molecule during TM AFM. This increase in 
size is also supported by literature [67, 142, 146, 156, 157]. The distributions in 
Figure 3.5 [A], [B], [C] and [0] complement each other and show similar trends 
displayed in Figure 3.6 [A], [B], [C] and [0] to explain the impact of 
lyophilization on the level of aggregation. However, from the Figure 3.6 [0], the 
increase in the proportion of (5 - 12 nm3) aggregates after lyophilization and 
decrease in the proportion of aggregates ( > 2000 nm3) appears doesn't appear to 
correspond to area distributions in Figures 3.6 [A]. This could be due to the 
reason of the distortion of the single proteins caused during the taping mode 
AFM [67, 142, and 157]. Moreover, the larger proportion of smaller aggregates 
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both in air is likely due to the drying forces in air which set individual molecules 
apart and even breaks protein in to subunits. In liquid, the other likely reason is 
repulsion caused by the hydrophilic surface of mica, because isolectric point (pI) 
of ferritin native is 7.3 [65]. Therefore, it would be appropriate to omit volume 
distributions, and draft conclusions on the basis of data given in area, width, and 
length distributions. To be more precise, the width or length distributions serve 
the best purpose to explain the effect of lyophilization on aggregation, because 
the size of the ferritin deposits equivalent corresponding to the size of individual 
ferritin molecules (monomers) or dimers was best illustrated by width or length 
distributions. 
Over all, the SPIP analysis of AFM scans indicated that lyophilization caused a 
reasonable decrease in the proportion of m o n o m e r ~ c c and smaller aggregates both 
in air and liquid. However, in liquid the reduction in their proportion was 
relatively more. The particles observed diameter of the ferrtin molecules was 
found identical as well as larger than that reported in literature [136, 142 - 147, 
158, 159]. This finding compliments to that reported in AFM studies of 
lysozyme, where the observed diameter was found about five times greater than 
that confirmed by X - ray crystallography [146]. Lyophilized samples in liquid, 
formed relatively lesser proportion of bigger aggregates ( > 2000 nm\ 
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3.6.4 Morphological studies of ferritin powders 
The morphology of the non-lyophilized and lyophilized ferritin deposits is 
illustrated by the SEM scan in Figure 3.7 Ferritin appears to be more porous 
prior to lyophilization. The larger agglomerates come into sight in both samples. 
Sharp crystalline surfaces also become visible and this effect predominates after 
lyophilization. 
Figure 3.7 SEM images of non-lyophilized and one time Iyophilied ferrtin. Top two 
(50 micron) obtained at low maginfication; bottom two (10 micron) collected at high 
magnification. 
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3.7 Conclusions 
AFM images of both non - lyophilized and lyophilized ferritin confirmed that 
deposits of ferritin molecules are randomly arranged onto the hydrophilic 
surface of mica. In air, arrangement of the deposits of ferritin molecules onto 
mica surface was denser than in liquid. Lyophilization was found to reduce the 
proportion of monomeric ferritin significantly more when the experiments were 
performed in liquid. Contrary effect was observed in case of aggregates (other 
than monomeric) whose proportion was found to increase after lyophilization 
significantly. Approximately 50 % of the population of ferritin species 
(monomeric) were detected in the non-lyophilized samples, both in air and in 
liquid, which suggests an inherent tendency of ferritin to resist aggregation. 
Lyophilization, however, significantly reduced the proportion of such species 
both in air and liquid. Furthermore, the propensity of ferrtin to remain porous is 
adversely affected by lyophilization. 
140 
Mudasir Ahmad Lone Chapter 4 
Chapter 4 
Nanoscale characterisation of the 
effect of multiple cycles of 
lyophilization on the aggregation 
of polyclonal IgG antibody 
without excipients 
4.1 Introduction 
This chapter describes the effect of multiple cycles of lyophilization on the 
aggregation of a polyclonal IgG (antiglucose-6-phosphate dehydrogenise) antibody 
without excipients. Antibodies and antibody based protein therapeutics currently 
represent a rapidly growing class of medicines. However, due their inherent 
tendency to aggregate especially in solution, protein inactivity may result [160]. 
The dry formulations are favoured to aqueous preparations as the water 
(nucleophile in hydrolysis reactions and a plasticizer) proliferates the molecular 
freedom of movement of reactive chemical moieties/groups. Therefore, making 
aqueous formulations of proteins therapeutics are inherently less stable than their 
corresponding dried form. This increased stability of dry formulations has 
captured the attention toward the development of drying methods, which has lead 
to the lyophilization, a popular and considered most effective process of water 
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removal. However, despite drying with lyophilization, undesirable changes still 
occur in the protein formulation, which destabilize protein. Consequently, the 
unstable proteins aggregate and result in the loss of monomers. This has been 
reported for various proteins which reconstituted again after being exposed to 
lyophilization [46, 51, 160, 161, 162, 163]. The extent of change from native 
state produced in the protein as a consequence of lyophilization or reconstitution 
following lyophilization depends on the nature of a protein based formulation as 
discussed in the introductory chapter [1, 13, 55, 163, 164]. The occurrence of 
aggregates in protein formulations is detrimental, because aggregation reduces 
the therapeutic effectiveness due to the loss of the active (usually monomeric) 
form of the protein. Furthermore, administration of such proteins based drugs to 
a patient can lead to immunological repercussions and can be fatal [165]. In this 
way, aggregate formation is a hindrance in the development and 
commercialization of therapeutic proteins [165]. Over the last few decades 
quantification and identification (type) of aggregates present in protein 
formulations has become increasingly important for drug development 
companies and regulatory agencies. Sub-visible aggregates (0.1 - 111m) 
represent the most threatening species amongst all aggregates, primarily due to 
difficulty in their detection by majority of the standard techniques presently 
employed for such an analysis and are potentially due to their ability to mimic 
highly immunogenic viruses and bacteria with respect to size [90, 166]. The 
presence of sub-visible and visible (1 - 50 11m) aggregates in protein 
formulations has made the characterization of protein aggregates a complex 
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phenomenon and therefore, justified the demand for the use of several analytical 
techniques to detect and quantify different aggregates that comes under their 
detection capability [77, 78, 79, 80,81, 82, 161, 167]. In this chapter, an attempt 
has been made to detect and quantify such aggregates in an IgG antibody sample 
and to probe the ability of an IgG antibody to withstand such changes that could 
trigger aggregation. IgG was lyophilized multiple times (0 - 7) and the 
aggregation state of the antibody was investigated in the liquid state and in dry 
form. Several parameters were examined in these studies such as the particle 
size, the effect of protein concentration, thermal and structural stability, and 
morphological characteristics. 
4.2 Aims and objectives 
The main aim of this study was to examine the behaviour of a polyclonal IgG 
antibody in response to the effect of multiple cycles of lyophilization (MeL). 
The exposure of IgG to MeL was to probe the indigenous capability of IgG to 
resist aggregation. Probing the potential of IgG (without any dissolved 
lyoprotectant) to counter aggregation is part of the development of a novel 
standard screening method that would enable us to scrutinize the impact of MeL 
when IgG will be lyophilized with lyoprotectants for comparative analysis. 
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4.3 Materials 
Lyophilized powder of anti-glucose-6-phopshate dehydrogenase (G-6-PDH) 
antibody produced in rabbit (IgG fraction of antiserum in 0.01 M PBS), 
phosphate buffered saline (PBS) tablets, Mica (G250-1, 3"x 1"). Deionised 
water of 18 M n cm resistivity was used for the preparation of 0.01 M PBS (pH 
7.4) solution, which was filtered (0.2 J.lm) and subsequently used for the 
reconstitution of ,lyophilized IgG, and as a medium for conducting size 
measurements of IgG aggregates. Sterile 0.2 ~ m m Ministart filters for filtration of 
deionized water. Silicon nitride AFM cantilevers (termed -'DNP-S' and 'SNL'), 
from Nanoprobes (Veeco) CA for imaging in liquid. Silicon nitride AFM 
cantilevers (RTESPA, Nanoprobes (BrukerNano, Coventry, UK) were utilized 
for tapping mode AFM imaging of powdered formulations of lyophilized IgG in 
air. 12.5 mm aluminium pin stubs and black carbon discs from Agar Scientific 
were employed for conducting SEM imaging experiments. The batch numbers 
of all the indicated materials are listed in the Appendix 1. 
4.4 Sample preparation methodology 
4.4.1 Preparation of IgG solution 
This has been already described in section 2.1.1.2 of Chapter 2. 
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4.4.2 Lyophilization of IgG 
Lyophilization of IgG has been discussed in section 2.1.4.2 of Chapter 2. 
4.4.3 Formulations of IgG 
Samples of IgG (1.2 roM) exposed to multiple (1, 2, 3, 4, 5, 6, and 7) cycles of 
lyophilization were formulated in the form of liquids and dry powders. 
4.4.3.1 Samples from liquid IgG formulations 
The mode of sample preparation of IgG from liquid formulations was decided 
by the parameter (attribute) to be analyzed and the working methodology of an 
investigating appliance. Initial studies involved the preparation of IgG samples 
for particle size analysis with AFM. The high sensitivity of the employed 
instruments and the natural tendency of IgO to aggregate at high concentration 
led us to work with a minimum possible concentration of IgG. 
4.4.3.1.1 Liquid samples for AFM particle size analysis 
Two types of samples with two different concentrations were prepared. The 
scheme of sample preparation for probing the effect of lyophilization on particle 
size is presented in Table 4.1 
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Sample Preparation scheme 
20 !!l of zero cycled IgG, (concentrations: 0.75 !!g/ml and I !!g/ml) 
1. was deposited onto a clean mica surface supported by a round steel 
disc, and then directly imaged with AFM in 0.01 M PBS 
20 !!l of lyophilized (one cycled) IgG, (concentrations: 0.75 !!g/ml 
2. and 1 !!g/ml) was deposited onto a clean mica surface supported 
by a round steel disc, and then directly imaged with AFM in 
0.01 M PBS 
Table 4.1 Scheme of the preparation of IgG samples for AFM particle size 
analysis 
4.4.3.1.2 Liquid samples for light scattering experiments 
Samples of IgG (1.2 mM) exposed to 1, 2, 3, 4, 5, 6, and 7 cycles of 
lyophilization were reconstituted in filtered deionised water and subjected to 
light scattering for particle size analysis. IgG was also analysed at three 
different concentrations: 0.125 mg/ml, 0.25 mg/ml, and 0.5 mg/ml of IgG in 
order to investigate the impact of concentration. 
4.4.3.1.3 Samples from powdered IgG formulations 
Powdered formulations of IgG (1.2 mM) exposed to (1 - 7) cycles of 
lyophilization were directly utilized for required examination such as AFM, 
SEM, DSC, and A TR-FfIR. 
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4.5 Methods of analysis 
4.5.1 Atomic force microscopy 
AFM tapping mode imaging was utilized for particle size analysis as well as to 
study the different components in the powdered lyophilized formulations of 
IgG. Taping mode (TM) AFM imaging in liquid for particle size analysis was 
performed using a. Multimode AFM with a Nanoscope V controller (Bruker 
Nano) equipped with an E-scanner (approximately 14 !lm X-Y scan range). IgG 
samples (1 and 2) described in section 4.4.3.1 were imaged with "DNP" silicon 
nitride (ShN4) cantilevers at room temperature. IgG samples were imaged in 
liquid (0.01 M PBS) only and PBS was directly injected into the cell, followed 
by the injection of protein (lgG) in order to evade the aggregation of protein. 
Imaging (topography and phase) of dry powders was performed with aD - 3000 
AFM and a Multimode II AFM (Bruker Nano) equipped with an E-scanner. 
RTESPA" silicon nitride (ShN4) cantilevers were used for imaging of powdered 
samples at room temperature. The amplitude of oscillation was set constant 
during the image acquisition. The images were acquired at a scan speed of 2 
kHz (512 x 512 pixels). 
4.5.1.1 Analysis of AFM images 
Grain analysis of the acquired AFM images obtained for IgG in liquid was 
carried out by making use of Scanning probe image processor (SPIP) ™ V 4 10 
the same way as described in the section 2.6.1.2 of Chapter 2. 
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4.5.2 Light scattering 
4.5.2.1 Dynamic light scattering 
The characterization of particle size was also conducted using a Viskotek DLS 
(Malvern Instruments Ltd, Worcestershire, UK) equipped with a 630 nm laser. 
Approximately 80 JlI of sample solution was injected into the cuvette to 
determine particle size. Each sample was first equilibrated for 30 minutes at 25 
°C prior to the first measurement. Data collection was performed by taking 40 
acquisitions for each measurement. 
4.5.2.2 Nanosight Nanoparticie tracking analysis 
NanoSight LMIO (NanoSight Ltd., Amesbury Wiltshire, UK), enabled with 
laser output of 40 mW at 640 nm was also introduced for particle size 
characterization. A syringe was employed to introduce 10 - 30 JlI of protein 
solution into the sample chamber until the liquid sample reached the tip of the 
nozzle. For each sample, a minimum of three measurements were recorded. All 
measurements were recorded at room temperature. Nanosight software enabled 
the image analysis (tracking of individual particles and their size measurement). 
The displayed frequency size distribution histograms by software were output to 
a spread sheet for comparative analysis with DLS results. 
148 
Mudasir Ahmad Lone Chapter 4 
4.5.3 Scanning electron microscopy 
The effect of lyophilization on the particle morphology and porosity was 
examined using a lEOL lSM-6060LV (lEOL (UK) Ltd., Welwyn Garden City, 
and UK) at various magnifications. The powdered samples of IgG (lyophilized 
and non-lyophilized) were mounted onto carbon stub and gold coated at 30 rnA 
for 2 min in an argon atmosphere prior to SEM analysis. SEM analysis was 
conducted under high vacuum at a voltage 10 - 14 kV. Scan sizes were variable 
(1- 50 Ilm). 
4.5.4 Thermal stability analysis 
A Q-2000, differential scanning calorimeter (T A Instruments Ltd, Fleming 
Centre, Manor, Crawley, West Sussex, UK) with purged nitrogen gas was 
used. Dry powdered samples (2-5mg) were analyzed in crimped hermetically 
sealed aluminium pans. Samples were heated from 0 DC - 200 DC at a scan 
rate of 10 DC/min. The melting points of the IgG antibody lyophilized 
multiple times on its own were obtained as the midpoint of the corresponding 
transition by integrating the slope of the DSC curve. 
4.5.5 Structural stability analysis in the solid state 
A Nicolet FT-IR-spectrometer was employed to record spectra for the 
determination of changes in the secondary structure of lyophilized IgG. Sample 
powder (2 - 3 mg) was placed on a clean glass slide and then mounted on the 
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sample stage. The spectra for each sample were recorded from 4000 to 650 cm"1 
in ATR mode at room temperature. Each measurement was an average of 200 
scans, at a scan speed of 0.15 sec"1 and a resolution of 2 cm- I . The optical bench 
was purged with dry nitrogen to avoid interference from water vapour infrared 
absorption. Each spectrum was background corrected for the glass slide. The 
amide I (1720 - 1600 em"l) and amide 11(1575 - 1480 em"l) regions were used 
to analyze changes in the secondary structure of protein [129]. 
4.6 Results and Discussion 
A first step in this study involved particle size characterization of the effect of 
multiple cycles of lyophilization on the aggregation profile of IgG. The particle 
size characterization was performed with AFM, DLS and NT A. In the next set 
of experiments, AFM and SEM imaging of lyophilised powders of IgG was 
performed. Subsequently, the lyophilised powdered samples of IgG were 
subjected to DSC and ATR - FTIR analysis for mapping any changes in the 
thermal and structural stability. 
4.6.1 Imaging of IgG samples in liquid 
The comprehensive characterisation of IgG on solid/liquid interfaces is of 
considerable significance for antibody based applications in medicine and 
industry [168, 169,170, 171]. However, an inability to control and eliminate 
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non- pecific ad orption of IgG to solid interfaces creates a hindrance for their 
application in the above mentioned field [ 169, 170, 171] . The other reason is 
repul ion cau ed by the hydrophilic surface of mica. It has been also reported 
that a one move away from i olectric point (pI - 6) of IgG, the decrease in 
ad orption rate becomes evident at pH 8.0 than that at pH 4.0. The reason is an 
increase in the electrostatic repulsion between the charged antibody molecules 
within the ad orbed layer [72, 74, and 172]. Therefore, these imaging 
experiments (IgG in liquid) were performed with care to avoid surface induced 
aggregation. Surface induced aggregation was confirmed for an IgG sample 
which was prepared, when 20 ~ l l of IgG [(1 ~ g / m l ) , , once lyophilized] was 
incubated onto the urface of sub trate for one minute and dried prior to liquid 
imaging Figure 4.1. 
B 
Figure 4.1 3D . TM AFM one micron scans of lyophilized (Cycle 1) sample of IgG 
(concentration 1 /lg/ml): [Al Sample directly injected into the liquid cell; Z - scale 6.7 
nm. [B] Sample incubated on mica in air for a minute; Z - scale is 16.7 nm. Slight 
expo ure to an air pronounced the formation of much larger aggregates of IgG 
aggregation. The formation of monomeric and lower multi-merk forms were not 
detected. 
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On expo ure to air, IgG ignificantly aggregate on a hydrophilic surface [173] . 
Thi icon i tent with the ob ervation here of large aggregates (Figure 4.1) 
formed due to a lateral reorganization of the adsorbed protein layer at the air -
liquid interface [173. 174]. The pattern of the aggregate formation depends on 
the nature of protein and orne propertie of the ad orbed protein (such as the 
number of contact point with the surface) [173, 174]. In order to avoid the 
po ible chance of urface or drying induced aggregation, IgG sample solution 
(in 0.01 M PBS) were directly injected into the liquid cell rather than allowing it 
to incubate onto the mica urface. Figure 4.2 represents tapping mode AFM 
image of zero-cycled and once lyophilized samples of IgG immobilized on 
hydrophilic mica urface in buffer (0.01 M PBS) after direct injection. In 
general, more than 40 image indicated that the arrangement of IgG molecule on 
mica was lib-monolayer coverage at thi concentration. 
Figure 4.2 TM FM cans of: [A] Non - lyophilized and [B] Lyophilized IgG 
molecule on the hydrophilic urface e of mica. Z - scale for each scan is 6.7 nm. 
Concentration of both ample was I Ilglml. 
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AFM scans of zero and one time lyophilized IgG show a range of aggregates (up 
to 200 nm in diameter) and randomly immobilized IgG particles on the 
hydrophilic surface of mica is shown in Figure 4.2. The randomness and sparse 
distribution of IgG molecules is most likely due to the poor physisorption of IgG 
molecules to the hydrophilic mica surface as well as the concentration 
employed. Moreover, the adsorption of soft proteins (such as IgG) onto solid 
interfaces is governed by several factors, which makes it difficult for AFM to 
characterise the protein properly due to relatively uncontrolled and random 
orientation of the protein on a surface. For example when mica is used, 
electrostatic forces can develop and can play a significant role in protein 
adsorption [136,171,175]. 
In both samples most of the IgG features on the surface have an average 
dimensions (x - in the range of 8 - 12 nm and y - in the range of 18 - 25 nm). 
This is the very close to the size reported for monomeric IgG [67, 176]. The 
dimensions of monomeric IgG measured from AFM imaging data, are slightly 
larger than that reported in literature from other techniques [ 177]. This 
disagreement in size is mostly likely due to the compression of the tip that 
enhances the - x and - y dimensions of the imaged proteins and tip - sample 
convolution effects. The proportion of multimeric (60 nm) and larger aggregates 
with diameters ( > 100 nm) increased after lyophilization. 
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4.6.2 AFM particle size analysis 
The grain analysis of all the individual TM AFM scans of IgG nanoparticles 
(non-lyophilized and lyophilized) was performed as described in section 3.5.3. 
Both samples of IgG were scanned with AFM at a concentration of 1 ~ g / m l . . The 
AFM scans obtained were subjected to SPIP analysis as described in section 3.1 
and 3.2 to produce distributions as shown in Figure 4.3. Size analysis suggested 
the formation of a range of aggregates which were binned into several groups as 
follows: on the basis of area (Figure 4.3 [A], length (Figure 4.3 [B]: width 
(Figure 4.3 [C] and volume (Figure 4.3 [D]. The four parameters: - area, length, 
width and volume were set to ensure proper size characterization of IgG which 
is quite intricate because IgG molecules are highly susceptible to multiple 
surface attachment orientations due to their two dimensional and extremely 
flexible natures [178]. The aggregation profile of the detected grains produced in 
this way made it convenient to quantify the effect of lyophilization [Figure 4.3]. 
AFM was able to detect particle species of IgG with variable dimensions. The 
IgG features measuring (200 - 300 nm2), (18 - 25 nm), (8 - 12 nm) and (12 -
100 nm3) respectively on the basis of area, length, width and volume constituted 
the largest proportion of features both before and after cycle one of 
lyophilization. The indicated aggregates in Figure 4.3 [A] and [D] are multiples 
of the 1trI2, and 4/31tr/ respectively where rl is half of the diameter of IgG 
fragments, and could be anywhere in the range of (1 - 12 nm) because of the 
distortion and r2 is the height of fragments from the surface and could be (1.3 -
1.5 nm). These findings are comparable to that reported in literature for IgG [9]. 
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Figure 4.3 Relative particle size distribution of: IgG (cycle 1) in liquid at a 
concentration of 1 ~ g l m l . . Blue and red bars respectively represent data before and 
after lyophilization. [A], [B], [C], and [D] respectively show the comparison of the AFM 
mea urements of the areas, lengths, widths and volumes of IgG deposits in zero - cycled 
and once lyophilized IgG in 0.01 M PBS. In each et, blue and red bars represent data 
obtained form 40 AFM scans (I Ilm each) before and after lyophilization, (a) and (b) 
respectively show standard deviations and an average size of adsorbed IgG features in each 
distribution before and after lyophilization. 
In Figure 4.3 [C], the ize of the features measuring (8 - 12 nm) in width, most 
probably represent whole IgG molecules with two roughly equivalent domains 
(- 8 - 12 nm) across, whereas (13 - 18 nm) likely correspond to single IgG 
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domain [C] most likely correspond to antibody fragments (Fab or Fc) and were 
produced only prior only in zero cycled sample of IgG. This could be probably 
due to distortion with an AFM tip and flexible nature of of IgG thatthat might 
have resulted in overlapping of the antibody fragments over each other. The (18 
- 25 nm) features shown in Figure 4.3 [B and C] more closely correspond to the 
size of individual IgG molecules, because the IgG molecule has been described 
as an ellipsoid with axes of 14.5 nm x 8.5 nm and thickness of 4 nm [179]. 
Moreover, the (18 - 25 nm) features could also be either one whole distorted 
AFM or two Fab fragments together. This is better supported by the data given 
in Figure 4.3 [C], which confirms the presence of IgG features measuring (8 -
12 nm). The (25 - 50 nm) features more probably represent one distorted IgG or 
two to three whole IgG's together depends upon their alignment on the surface. 
The rest of the features (50 - 100 nm), (100 - 200 nm) and above) correspond to 
aggregates formed from larger numbers of IgG molecules. This is possibly due 
to the concentration of the applied IgG and the exposure time at the interface is 
long enough to decrease the probability of detecting individual IgGs. Moreover, 
it is also well-known that under such experimental conditions there is a high 
propensity for IgG to aggregate [180]. Another possible reason could be 
sweeping of the adsorbed or weakly bound proteins during imaging even in 
tapping mode, the AFM tip can move the proteins from their position and can 
promote aggregation [179]. All these findings are supported by other 
measurements reported in AFM and X-ray crystallographic studies [178, 179]. 
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Table 4.2 gives a simplified and summarized account of percentage change 
produced in each indicated group of aggregates in Figure 4.3. Analysis of data in 
Table 4.2 is an indicative of a significant change produced in the aggregation 
profile as a consequence of lyophilization. This was confirmed by observing 6 % 
and 4.2 % decrease respectively in the proportion of the first (200 - 300 nm2) 
and second ( > 1000 nm2) largest family of aggregates. However, the proportion 
of aggregates measuring (300 - 1000 nm2) increased 18 % after lyophilization, 
though their contribution towards total aggregate proportion was significantly 
much lesser than the first and second largest families. This has not been reported 
in earlier studies [180, 181]. 
Similarly length and width (Figure 4.3 [B and C)) distributions demonstrated 
almost an identical aggregation profile. The percentage decrease (7 - 9 %) 
produced in distorted Fab or Fc (4 - 8 nm) in lyophilized IgO was almost 
identically addressed by length and width (Figure 4.3 [B and CD distributions. 
However, following lyophilization, an increase in the proportion of 8 - 12 nm) 
species [two Fabs together or whole IgO] by 2.5 % and (12 - 18 nm) particles 
[longest axis IgOs and one whole IgO or couple of IgO's together] by 9 % was 
better picked up by width distribution [for results see Table 4.2]. The increase 
(12.7 %) in propensity of IgO molecules to form lower multimeric forms (25 -
50 nm) for lyophilized IgO was confirmed by length distribution. The increase 
in the proportion of higher multimeric (50 - 100 nm) aggregates by almost 6.33 
157 
Mudasir Ahmad Lone Chapter 4 
% (Figure 4.3 [BD was also confirmed by width distribution (Figure 4.3 [CD by 
2 %. Despite some similarities or dissimilarities, the aggregation profile 
displayed in Figure 4.3 [A and D) confirmed the indicated group (200 - 300 
nm\ (12 - 100 nm3) that represented the largest proportion of aggregates 
observed a significant decrease after lyophilization. In contrast, the increase in 
the proportion of other large indicated groups of aggregates was less significant 
(Figure 4.3 [A and D). Moreover, the aggregation profile displayed in Figure 4.3 
[B and C) confirmed significant decrease in the proportion of fragments, and 
increase in the proportion of likely monomeric and distorted IgGs (one, two or 
three together). This is likely caused either by drying stress or due to the 
distortion produced by intermittent tapping of the tip with the surface of the 
substrate or both (178). The data are consistent with that reported in literature 
for IgG aggregate formation at the ice/freeze-concentrate interface (179). The 
statistical significance was determined by utilizing t-test discussed in the section 
4.7 of chapter 2. 
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Table 4.2 Percentage increase in the proportion of IgG aggregates 
after lyophilization (- means decrease) 
AREA (om2) 
3.5 -8 2.8 % 
8.0-30 5 % 
30 -200 0.6 % 
200 - 300 (First largest family - 50%) 6.1 % 
300-500 - 9 % 
500 - 1000 - 9.8 % 
~ ~ 1000 (2nd largest family - 30%) 4.15 % 
WIDTH (om) 
4 - 8 (Distorted Fab or Fe) 8.7 % 
8 - 12 (Two Fabs or whole IgGs) 2 % 
12 - 18 (Longest axis IgGs) - 2.5 % 
18 - 25 (One deformed or two whole IgGs ) - 9 % 
25 - 50 (Two deformed or three whole IgGs ) 0.5 % 
50 - 100 (Aggregates) 6.3 % 
~ ~ 100 1.8 % 
LENGTH (nm) 
4 - 8 (Deformed Fab or Fe) 7.09 % 
8 - 12 (Two Fabs or whole IgGs) 0.61 % 
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12 - 18 (Longest axis IgGs) 0.61 % 
18 - 25 (One deformed or two whole IgGs ) 0.29 % 
25 - 50 (Two deformed or three whole IgGs - 12.7 % 
50 - 100 (Large aggregates) 1.9 % 
100 - 200 (Larger aggregates) 
- 2.9 % 
~ ~ 200 (Largest aggregates) 4.5 % 
VOLUME (nm3) 
4.5 -12 - 8.1 % 
12 - 100 14.5 % 
100 - 500 - 11.8 % 
500 - 1000 - 1.5 % 
1000- 2000 - 5.1 % 
~ ~ 2000 12.1 % 
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4.6.3 Size measurements with DLS 
The multiple times lyophilized samples of IgG were separately subjected to DLS 
analysis for the determination of particle size (hydrodynamic diameter). Multiple 
measurements were recorded for each sample Figure 4.4 displays a typical DLS 
intensity distribution of lyophilized IgG sample (cycle 0 at 0.25 mg/ml) that was 
recorded at the mid-point of an experiment. The intensity distribution for each 
sample was obtained after compiling more than 40 readings together at 25°C and 
measurements were performed in 0.01 M PBS. The DLS intensity distribution 
(Figure 4.4) is an indicative of a heterogeneous protein solution containing 
particles of different diameters. An increase in hydrodynamic radius or 
broadening of the distribution peak suggests an increase in protein aggregate size 
[70, 79, 89, 88, 182, 183]. The DLS data shown in Figure 4.4 [A] confirms the 
population of aggregates in the size range of (4 - 1700 nm). The peak measuring 
5.7 nm corresponds roughly to the size of monomeric IgG, whereas 34.4 nm 
particles pertain to the existence of smaller aggregates formed during 
lyophilization. The highest intensity peak (146 nm) in the distribution represents 
the aggregates that scatter most of the incident light. The aggregates measuring 
above 1000 nm (for instance 1671 nm in Fig 4.4) were of lesser significance, due 
to their relatively lower and almost negligible proportion in the sample solution 
(details given in Chapter 2). DLS measurements of multiple times (0 - 7) 
lyophilized formulations of IgG were recorded at three different molar 
concentrations (0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml). It is important to 
mention that the DLS data is inter-convertible as shown in Figure 4.4 [B], which 
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Figure 4.4 Typical DLS intensity distribution of IgG (0.25 mg/ml). [A] Cycle 0 and 
[B] Cycle 1: repre enting an example of data inter-conversion from bar to line chart . 
The intensity distribution was obtained after compiling more than 40 readings together 
at 25 DC and measurements were performed in 0.01 M PBS. 
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proved to be useful for overlaying multiple data sets for comparative analysis as 
shown in Figure 4.5 . 
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Figure 4.5 Overlaid aggregation proftles of: multiple times (0 - 7) lyophilized 
samples of IgG obtained by DLS at room temperature (0.25 mglmJ). The shift of the 
larger peak towards right demonstrates increase in aggregation with increase in the 
number of cycles of lyophilization. 
The DLS aggregation profiles of all the multiple times (0 - 7) lyophilized 
formulations of IgG without excipients (Figure 4.5) demonstrated similar 
propensity toward aggregation and confirmed the formation of aggregates of 
variable izes which were categorised into seven classes: (4 - 7 nm), (10 - 15 
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nm), (15 - 20 nm), (20 - 30 nm), (30 - 100 nm), (100 - 500 nm) and (500 -
1000 nm). Most of the aggregates detected by DLS in all lyophilized samples 
had a hydrodynamic radius between (100 - 200 nm) [184]. The proportion of 
these aggregates in all the multiple times lyophilized samples was the highest, 
and were almost produced more or less in identical proportion in all samples: 
cycle 1 (46.7 %), cycle 2 (45 %), cycle 3 (44.5 %), cycle 4 (43.4 %)] and the 
lowest in the 6n times lyophilized sample (32.2 %). The general shift observed 
in the major peak of the intensity distribution towards larger particle size 
suggested that successive lyophilization enhanced aggregation. However, the 
observed shift in the major peak of the intensity distribution does not effectively 
address the behaviour of therapeutically more significant particles such as 
monomers and smaller aggregates in the antibody sample. This is because the 
DLS intensity distribution is biased to larger particles (see section 2.8.1). 
Therefore, the number distributions presented in Figure 4.6 were taken into 
consideration. It was observed that there was a consistent decrease in the 
proportion of monomeric and other smaller sized IgG aggregates with multiple 
cycles of lyophilization which is consistent with AFM results. This indicated that 
the exposure to repeated cycles of lyophilization increases aggregation propensity 
and is likely due to the repeated stress caused to the protein during multiple cycles 
of lyophilization. Such stresses include for an example, an increase in the effective 
solute concentration that occurs during initial freezing of the protein solution and 
can lead to changes in the pH, and possible increases in the inter protein interaction 
during the sublimation phase in vacuum [54, 57, 185, 186]. 
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Figure 4.6 Influence of successive cycles of lyophilization: on the aggregation of IgG 
(l mglml) without added excipients. The figure shows size analysis of the particles after 
successive lyophilization. The error bars represent average of the standard deviations of 
three sets of measurements recorded for each sample. Blue bar towards the extreme left 
corresponds to the size of IgG in non-lyophilized sample, whereas pink towards the 
extreme right shows the size of IgG features in seven times lyophilized sample of IgG. 
4.6.4 Nanosight measurements of IgG 
The multiple times (0 - 7) lyophilized formulations of IgG studied In 
DLS experiments were monitored in situ In the NanoSight sample 
chamber at room temperature. NTA enabled real time visualization of the 
multiple time (0 - 7) lyophilized formulations of IgG at two different molar 
concentrations (0.25 mg/ml and 0.5 mg/ml). A minimum of three measurements 
were recorded for each sample by NT A. All measurements were recorded for 50 
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Figure 4.7 Size distribution of (10 - 400 nm) population acquired: from NTA 
measurement of non-lyophilized sample of IgG that was formulated in PBS at a molar 
concentration of 0.5 mg/ml (middle section) with the corresponding NTA video frame 
(top section) and 3D graph (intensity versus size (concentration); bottom ection). 
Measurement wa recorded at room temperature for zero-cycled sample of IgG at molar 
concentration of 0.5 mg/mI . 
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seconds with manual shutter and gain adjustments. The different particle species 
were captured by.employing single shutter and gain mode operation. Figure 4.7 
demonstrates a representative example of one such measurement recorded in 
non-lyophilized IgG (cycle 0) at room temperature. 
The particle sizes with different scattering intensities can be observed in 
the NT A video frame, size distribution graph and can be visibly 
distinguished in the 3D graph (Figure 4.7). NT A analysis of IgG (zero 
cycled) formulated at 0.5 mg/ml displays populations of aggregates of 
different sizes. The larger light scattering centres shown in top panel are 
more than smaller scattering centres. This is mainly caused by a masking 
effect of the larger aggregates over the smaller ones. The smaller species 
that are close to monomers and lower multimeric forms travel so quickly 
that they frequently travel out of focus in the detection area before they 
can be tracked to be studied for the ultimate result. The disparity in 
scattering intensities displayed by the 3D graph confirms the attendance of 
different populations of similar sizes. The multiple peaks stationed at 
different positions between (10 - 400 nm) shown by the 2D graph are 
complemented by several distinct size populations (blue, purple and red) 
displayed in 3D graph. Therefore, the third dimension (scattering 
intensity) in NTA sheds light on the resolution of aggregate populations 
and also provides information about the nature of the aggregates. NTA 
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allowed precise sizing and a clear distinction of the several size populations 
for the entire multiple times lyophilized samples of IgG. With optimized 
settings, all populations of aggregates in the size range of (12 - 1000 nm) 
in the multiple times (0 - 7) lyophilized samples were detected and sized 
by NTA and are displayed in Figure 4.8. The NTA studied formulations of 
IgG showed aggregation profiles with multiple peaks which is indicative of 
the presence of multiple populations of aggregates of same size. The effect 
of successive lyophilization that was demonstrated by NT A aggregation 
profiles was compared with those produced by DLS. It was observed, that 
the Nanosight produced aggregation profiles (Figure 4.8) for all multiple times 
lyophilized formulations of IgG were similar to those of DLS with a main peak 
under and at around 200 nm. Both techniques show broadening of the 
distribution peak and therefore, suggested an increase in the hydrodynamic radii 
of the aggregates with multiple cycles of lyophilization. 
The aggregate distribution obtained by NT A shows polydispersity and an overall 
increase in the concentration of the larger aggregates with successive 
lyophilization. However, the dissimilarity in the lower detection limits of the 
two techniques was obvious when characterizing the monomers. DLS was 
able to detect the monomeric IgG (- 4 - 8 nm) due to the better lower 
detection limit compared to Nano sight. The monomeric IgG only detected 
by DLS with an average size in the range (- 4 - 8 nm) is consistent 
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Figure 4.8 Aggregation profiles of: multiple times (0 - 7) lyophilized and 
reconstituted IgG formulation (0.25 mglmJ) obtained by NT A at room temperature. 
169 
Mudasir Ahmad Lone Chapter 4 
with literature data for IgG at neutral pH [49,63]. The smallest species 
detected by Nanosight were around (-10 - 12 nm). The mean size values 
achieved by NT A were less than the Z-average specified by DLS (Figure 4). 
Furthermore, in contrast to DLS, NT A measurements indicated a smaller shift in 
the intensity of mean peak value (MPV) towards larger particle size with 
successive lyophilization. The difference in the mean size values is most 
likely due to the fact that DLS considers all species (monomers and all 
aggregates) for the Z - average and gives only a single peak shifted 
towards the larger particle size present, which is linked to its predisposition to 
form larger particles, whereas NT A considers only those tracked particles 
for calculating the mean particle size. Although, in essence, all the particle 
size distributions are same; however, alteration in the optimization for the same 
sample could lead to variability in the detection of the number of larger particles 
by the NTA software. DLS in contrast has the ability to automatically regulate 
the attenuator to acclimatise to a variety of sample concentrations. The NT A 
data presented in Figure 4.8 complimented DLS size distribution (Figure 4.5) in 
confirming IgG particles of different sizes. The formation of ( 10 - 15 nm), (15 -
20 nm), (20 - 30 nm) and their decrease upon lyophilization displayed a pattern 
identical to that shown by DLS. The class of IgG aggregagtes in the size range 
of 100 - 200 nm represented the largest proportion of aggregates was shown by 
NT A. This finding and consistent increase in the formation of (500 - 1000 nm) 
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aggregates with multiple cycles of lyophilization was complimentary to DLS. 
However, in contrast to DLS, NTA showed relatively more decrease in the 
proportion all smaller aggregates (10 - 15 nm, 15 - 20 nm, 20 - 30 nm and 30-
100 nm) towards the final cycles of lyophilization (6, 7). This is probably 
caused due to the IgG fragmentation (an effect of repeated stress) which 
Nanosight is not able to detect. 
In case of DLS results for all the multiple times lyophilized 
formulations, the standard deviations of the aggregate sizes measuring 
between (100 - 1000 nm) are larger than the ones displayed for NTA 
results. This is associated to the fact that the DLS software has to fit 
the data of an autocorrelation curve of a sample that has populations with 
size differences smaller than the peak resolution limit of DLS. As a 
consequence, the single peak as calculated by the DLS software is 
susceptible to alterations in shape and position between successive 
measurements. 
Over, all it appeared, that with multiple cycles of lyophilization, the proportion 
of larger aggregates (200 - 1000 nm) increased, whereas that of monomeric and 
lower multimeric forms decreased due to the obvious reasons of repeated stress 
that causes protein denaturation. The different analytical methods applied show 
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results in their respective measurement range [67, 114, 177, 178, 184, 187]. 
However, AFM size analysis detected much smaller and more diverse particle 
sizes than both DLS and NT A. AFM, DLS and NT A data can be compared and 
are complementary. Both AFM and DLS distribution of the IgG-samples 
confirmed that not only the particles within reported size are present, but a wide 
range of aggregates exist in IgG samples. 
4.6.5 Morphology of the lyophilized powders of IgG 
4.6.5.1 Characterization with AFM imaging 
One and seven times lyophilized powders of IgG, prepared and reconstituted 
in filtered deionized water (without excipients) were studied by AFM 
(Figure 4.10). The topography data for the one and seven cycle sample (Figure 
4.10 [A, CD shows surfaces decorated with globular features. The phase data is 
particularly clear as the variation of tip interaction with the surface of the protein 
particles and provides the basis for the observed contrast [188]. The phase 
images of both one and seven times lyophilized samples show surfaces proposed 
to be primarily consisting of solidified salts with some smaller and larger 
globular features (Figure 4.10 [B, DD. The globular features associated with 
amorphous appearing regions represent aggregates of IgG. However, it is hard to 
say that the solidified salts are crystalline, because their edges are not straight. It 
is evident in the phase data that the smallest globular features are consistent in 
size with monomeric IgG (-11 - 15 nm) and were present in both samples 
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(Figure 4.10 [B, D]). This is close to the size of IgG molecules reported in AFM 
studies [67, 176, 187, 189]. However, the mean size of the agglomerates 
increased significantly with successive cycles of lyophilization [(cycle 1:-
minimum - 31 nm, maximum - 245 nm, (Figure 4.10 [B]): (cycle 7:- minimum 
- 45 nm and maximum - 358 nm, Figure 4.10 [D]). This increase in the 
propensity of IgG to form larger aggregates with repeated lyophilization lie in 
agreement with DLS findings reported in this chapter as well as earlier reported 
[47,49,51,61,70]. 
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Figure 4.10 [A . C] and [B . D] respectively represent the AFM topography and 
phase images of: 1, and 7 time lyophilized IgG powders which were formulated and 
subsequently reconstituted in filtered deionized water. All the samples were imaged at 
room temperature under ambient conditions. Each scan is one micron. All images have 
height (Z - scale) of 100 nm and a phase angle of 160°. Concentration of the lyophilized 
protein was 2 mg/ml when in solution. AFM phase images [C and D] reveal both 
crystalline (white particulates) and amorphous (brown areas) like features. Globular 
features con i tent with IgG in term of size can also be observed. The size of the 
smaller globular features is similar to the size of monomeric IgG (- 16 - 20 nm) 
reported in previou AFM studie (Ultramicroscopy 105: 103 - 110). The larger 
globular features likely repre ent aggregates of IgG. 
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Similar AFM inve tigation were conducted for one, two and three time 
lyophilized powder of IgG reconstituted in PBS (O.OlM PBS) in order to 
addre the effect of induction of alt into the system upon reconstitution. 
Figure 4.11 [A], [B], and [C] respectively represent the AFM phase images of: I , 2, 
and 3 time lyophilized IgG powders without added excipients formulated and 
sub equently recon tituted in filtered 0.01 M PBS. All the samples were imaged at 
room temperature. Each can is one micron . All images have height (Z - scale) of 100 
nm and a pha e angle of 160". Concentration of the lyophilized protein was 2 mglmJ 
when in solution. AFM images reveal larger cry talline like structures when compared 
to amorphou feature. Globular, protein like features mostly appear to be associated 
with amorphou region. The dimen ions of the globular features and the propensity of 
the formation of cry talline like tructures increa ed due to repeated Iyohilization. 
AFM pha e image of one, two, and three times lyophilized sample 
demon trated the pre ence of ignificant crystalline areas, likely corre ponding 
to the exces alt in the system (Figure 4.11). Furthermore, an increa e in size of 
the revealed globular feature (attributable to the IgG) ob erved was consistent 
with the increa e in the proportion of cry talline material, which re ults in the 
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expulsion of solutes during lyophilization [190]. Hence compliments the DLS 
findings in that repeated stress caused to the antibody formulation during 
successive lyophilization enhances aggregation. This could be probably due to 
an increase in the content of crystalline material (salts) as revealed by AFM. In 
addition, the difference in the freezing point of the constituent salts species 
(0.138 M NaCI and 0.0027 M KCI) within the buffer (0.01 M PBS), and 
disparity in the ionized state of each salt can be different from that of their 
respective nonionized (free) states during initial freezing of the protein solution 
in the lyophilization process. The drastic change in pH as a result of this 
difference in freezing point could denature the protein being lyophilized and has 
been previously reported [13, 55, 191], and most probably enhances buffer salt 
crystallization in case of studied IgG formulations. 
4.6.5.1 Characterization with SEM imaging 
The morphology of the multiple times lyophilized deposits is illustrated by the 
SEM scans in Figure 4.12. IgG appears to be more porous and flaky prior to 
lyophilization. The more porous nature of the formulation is an indicator of 
potentially better solubility of the powder. The formation of aggregates clearly 
occurs after cycle 1 and the proportion of these aggregated areas became more 
apparent with increasing number of cycles of lyophilization. The growth of 
crystalline like areas becomes visible after cycle 1 and increases remarkably 
with successive lyophilization. Therefore, SEM micrographs demonstrated an 
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Figure 4.12 Labelled SEM observation of multiple times lyophilized (l - 7) IgG: 10 
micron scans obtained at magnification between 10 kV - 16 kV. 
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an effect similar to that displayed by AFM images, and strongly supports the 
DLS findings with this impression that the dissolved salts likely get crystallized 
during/after lyophilization due to the reasons discussed earlier in the section 
4.6.5.1 (AFM results). 
4.6.6 Thermal Stability 
The thermal stability of organic polymers could also be influenced by the stress 
produced during lyophilization [192]. This is because stress initiated changes in 
the protein structure reduces the strength of bonds between the polymer chains, 
hence, making it more susceptible to melting or/thermal denaturation. For 
example: in the case of organic polymers (such as IgG antibody), secondary, 
non-covalent bonds between the polymer chains become weak above the (T g) 
[ 193]. Higher values of (T g) are indicative of greater stability against 
denaturation. This effect was studied by differential scanning calorimetry which 
gives a measure of the melting of the protein [194]. Therefore, in these follow 
up studies, the melting points were analyzed for IgG lyophilised on its own 
without added sugars in order to find out any relevance with results shown by 
AFM, DLS, NT A and SEM. 
4.6.6.1 EtTect of lyophilization on the melting of IgG 
DSC thermogram of each time lyophilized IgG sample showed two transitions: 
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DSC thermogram of each time lyophilized IgG sample showed two transitions: 
one distinct and prominent transition peak proposed to be the denaturation 
temperature around - 58.2 °C with an enthalpy, L\H = 0.26 Jig (Figure. 4.] 3). 
Thi is similar to that reported for IgG molecules (- 61°C) [195, 196]. 
o 
No unfolding of Fe 
Unfolding of 
Fabs - 58°C 
nfolding of 
Fc- 6 °C 
Temperature eC) 
Figure 4.13 Overlaid standard DSC heating profLies of: one to seven times 
lyophilized IgG powder. The powdered formulations were heated up to 200°C at the 
rate of 10 °C per minute. IgG denatures around 58°C irrespective of the number of 
cycle of lyophilization. 
The fir t tran ition i believed to correspond to the unfolding of the two F(ab) 
domain in multi-domain IgG protein [195, 197] . The second transition 
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corresponds to the melting of the Fc domain and wa found to decrease with 
repeated lyophilization (from - 85 °C to below - 67 0c) (Figure 4.13). Tg could not be 
mea ured in antibody sample prepared without excipients [J 98]. DSC thermograms of 
one to seven time lyophilized powders of IgG demonstrate that the melting 
temperature (T m) or the temperature of denaturation of IgG lyophilized on its 
own remained unchanged irrespective of repeated lyophilization. 
Table 4.3 Tg and melting points of multiple times (1 - 7) lyophilized 
(AG - 6 - PDH) antibody formulations 
No. of cycles Formulation Protein: Exicipient Melting point (OC) 
Powdered Concentration (mM) First transition 
1 IgG 1.2:0 -58±O.15 
2 IgG 1.2: 0 - 58 ± 0.16 
3 IgG 1.2: 0 - 58 ± 0.15 
4 IgG 1.2: 0 - 58 ± 0.12 
5 IgG 1.2:0 - 58 ± 0.13 
6 IgG 1.2:0 - 58 ± 0.18 
7 IgG 1.2:0 - 58 ± 0.11 
* Tg indicates glass transition temperature, 
(AG - 6 - PDH): antiglucose - 6 - phosphate dehydrogenase antibody 
There wa no ignificant change observed in the temperature at which first 
transition initiated (Table 4.3). This suggests the ability of IgG to resi t the 
unfolding stres es induced during multiple cycles of lyophilization (Figure 
4.13). However, the effect of succes ive cycles of lyophilization on the 
unfolding of IgG i not identical, as shown by nature of DSC traces. DSC traces 
how that the propensity of antibody to unfold appears to increase during 
180 
Mudasir Ahmad Lone Chapter 4 
repeated lyophilization. This was further confirmed by observing shift in the 
melting point of Fc fragment from - 85°C (Cycle 1) to - 67°C (Cycle 7). 
Therefore, our results suggest that repeated stress caused due to lyophilization 
weakens the covalent structure of Fc fragment, therefore, making it more 
susceptible to unfolding. This may also arise from intrinsic structural elements 
of the Fc fragment which are more susceptible to stress than the F(ab) fragments 
(albeit that the Fc has a higher transition temperature and is therefore inherently 
more stable). It is also known that increased flexibility is induced to the hinge 
region due to repeated lyophilization [195,196]. During successive 
lyophilization the tendency of IgG (when lyophilized on its own) to unfold 
increases, therefore, makes IgG more prone to aggregation, and hence, supports 
the conclusions drawn from the DLS and AFM studies. 
4.6.7 Effect of lyophilization on the secondary structure 
The endothermic enthalpic change observed in DSC experiments is assigned to 
the unfolding of a part of the protein molecule. DSC does not give any detailed 
information on a molecular scale, about the change in the protein structure. 
Therefore, any possible damage caused to the secondary structure of an IgG 
antibody during multiple cycles of lyophilization IgG was investigated using 
FT -IR spectroscopy. 
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Figure 4.14 Overlaid, base line corrected and normalized FTIR - A TR spectra of: 
one to seven time lyophilized IgG deposited on the clean surface of a glass slide. 
Spectra were recorded between 1300 and 1800 em- I. The two main peak towards right 
under each curve corre pond to amide bands I and II. 
The overlaid ATR pectra for the one to even time lyophilized IgG powders 
(without added excipient) are hown in [Figure 4.14]. Typical amide I and 
amide II A TR ab orbance pectra were observed for each sample. This 
identified that the removal of water through lyophilization had a negligible 
impact on the appearance of the amide bands I and II absorbance spectra. 
Typically, FT-IR pectrum of any tructurally stable protein such as an IgG 
antibody how two main molecular absorption region or amide bands (I and II) 
[199]. The amide I and II ab orption region emanate from two chemical group 
of the peptide back bone. The amide I band primarily represents the C = 0 
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stretching vibrations of the peptide bond groups (coupled to the in plane NH 
bending and C-N stretching modes) [200]. The frequency of this vibration 
depends on the nature of the hydrogen bonding in which the C = 0 group is 
involved. Consequently, the nature of the hydrogen bonding determines the type 
of secondary structure adopted by the polypeptide backbone. For an example: -
a-helices [average -1652 em-I, range: 1650 - 1658 em-I], ~ - s h e e t t [(i) average 
-1617 em-I, range: 1615 - 1620 em-I (ii) average -1639 em-I, range: 1628 -
1645 em-I, (iii) average - 1690 em-I, range: 1686 - 1697 em-I], non-ordered 
structures [average - 1645 em-I, range: 1640 - 1650 em-I], and finally turns [(i) 
average - 1670 em-I, range: 1660 - 1667 em-I, and 1676 - 1680 cm-1 [26, 31]. 
Molecular absorptions in the regions from (1690 - 1638 em-I) and (1568 - 1517 
em-I) respectively correspond to amide bands I and II (Figure 4.14). Our results 
show amide I and II peaks centred at 1639 em-I and 1545 em-I which is an 
indicative of IgG powders rich in ~ ~ - sheet content [201, 201]. The absorbance 
spectra in this region are used frequently for determining the secondary structure 
composition of various proteins, including IgG [199, 202, 203, 204, 205]. These 
values are close to those reported in literature (1690 - 1600 em-I) and (1600-
1480 em-I) and appeared in all lyophilized samples of IgG [200, 201,206]. This 
suggests maintenance of secondary structure during repeated lyophilization. 
Therefore, secondary structure of the IgG molecules within the lyophilized 
formulations can be described as native. However, in order to quantify the effect 
of successive cycles of lyophilization on the structure of IgG, ATR-spectrum 
obtained from each sample of IgG (data shown from 1 - 7), were normalized 
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(smoothed and base line corrected) and the ratio of the area of amide bands I and 
II were calculated. The ratio of areas under amide bands IIII determine the ~ ~ -
sheet character present in the protein. Our results demonstrated no significant 
change in the amide IIII ratio during multiple cycles of lyophilization (Figure 
4.15 blue bars). Apparently, it seems, as if aggregation is not a consequence of 
changes in the secondary structure which could be detected by FT-IR. However, 
the small changes in the amide IIII ratio are attributed to differences in the 
secondary and possible tertiary structure. 
3.00 Amide IIII 
2.50 j 
2.00 
~ ~ 1.50 J ~ ~
.. 
1.00 j < 
0.50 j 
0.00 
1 2 3 4 5 6 7 
Number of Cycles of Lyophilization 
Figure 4.15 Ratio of areas under bands I and II in: one to seven times lyophilized 
IgG powders. The error bars represent standard deviations (SD - 0.08) recorded for 
three set of mea urements recorded for each sample. Successive lyophilization appears to 
have no ignificant impact on the amide IJII ratio. 
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The secondary structural changes are induced because of stress caused due to 
repeated lyophilization which consequently produce the deformation, bending 
stretching, and more importantly di ruption of carbonyl - C = 0, and -N-H 
bonds of the peptide backbone. Considering the fact that the sensitivity of the 
amide band II for the polypeptide is small and IgG largely consists of B-sheet 
structures (76 %) whereas a-helix content is relatively small (- 9 %) has been 
previously reported [198, 200]. 
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Figure 4.16 Curve fitted amide band I of: one and seven time lyophilized IgG on its 
own. Recon titution wa performed in filtered deionized water. Large peak corresponds 
to amide band I and predominantly repre ent ~ ~ - sheet structure. Each band contains 
five fitted component: - (i) green ( ~ ~ - sheet with anti-parallel structure (ii) pink ( ~ ~ -
tum) and (iii) blue (a - helix), (iv) red (predominant ~ ~ - sheet with parallel structure) 
and (v) black (amino-acid side chains). The short band next to band I represents amide 
band II, more likely how change arising from N-H bending vibration and al 0 some 
contribution from CoN stretching [129, 207]. 
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The interpretation of data was further carried out utilizing only amide band I by 
performing the structural analysis of different components stationed in amide 
band I during multiple cycles of lyophilization. It was observed that total area 
under the amide band I significantly increased in the i h cycle. The structural 
analysis is complicated because the absorption bands of different structural 
components almost overlap in the amide I band. Therefore, it became vital to 
improve the processing of the spectral data. In our studies, this was achieved 
with the help of CAS A - XPS peak fitting software. Such analysis of the amide I 
band of the normalized data shown in Figure 4.14 for one to seven time 
lyophilized IgG samples was carried out by fitting curves to the amide bands I as 
shown in Figure 4.16, in order to determine the relative proportion of various 
structural components of [(i) ~ ~ - sheet side stretches (1617 em-I), (ii) 
predominant ~ ~ - sheet (-1640 cm-I), (iii) a - helix (1652 cm-I), (iv) ~ ~ - turns 
(-1670 cm-I) and (v) ~ ~ - sheet with anti-parallel structure (-1690 cm-I), 
stationed within amide band I [206, 207]. It was observed that percentage of ~ ~
sheet character in IgG increased during multiple cycles of lyophilization [Table 
4.4]. 
On the other hand, a - helical content was observed to disappear after cycle one. 
The consistent increase in the ~ ~ - sheet character coupled with complete absence 
of a - helical content is consistent with an increase in the probability of 
aggregation, by enhancing inter-protein interactions during solution phase and 
drying. Hence, aggregation gets initiated. The decrease in the a-helical content 
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upon lyophilization has been reported in other proteins (such as poly (L -lysine) 
[208], Insulinotropin [209], fibronectin [210], lysozyme [211], and 
chymotrypsin [212]. 
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Table 4.4. Structural analysis of different structural components stationed in amide band I 
Percentage concentration and area under occupied by each component 
Amide band I Comoonent 1 Comoonent 2 Comoonent 3 Comoonent4 ComoonentS 
(-1690-1600 em-I) fl- sheet p -sheet a - helix p - turns p - sheet 
Amino-acid Main in the Anti-parallel 
Side chains Middle Amide I structure 
Range (-1615 -1620 em-I) (-1628 -1645 em-I) (-1650 -1658 em-I) (-1660 -1677 em-I) (-1686 -1697 em-I) 
Peak position (-1617 em-I) (-1639 em-I) (-1652 em-I) (-1670 em-I) (-1690 em-I) 
Cycle 1 
(% :area) 2 : 4.1 55.37 : 110.7 10.5 : 20.1 2.02 : 4 30.54 : 61.1 
Cycle 2 4.1 : 2.03 52. : 90.07 0 : 0 15.35 : 24.4 27.7 : 44 
Cycle 3 0 : 0 52.71 : 175.5 0 : 0 4.32 : 13.5 39.32 :123.1 
Cycle 4 0 : 0 52.70 : 127.4 0 : 0 33.8 : 81.8 13.54 : 32.7 
Cycle 5 0 : 0 59.57 : 177.5 0 : 0 4.30 : 13.7 39.5 : 122.9 
Cycle 6 0 : 0 46.95 : 69.1 0 : 0 51.34 : 75.6 1.71 : 2.5 
Cvcle7 0 : 0 38.75 : 73.40 0 : 0 61.25 : 109 0 : 0 
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However, in case of IgO studied, the complete absence of a-helical content 
associated with concomitant increase in P - sheet struture upon repeated 
lyophilization (Table 4.4) has not been previously reported. This is because in 
suspended state, water molecules which remain hydrogen bonded to the C = 0 
moieties present in a - helical slices, when undergo dehydration during 
lyophilization only affects a - helical content and not p - sheet [213, 214]. 
Therefore, the one of the likely reason that could be asserted for observed 
increase in the p - sheet content upon dehydration during lyophilization is 
forced intermolecular cohesion between protein molecules with no competition 
from water molecules, and are considered energetically attractive, which 
otherwise in suspended state are entropically prohibitive (not favoured). 
Therefore, this structural rearrangement may also explain the exothermic 
aggregation peak (depth of the first transition peak: unfolding of Fabs). Fabs are 
heat sensitive [215]. The above described structural rearrangement quickens the 
thermal denaturation (unfolding) of Fabs. However, the proportion of 
completely or partially unfolded molecules within the aggregates depends on the 
intensity of structural rearrangement (proportion of p - sheet). The successive 
lyophilization induced greater structural rearrangement (P - sheet character). 
Consequently, the rate of aggregation would be correspondingly faster in the 
sample that has been exposed to more cycles of lyophilization. At a faster rate, 
IgO molecules that participate in aggregation had not enough time to unfold 
completely. Thus, it could be proposed that the proportion of partially unfolded 
molecules will be more in the samples having undergone maximum structural 
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arrangement, which obviously in our studies would be the sample exposed to 
more number of lyophilization cycles (cycle 7). Furthermore, Fc is more 
sensitive to lowering pH [215]. The lowering of pH caused by significant 
increase in the proportion crystalline material demonstrated by AFM (Figure 
4.11) could well explain the increase in the unfolding (melting) propensity of Fc 
fragment during repeated lyophilization. 
The secondary structural changes in the components of multiple times 
lyophilized IgG (Table 4.4) is an indicative of protein in the aggregated state, 
therefore, validates our DLS findings, where we observed an increase in the 
propensity of size IgG to form larger aggregates. This also lies in agreement 
with AFM results, where an increase in the size of aggregates and proportion of 
crystalline material was found during repeated lyophilization. Furthermore, an 
increase in the magnitude of unfolding peak (depth of the first transition peak) 
during successive lyophilization shown by DSC (Figure 4.13) complements the 
fact that secondary structural changes shown by A TR weakened the intra-protein 
bonded network, and therefore, reduced the thermal stability of IgG. 
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4.7 Conclusions 
The present study provides a comprehensive analysis of the effect of repeated 
lyophilization on the aggregation, stability and protection of a polyclonal IgG 
antibody on its own. The tendency of IgG to aggregate increased during 
multiple cycles of lyophilization. IgG lyophilized on its own offers some 
resistance against aggregation, however, this resistance is not enough to 
withstand stresses during multiple cycles of lyophilization. The increase in 
the mean size of the globular features and their association with amorphous 
regions in the powdered formulations shown by AFM compliment the DLS, 
NTA and DSC findings respectively. The porosity of antibody formulation 
decreased whereas likely crystalline content increased with multiple 
lyophilizations was confirmed by SEM results. Moreover, the growth of 
crystalline material shown by SEM is complimented by AFM. The unfolding 
of IgG is probably a complex process. The significant increase in the p-sheet 
character (structural rearrangement) compliments DSC in proving that the 
propensity of unfolding of IgG increased. This research is pharmaceutically 
significant in that it provides insight into the underlying factors which govern 
aggregation phenomenon at nanoscale level. This work can be employed as a 
broad spectrum strategy to characterize aggregation in protein therapeutics. 
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Chapter 5 
Nanoscale characterization of the 
effect of sucrose and mannitol on 
aggregation of poly clonal IgG 
during multiple cycles of 
lyophilization 
5.1 Introduction 
The propensity of IgG to withstand the alteration in its intrinsic state that is 
produced by lyophilization or reconstitution following lyophilization was 
investigated in the previous chapter. It was observed that the inclination of IgG 
to aggregate increased during multiple cycles of lyophilization. A possible reason 
for this is dehydration that can cause undesirable protein 
denaturation/aggregation which in turn could result in the loss of an activity upon 
rehydration [214, 216]. The effect of crystallization of the dissolved salts could 
be another possibility [216]. Several studies on the stabilization of proteins have 
indicated that additives like sucrose, trehalose, sorbitol etc can resist protein 
aggregation throughout lyophilization and storage in the dried form [9, 217, 
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218]. However, as discussed in the introductory chapter, there is disagreement 
over the mechanisms by which such additives stabilize proteins; with 
dehydration being most often cited [12, 25, 26, 27, 29, 30, 31, 32, 218]. This 
impression of guarding protein activity/stability during lyophilization and drying 
is endorsed by Timasheff preferential exclusion mechanism [219], the glassy 
state hypothesis [220] and the water replacement hypothesis [221], although the 
use of sugar additives prone to crystallization during lyophilization should be 
avoided [13, 55].The storage stability of a protein formulation has been reported 
to be a characteristic of its glass transition temperature (Tg), noting that it should 
be stored well below its (Tg) [223]. 
In the light of the above discussed criteria, we investigated the stability of a 
polyclonal IgG antibody by formulating the protein with sugar excipients such as 
sucrose and mannitol, individually and in combination during multiple cycles of 
lyophilization (up to 7). In these investigations, the choice of excipients was 
based on previous studies [10, 12, 200, 223]. The samples formulated were 
stored at - 4 DC for up to several months, and their protein stabilities were 
compared. To characterize potential changes that occur during lyophilization 
dynamic light scattering (DLS) was used to study the size of the protein and any 
aggregates in solution and atomic force microscopy (AFM) to image the dried 
formulations at high resolution [68]. In addition, thermal analysis was carried out 
using differential scanning calorimetry [224] to study glass transition, 
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crystallization and melting events and Ff -IR in attenuated total reflection (ATR) 
mode to determine changes in the secondary structure [225]. Taken together 
these complementary approaches were selected to provide physical and structural 
insights into the multiple times lyophilised formulations of IgG. 
5.1.1 Excipients and their chemical structure 
Sucrose and mannitol were the two excipients used in this study. The molecular 
fonnulae, molecular weight and chemical structure for the indicated excipients are 
presented in Table 5.1. 
I. Mannitol 
Mannitol is white, odourless, crystalline monosaccharide, usually used as an 
additive for matrix fonnation during lyophilization. Typically when introduced at 
concentrations up to 10 % w/v, mannitol becomes able to produce an amorphous 
matrix that can effectively support bio-pharmaceuticals (such as proteins) during 
lyophilization [13, 226, 227]. The amorphous structure produced during frozen state 
enables mannitol to prevent collapse of therapeutic protein while creating small 
canals for water sublimation during secondary drying of the lyophilization process. 
The other remarkable attribute of mannitol is its general inertness and instantaneous 
rehydration following lyophilization [13,226,227]. 
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II. Sucrose 
Sucrose (a - D - glucopyranosyl - (l - 2) - ~ ~ - D - fructofuranoside) is a white 
crystalline solid, a non-reducing disaccharide formed by a glycosidic linkage 
(bond) between carbon atom one of alpha D - glucose and the carbon atom two 
( ~ ) ) form ofD - fructose. The glycosidic bond formed is also referred to as an a -
~ ; ; 1 - 2 bond, because there is an a - OH from the glucose bonding to a ~ ~ - OH 
from the sucrose. As both of the hydrogen atoms removed during dehydration 
come from OH groups (a - 1 and ~ ~ - 2) that were created during ring closure. The 
glycosidic linkage is established between the reducing ends of both glucose and 
fructose, and not between the reducing end of one and the non-reducing end of 
the other. Consequently, this results no free anomeric carbon atom available for 
the further establishment of bonds with other sugar molecules. Therefore, 
sucrose becomes a non-reducing sugar due to lack of free ketone or aldehyde 
group. Sucrose is considered an active lyoprotectant for the lyophilization of 
therapeutic proteins. During the lyophilization process, therapeutic proteins can 
denature as water is expelled unless a replacement molecule is offered to support 
the protein structure. Sucrose fills the vacancies left by the dehydration of water 
molecules, and therefore, prevents protein denaturation [13, 226, 227]. 
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A 
OH OH 
HO 
OH OH OH 
Excipient 
Name 
Molecular Molecular Melting 
point formula weight 
182.17 glmol 167°C 
B HO 
-
-. . 
Boiling 
point 
295 °C 
Chapter 5 
OH 
Tg 
- 85 °C 
342.20 glmol 186°C Decomposes - 70 °C 
Table 5.1 The chemical structures presented above are of: the excipients used in this 
study; [A] Mannitol and [B] Sucrose. Summarized in the table are their corresponding 
physical property values [224, 227]. 
5.2 Aims and objectives 
Little work has been performed to date probing the effect of lyoprotectant on the 
tabilizationlprevention of aggregation of IgG during multiple cycles of 
lyophilization. The main objective of this study was to scrutinize a polyc1onal 
IgG antibody lyophilized with sucrose and mannitol (alone and in combination in 
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various molar ratios) in response to the influence of multiple cycles of 
lyophilization. This exploration of the latent impact of lyoprotectants on the 
aggregation of JgG is another advancing step towards the development of a novel 
standard screening method that would enable us to improve an overall 
therapeutic efficiency of JgG and other such proteins. 
5.3 Materials 
All other materials which were employed were same as described in the 
section 4.2 of Chapter 4. 
5.4 Sample preparation methodology 
5.4.1 Reconstitution of lyophilized protein (IgG powder) 
This has been already described in section 2.1.1.2 of Chapter 2. 
5.4.2 Lyophilization of reconstituted IgG 
Lyophilization of JgG has been discussed in section 2.1.4.2 of Chapter 2. 
5.4.3 Preparation of IgG formulations 
JgG was lyophilised on its own, with sucrose and mannitol alone, and in 
combination with both. Dry sucrose and mannitol powders were dissolved in 
filtered deionized water containing 0.01 mM PBS to the desired 
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concentration. The concentrated IgG olutions were directly mixed with 
appropriate amount of ugar from stock solutions to achieve the desired 
protein and ugar concentrations. Sample of IgG exposed to 1, 2, 3, 4, 5, 6, 
and 7 cycle of lyophilization were prepared. Formulations were prepared in the 
form of liquid and dry powder . 
5.4.3.1 Liquid formulations 
IgG (6.67 ~ ) ) liquid formulation which were prepared with sucrose and 
mannitol alone, and in combination are pre ented in Table 5.2. 
Serial Formulation Number of 
No. ~ ~ Cycles 
(i) IgG (0-3) 
(ii) JgG + Sucrose (1.8 mM, 3.6 mM, 5.8 mM) (0 - 3) 
(iii) JgG + Mannitol (1.8 mM, 3.6mM, 5.8 mM) (0 - 3) 
(iv) JgG + Sucrose (1.8 mM) + Mannitol (1.8 mM) (0 - 3) 
(v) IgG + Sucro e (1.8 mM) + Mannitol (3.6 mM) (0-3) 
(vi) JgG + Sucrose (3.6 mM) + Mannitol (1.8 mM) (0-3) 
(vii) JgG + Sucrose (3.6 mM) + Mannitol (3.6 mM) (0-3) 
Table 5.2 Break down of the liquid formulations of IgG lyophilized with 
sucro e and mannitol in different molar ratios. 
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5.4.3.2 Powdered formulations 
IgG (1.2 rnM) powdered formulations which were prepared with sucro e 
and mannitol alone, and in combination are presented in Table 5.3. 
Serial Formulation Number of 
No. ~ ~ Cycles 
(i) IgG (1.2 mM) (0-7) 
(ii) IgG (1.2 mM) + 20 mM Sucrose (1) 
(iii) IgG (1.2 mM) + 40 mM Sucrose (1) 
(iv) IgG (1.2 mM) + 20 mM Mannitol (1) 
(v) IgG (1.2 mM) + 40 mM Mannitol (1) 
(vi) IgG (1.2 mM) + 20 mM Sucrose + 40 mM Mannitol (1) 
(vii) IgG (1.2 mM) + 40 mM Sucrose + 20 mM Mannitol (1) 
Table 5.3 Break down of the powdered formulations of IgG lyophilize with 
sucro e and mannitol in different molar ratios. 
5.5 Methods of analysis 
5.5.1 Dynamic light scattering 
The characterization of particle size wa conducted using a Viskotek DLS 
(Malvern In trument Ltd , Worce ter hire, UK) equipped with a 630 nm laser. 
Approximately 80 l.tI of ample solution was injected into the cuvette to 
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determine particle size. Each sample was first equilibrated for 30 minutes at 25 
°C prior to the first measurement. Data collection was performed by taking 40 
acquisitions for each measurement. 
5.5.2 Atomic force microscopy 
AFM tapping mode imaging was employed to study the different components 
in the powdered lyophilized formulations of IgG. Imaging (topography and 
phase) was performed with a D - 3000 AFM and a Multimode II AFM (Bruker 
Nano, Coventry, UK) equipped with an E-scanner. All images were taken at a 
scan rate between I - 2 Hz, with a 512 x 512 pixel resolution. 
5.5.3 Differential scanning calorimetry (DSC) 
A Q-2000, differential scanning calorimeter (TA Instruments Ltd, Fleming 
Centre, Manor, Crawley, West Sussex, UK) with purged nitrogen gas was 
used. Dry powdered samples (2 -,- 5 mg) were analyzed in crimped 
hermetically sealed aluminum pans. Samples were heated from 0 °C - 200 
°C at a scan rate of 10 °C/min. The melting point of the IgG antibody 
lyophilized multiple times on its own and Tglmelting point of the sugar-
containing antibody formulations were obtained as the midpoint of the 
corresponding transition by integrating the slope of the DSC curve. 
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5.5.4 ATR-FTIR spectrometry 
A Nicolet Ff -IR-spectrometer was employed to record spectra for the 
determination of changes in the secondary structure of lyophilized IgG. Sample 
powder (2 - 3 mg) was placed on a clean glass slide and then mounted on the 
sample stage. The spectra for each sample were recorded from 4000 to 650 cm-I 
in A TR mode at room temperature. Each measurement was an average of 200 
scans, at a scan speed of 0.15 sec·1 and a resolution of 2 em-I. The optical bench 
was purged with dry nitrogen to avoid interference from water vapour infrared 
absorption. Each spectrum was background corrected for the glass slide. The 
amide I (1720 - 1600 cm-I) and amide II (1575 - 1480 cm· l ) regions were used 
to analyse changes in the secondary structure of protein. 
5.6 Results and Discussion 
5.6.1 DLS analysis 
The effect of sucrose and mannitol on the aggregation of IgG was studied both 
individually and in combination in two subsequent sets of experiments. 
5.6.1.1 Individual effect of sucrose and mannitol 
The separate effect of the concentration of sucrose and mannitol on the 
aggregation of IgG was investigated using DLS for three cycles of lyophilization 
(Figure 5.1). 
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Figure 5.1 The comparison of an influence of sucrose (red bars) and mannitol 
(green bars) during successive cycles of lyophilization: on the aggregation of IgG 
lyophilized on its own (blue bars). [A] and [B] represent data obtained when IgG (I 
mglmJ) was lyophilized with SucroselMannitol at molar concentration of 1.8 mM, and 
3.6 mM re pectively. (Mean size ± SD). Sucro e appears to have an inhibitive effect on 
aggregation and thi effect i more pronounced at higher concentration . This is in 
contra t to that of mannitol which significantly promotes aggregation even at higher 
concentration. 
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The observed particle size in sucrose was reduced compared to the IgG alone. This 
effect was more pronounced at the higher concentration of sucrose (Figure 5.1 
[A]). In contrast, mannitol did not appreciably effect aggregation (Figure 5.1 [B]). 
The better protection given by sucrose is believed to be due to its ability to form an 
amorphous phase during lyophilization [228,229]. In contrast, it has been reported 
that mannitol extensively crystallizes during lyophilization [230]. The maintenance 
of the amorphous or partially amorphous state of a lyoprotectant is highly 
significant for protein stabilization, as this phase can interact with protein 
molecules to prevent them from denaturing i.e; the protein molecules are trapped 
in their native folded state in the glassy sucrose matrix. The crystallisation of the 
lyoprotectant, results in the expulsion of the solutes from the heterogeneous 
protein solution, as a consequence molecular interaction of the protein with 
lyoprotectant is reduced and the probability of denaturation of protein increases 
significantly [228]. 
5.6.1.2 Collective influence of sucrose and mannitol 
To further evaluate the potential stabilizing effect of sucrose and mannitol, the 
combined effect of sucrose and mannitol on the aggregation of IgG during 
multiple cycles of lyophilization was investigated. Again, it was observed that the 
increased presence of sucrose decreased particle size and by inference aggregation 
(Figure 5.2). The improved effect of combining sucrose and mannitol is possibly 
due to the known inhibitory effect of sucrose on the crystallization of mannitol 
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. IgG + 3.6 mM Sucrose + 1.8 mM Mannitol 
Figure 5.2 The comparison of an influence of the effect of increase in the 
concentration of sucrose/and mannitol during successive cycles of lyophilization: on 
the size of IgG formulated with mannitol and sucrose in combination. (Mean size ± SD). 
The presence of sucrose within the combined formulations appears to decrease the 
observed aggregation enhancing effects of mannitol (when used on its own). The data 
indicate an increase in the molar concentration of sucrose provides better protection than 
mannitol in the combined formulations. However, in combination with mannitol, IgG, 
formulated with sucrose at equal and optimum concentration shows enhanced 
protection. 
during lyophilization [228, 230]. Unlike, sucrose, the increased presence of 
mannitol within the combined formulations appears to have no significant 
protective effect on IgG aggregation (Figure 5.2 purple bars) . It was observed in 
combined formulations, at fixed molar concentration of sucrose (1.8mM) that 
doubling the molar concentration of mannitol from 1.8 mM to 3.6 ruM does not 
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inhibit aggregation (Figure 5.2 green bars). However, switching the molar 
concentration of sucrose from 1.8 mM to 3.6 mM (keeping that of mannitol (1.8 
mM) unchanged) reduced aggregation (Figure 5.2 Purple bars). The superior 
stabilizing effect of sucrose was reflected in the combined formulations. IgG 
was best protected against aggregation for the conditions studied, when it 
was lyophilized with sucrose and mannitol in combination in the molar ratio 
of 6.67 ~ M M : 3.6 mM : 3.6 mM Mannitol, (l mg/ml of IgG). 
5.6.2 AFM analysis of the lyophilized formulations (powders) 
The AFM topographic and phase imaging data of the lyophilized powders of IgG, 
formulated with sucrose and mannitol (alone and combination) was collected as 
descri1;>ed in Methods (Chapter 2). 
5.6.2.1 Controls for lyophilized powders of sucrose and mannitol 
Before investigating the effect of sugar lyoprotectants (sucrose and mannitol) on 
the stability of IgG (anti-glucose - 6 - phosphate dehydrogenase antibody) 
during lyophillization, sucrose and mannitol were separately formulated in 0.01 
M PBS prior to lyophilization. Figure 5.3 shows representative imaging data 
from TM-AFM control experiments for one time lyophilized powders of 
mannitol and sucrose. The AFM topography was exploited to investigate the 
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pattern of projections of lyophilized sugars, which demonstrated a non-identical 
behaviour of both sugars on the surfaces at nano - scale. Lyophilized powder of 
mannitol (Figure 5.3-A) and sucrose (Figure 5.3 - C) indicate heterogeneous and 
uneven surfaces. In Figure 5.3 (A and C), the regions of the substrate darker in 
colour exemplify that they lower in height or larger in phase lag. On the other 
hand, patches lighter in colour are relatively higher in topography (small phase 
lag) [231]. The corresponding phase imaging data of mannitol (Figure 5.3 - B) 
and sucrose (Figure 5.3 - D), illustrate a multiple component surface (light 
yellow, dark yellow and white particulates) with significant phase contrast. The 
phase image which is produced as a result of phase change between the 
cantilever oscillation and the driving amplitude (signal applied to the piezo) 
during tip-sample interaction, reveal information about the nature of probe -
sample interactions and the properties of the material imaged [231, 232]. The 
dark yellow components in colour are an indicative of high probe-sample 
adhesion (viscoelasticity), which results in the dissipation of more energy in 
from the oscillating AFM probe, and have been known to occur as a consequence 
of negative phase shift (phase lag) or holding up of AFM tip in these regions 
compared to the rest of imaged surface. This kind of tip-sample interaction 
produces deformation in a sample and has been proposed (reported) for 
amorphous materials [232, 233]. In contrast, light yellow components illustrate a 
relatively less probe-sample adhesion, less energy lost into the material during 
probe-sample interaction, as a result of positive phase shift and a characteristic 
for hard materials [232, 233]. Therefore, a possible reason of significant phase 
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contrast observed in Figure 5.3 (B and D) is related to the formation of 
crystalline (light yellow) and amorphous (dark yellow) structures during 
lyophilization. In addition, it would be expected that a flatter and harder surface 
that would be presented by a crystalline state will lead to a lower contact area 
with the AFM tip and hence a lower energy loss in comparison to the same 
material in amorphous form. One would also expect the amorphous form to have 
a higher surface energy and hence more adhesion to the probe, again leading to 
greater energy loss. The white particulates are likely the crystals of NaCl. TM -
AFM phase images clearly demonstrate that mannitol has a larger propensity to 
form crystalline structures than sucrose during lyophilization. It has been 
reported that mannitol has a high propensity toward crystallization, however, the 
formation of an amorphous phase by mannitol in these studies (Figure 5.3 - B) 
could be due to the inhibition of crystallization by NaCI [234]. It can also be 
deduced from phase imaging (Figure 5.3 - D) that sucrose forms distinct 
amorphous and crystalline structures almost in equal proportion at the surface 
during lyophilization. 
Furthermore, if the white particulates are likely to be crystals of NaCl, it can be 
said that the tendency of NaCI to crystallize in mannitol is larger than in sucrose. 
Therefore, our findings suggest that mannitol is more prone to crystallization 
than sucrose during lyophilization. These findings lie in agreement with literature 
[230]. Using an AFM to detect crystallinity in these studies stems from the fact, 
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that the crystalline and amorphous morphologies of other materials have been 
previou ly analyzed by atomic force microscopy such as those of polyamide 
nanofilm ad orbed on grafted gold [231]. 
Figure 5.3 [A - B] and [C - D] respectively represent the AFM images (topography 
and pha e) of lyophilized mannitol and sucrose powders. Each scan i one micron. 
All images have height (Z - cale) of 100 nm and a phase angle of 160°. For more 
image ee Appendix 5.5 
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5.6.2.2 IgG lyophilized with sucrose (powder) 
Taping mode AFM data of an IgG lyophilised with sucrose is shown in Figure 5.4. 
The topography images of 1.2 mM IgG lyophilised with 20 mM sucrose reveal 
that the deposited material is highly aggregated on the surface in a non-uniform 
manner. Furthermore, AFM topography images indicate non-uniformity in the 
flatness of the imaged surfaces. The corresponding phase images (Figure 5.4 -
right column) show a significant contrast and therefore, illustrate a multi-
component heterogeneous surface. IgG formulated with sucrose indicated the 
formation of an abundant. amorphous phase (dark rough areas) in comparison to 
that of crystalline (yellow smooth areas) during lyophilization. The formation 
and random deposition of agglomerated globular features of (proposed to be IgG) 
dissimilar size is clearly visible from the phase images. The globular features 
were predominantly found associated with amorphous regions and were smaller 
in size to those very few associated with crystalline regions. Moreover, the 
dimensions of some of the smaller aggregates were close to that expected for 
individual IgG molecules. The formation of more smaller sized IgG aggregates is 
more likely due to an inhibitory effect of sucrose on the aggregation of IgG 
[235]. This is because sucrose has the ability to form an amorphous phase during 
lyophilization. 
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Figure 5.4 AFM topography (left) and phase (right) images of 1.2 mM IgG 
Iyophilised with 20 mM sucrose. Each scan i one micron. The Z - cale of for 
both topography image were l20 nm whereas phase images were collected at an 
angle of 100°. 
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5.6.2.3 IgG lyophilized with mannitol (powder) 
Figure 5.5 displays the AFM data of 1.2 mM IgG lyophilised with 20 mM 
mannitol. The topography images of the indicated sample appear considerably 
flatter than in the case of IgG formulated with sucrose. The irregular 
immobilization of agglomerated globular features of IgG disparate in dimension, 
and distinct crystalline areas are clearly demonstrated by the phase images. 
However, unlike in case of IgG lyophilized with sucrose, most of the aggregates 
were found arranged in the form of a fine monolayer. This smoothness in the 
arrangement of globular aggregates of IgG is most probably facilitated by the 
flatness of crystalline surface offered by mannitol underneath. The crystalline 
surface is produced as a consequence of lyophilization. Some of the crystalline 
areas are devoid of any aggregates globular IgG. Moreover, the dimensions of a 
vast majority of the visible aggregates were significantly larger than in case of 
the IgG formulated with sucrose. 
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Figure 5.5 AFM topography (left) and phase (right) images of 1.2 mM IgG 
lyophilised with 20 mM mannitol. Each scan is one micron. The Z - scale of 
for topography images were 120 nm whereas phase images were collected at an 
angle of 100°. 
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5.6.2.4 IgG formulated with sucrose and mannitol in combination 
In case of lyophilised IgG (1.2 mM) formulated with sucrose (20 mM) and 
mannitol (40 mM) together, the amorphous and different crystalline structures 
which are noticeable from phase images are produced almost in similar 
proportion (Figure 5.6). IgG appears to form much smaller agglomerated 
globular features than when IgG was lyophilized with sucrose and mannitol 
individually. This suggests an inhibitory effect of sucrose on the crystallization 
of mannitol during lyophilization and consequently reduced IgG aggregation. 
However, the formation of different types of crystalline (such as needles and 
stripes) structures at higher molar concentration of mannitol was noted, as it 
makes one curious about the impact of a particular kind of crystal on aggregation 
of protein. Without changing the concentration of IgG (1.2 mM), the switching 
of the molar concentration of sucrose and mannitol from 1 : 2 to 2 : 1 removes 
the formation of crystalline areas (Figure 5.7 right pannel). Moreover, this effect 
enhanced the ability of IgG to oppose aggregation as a significant reduction in 
the size of the globular features of IgG was observed. Most of the globular IgG 
features displayed in phase images are closer to individual molecules/molecules 
(Figure 5.7). Therefore, suggesting an inhibitory effect of sucrose on the 
crystallization of mannitol during lyophilization and this effect pronounced at 
higher molar concentration of sucrose [235]. This suggests the superior 
protective ability or stabilizing effect of sucrose than mannitol on IgG during 
lyophilization [235, 236] as shown in Figure 5.6. The maintenance of the 
amorphous or partially amorphous state of lyoprotectants is important for protein 
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Figure 5.6 AFM topography [top]: and phase [bottom] images of powders of 
1.2 mM IgG lyophilized sucrose and mannitol in the molar ratio of 1 : 2. 
Each scan i one micron. The Z - scale of for topography images were 120 nm 
wherea pha e images were collected at an angle of 12°. 
tabili ation , becau e it i then only that the lyoprotectant can interferelinteract 
with protein molecule to prevent them from denaturation/crystallization because 
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sugars prevent the inactivation by interacting with the surface of proteins, and 
stabilize them by hydrogen bonding against heat and cold denaturation [13, 237]. 
The crystallization of the lyoprotectant removes solutes from the solution and 
blocks molecular interaction with protein during freeze lyophilization. Hence, 
protein cannot be protected from denaturation. Therefore, it can be said, that the 
difference in the proportion of polymorphic structures in the lyophilized powders 
of IgG is due to the difference in the amount of amorphous or partially 
amorphous state of lyoprotectants (sucrose and mannitol, alone and in 
combination) formed during lyophilization [237, 238]. Another factor could be 
the nature of the molecular interaction of the sugar with protein in solution phase 
during lyophilization [13, 237, 238]. 
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Figure 5.7 AFM topography [top] and phase [bottom] images of powders of 
1.2 mM IgG lyophilized ucrose and mannitol in the molar ratio of 2 : 1. 
Each can i one micron. The Z - cale of for topography images were 120 nm 
wherea pha e image were collected at an angle of 12°. IgG likely seems to have 
a cry talline urface underneath more probably formed by the partial or complete 
cry tallization of mannitol, allowing IgG molecules to land flat on the urface in 
an organized manner. The cry tallization of mannitol can be claimed from the 
control experiment , which wa later on al 0 proved during SEM imaging of 
mannitol. 
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5.6.3 Examination of thermal stability behaviour 
As described in Chapter 4 (section 4.8), the thermal stability could be affected by 
the lyophilization by weakening the strength of various bonds involved in the 
structural integrity of a protein. Generally sugar molecules such as sucrose also 
have been reported to protect proteins against such stresses [10, 223, 229, 237]. 
Therefore, in these complementary studies, the melting points and the glass 
transition (Tg) were analysed for multiple times lyophilized formulations of IgG 
formulated with added sugars (sucrose/mannitol alone and in combination). 
5.6.3.1 Excipients and their thermal behaviour 
The thermal behaviour of non-lyophilized and lyophilized sucrose and mannitol 
are presented in Figures 5.8 and 5.9 respectively. Table 5.4 summarizes the effect 
of lyophilization and formulation medium on the melting points of both sucrose 
and mannitol. The melting points of sugars were reduced, when exposed to 
lyophilization. In both sugars, there was no significant shift in melting points 
when samples were formulated in deionized prior to their lyophilization. In 
contrast, a significant decrease in the melting points was observed, when sugars 
were lyophilized in a medium containing dissolved buffer. This suggested that the 
presence of buffer in the formulation promoted the effect of lyophilization to 
reduce the strength of bonds in the sugar molecules. This also supports the idea 
that addition of an impurity (which in this case is buffer) decreases the melting 
point of bulk substance in the mixture. The melting-point depression as a result of 
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modifications (disorder) to bulk solid structure due to solid (bulk) - solid 
(impurity) transition of has been reported [239] . Furthermore, Tg around - 90°C 
wa observed only in case of sucrose samples which were formulated in buffer 
(Figure 5.10) uggesting the potential influence of buffer in the initiation of glass 
transition which is obvious due to the interaction of salt molecules with the bulk 
molecules. 
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Figure 5.8 Overlaid standard DSC heating profiles of sucrose: G 1 - green 
trace (non - lyophilized sucrose); G2 - green trace (sucrose lyophilized in 
deionized water) and red trace (sucrose lyophilized in 0.01 M PBS). The samples 
were heated up to 220 °C at the rate of 10 °C per minute. The endothermic peak 
toward the extreme right of the each trace is an indicative of the melting point of 
sugar in the re pective trace. 
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Figure 5,9 Overlaid standard DSC heating profiles of mannitol: Lyophilized 
in 0.01 M PBS (blue trace), and non-lyophilized (green trace)] . The samples 
were heated up to 220 °C at the rate of 10 °C per minute. The endothermic peak 
toward the extreme right of the each trace is an indicative of the melting point of 
sugar in the re pective traces. 
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Figure 5.10 Part of the DSC profile (red trace, Figure 5.8) of sucrose: 
Lyophilized in 0.01 M PBS displays a typical glass transition event - 90 °e. 
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Table 5.4 Effect of lyophilization on the melting points and Tg of excipients 
No. of Formulation Protein:Exicipient Melting Point (DC) Cycles 
(Powdered) Concentration (mM) of Excipient 
0 Sucrose (original powder) 00: 20 - 190.89 
1 Sucrose (in deionized water) 00: 20 -188.31 
1 Sucrose (in 0.01 M PBS) 00: 20 -178.00 
0 Mannitol (original powder) 00: 20 - 166.66 
1 Mannitol (in deionized water) 00: 20 - 162.36 
1 Mannitol (in 0.01 M PBS) 00: 20 - 152.49 
* Tg indicates glass transition temperature 
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5.6.3.2 Impact of sucrose and mannitol when used separately 
The representative melting curves of IgG (1.2 mM) lyophilized with sucrose and 
mannitol at two different molar concentrations (20 mM and 40 mM), are shown in 
Figure (5.11). 
g 
~ ~
~ ~ 10 
= unfolding of IgG 
~ ~
~ ~
-
r 
I 
·c 
Temperature eC) 
Figure 5.11 Overlaid standard DSC heating profiles of: 1.2 mM IgG lyophilized with 
mannitol [20 mM (blue trace), 40 mM (green trace)] and sucrose [20 mM (pink trace), 
40 mM (brown trace)]. The formulations were heated up to 220°C at the rate of 10 °C 
per minute. The inverted peak foIlowed by the slope in the beginning of each trace 
carre pond to the melting (Tm) of IgG and pha e transition (Tg) around - 90°C. The 
endothermic peak towards the extreme right of the each trace is an indicative of the 
melting point of ucro e/mannitol in the respective trace. 
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There was no significant shift in the melting temperature of IgG (changed from 58 
DC to 59 °C) without any obvious unfolding of Fc fragment. The measured Tg and 
melting points of sucrose and mannitol on their own and with IgG (both alone and 
in combination) are shown in Table 5.5. The effect of sucrose (Figure 5.8 pink 
trace) and mannitol (Figure 5.8 blue trace) at 20 mM concentration is similar, as 
clearly shown by the nearly identical unfolding (depth of first transition peak) of 
antibody. However, a significant delay in the thermal transition (unfolding) in 
samples containing 40 mM sucrose (Figure 5.11 brown trace: first peak) was 
observed. This is in contrast to that observed in case of mannitol (Figure 5.11 
green trace: first transition peak) at the same concentration. The better protection 
level at higher molar concentration provided by sucrose for an IgG antibody 
against thermal denaturation is in agreement with the previous results. 
Furthermore the decrease in the depth of the IgG unfolding peak (the significant 
phase transition around - 90 °C) followed by an increase in the melting point of 
sucrose in the presence of high molecular weight IgG (150 kDa) is indicative of 
an enhanced protection given to IgG during lyophilization (Figure 5.11). The 
observed Tg for sucrose seems higher than that generally reported in literature (-
58 - 70 °C) [240]. However, a Tg of sucrose around - 85 °C has been previously 
reported [240], The increased Tg of sucrose could be probably attributed to the 
very fast initial freezing of the solution [13]. Secondly, some of the sucrose 
molecules held in between protein molecules immobilized in the viscous sucrose 
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matrix could lead to high activation energies prerequisite for any transition to 
occur completely [241 - 244]. 
Mannitol lyophilized with IgG, observed a significant decrease (- 23°C) in its 
melting point and surprisingly was also able to produce glass transition effect 
almost similar to that produced by sucrose. However, it is necessary to mention, 
that without any significant decrease in the melting point, mannitol failed to 
produce any transition phase when lyophilized on its own (Figure 5.9). This more 
likely demonstrates a kind of molecular interaction/configuration between the 
sugar (mannitol) and the potential influence of antibody on the ability of a sugar 
to produce a glass transition effect coupled with decrease in its melting point. 
The trapping of antibody within the amorphous medium (sucrose/mannitol) stops 
inter-protein interactions and also prevents antibody from getting exposed to 
stresses and therefore, does provide enhanced protection against denaturation. 
5.6.3.3 Impact of sucrose and mannitol in combination 
The representative melting curves of IgG (1.2 mM) lyophilized with sucrose and 
mannitol in combination, are shown in Figure 5.12. There was no significant 
change in the unfolding temperature of IgG in the combined formulations (- 1°C). 
It was also observed that by switching the molar concentrations of sucrose and 
mannitol from 1 : 2 to 2 : 1 in the combined formulation significantly improves the 
glass transition (Tg) from - 90 °C to - 124°C). Sucrose and mannitol (molar ratio 
224 
Mudasir Ahmad Lone Chapter 5 
of 1 : 2) in combination provided a protective effect on the unfolding (first 
transition peak:: blue trace) of IgG (1.2 mM) similar to that produced by sucrose or 
mannitol alone. In contrast, the protective effect in combination on the unfolding 
of IgG (first transition peak: :green trace) significantly improved on switching the 
00 - - - - - t ~ t ~ - - ' - - - T - - - - ~ - - - - ~ - - - - ~ - - ~ _ , - - ~ _ , i r _ ~ · ·
_ rn I ~ ~ 10 
Temperature ee) 
Figure 5.12 Overlaid standard DSC heating profiles of: 1.2 ruM IgG lyophilized with 
ucro e and mannitol in combination. (i) 1.2 ruM IgG + 20 ruM sucrose + 40 ruM 
Mannitol (blue trace) and (ii) 1.2 mM IgG + 40 mM sucrose + 20 mM mannitol 
(green trace) sucrose. The formulations were heated up to 220°C at the rate of 10 °C per 
minute. The inverted peak in the beginning of each trace correspond to the melting (Tm) 
of IgG. Higher molar concentration of sucrose increases Tg in the combined formulation 
-124°C (green trace) , whereas at higher molar concentration of mannitol Tg event takes 
place around - 90°C. The melting point of sucrose increases even in the combined 
formulations , wherea melting point of mannitol reduces in combination as described in 
ection (5.6) . 
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molar concentrations of sucrose and mannitol from 1 : 2 to 2 : 1. This suggests, 
that even in the combined formulations, sucrose (40 mM) demonstrates the better 
protective ability. However, in the molar ratio of 2 : 1, it appears, that the glass 
forming propensity of sucrose (green trace) enhances in combination with 
mannitol. This reiterates the fact, earlier described by DLS results, that sucrose and 
mannitol work better in combination than sucrose alone. The' exchange of the 
molar concentration of sucrose and mannitol from 1 : 2 to 2 : 1 in combined 
formulations hardly influences the melting point of sucrose, but the melting point 
of mannitol reduces (- 50°C) significantly (blue trace) [Figure 5.12]. DSC 
showed that the Tg of sucrose enhanced in combination with mannitol 
improved the capability of sucrose to suppress aggregation (melting 
temperature peak) of IgG. 
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Table 5.5 T g and melting points of multiple times (1 - 7) lyophilized powdered IgG 
(AG - 6 - PDH) antibody formulations 
No. of Formulation Protein:Exicipient Melting Point (OC) Melting Point (OC) Tg (OC) Cycles 
(Powdered) Concentration First transition of Excipient (mM) 
1 IgG 1.2:0 - 58 ± 0.15 
1 IgG + Sucrose (I) 1.2: 20 - 59 ± 0.18 - 206 ± 0.45 - 90 ± 0.50 
1 IgG + Sucrose (II) 1.2: 40 - 59 ± 0.15 - 207 ± 0.87 - 91 ± 0.20 
1 IgG + Mannitol (I) 1.2: 20 -59±0.17 - 208 ± 0.61 - 90 ± 0.10 
1 IgG + Mannitol (II) 1.2: 40 - 59 ± 0.12 - 209 ±0.56 - 90 ± 0.30 
1 IgG + Sucrose + Mannitol (I) 1.2: 20 : 40 - 59 ± 0.13 - 210,120 ± 0.29 - 92 ± 0.34 
1 IgG + Sucrose + Mannitol (II) 1.2: 40: 20 - 59 ± 0.21 - 206 ± 0.50 - 124 ± 0.15 
* Tg indicates glass transition temperature, 
(AG - 6 - PDH): antiglucose - 6 - phosphate dehydrogenase antibody 
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S.7 Conclusions 
The present study provides a comprehensive analysis of the effect of repeated 
lyophilization on the aggregation, stability and protection of a polyclonal IgG 
antibody in combination with sugars, sucrose and mannitol. The tendency of 
IgG to aggregate increased during multiple cycles of lyophilization. The 
increase in the mean size of the globular IgG related features and their 
association with amorphous regions in the powdered formulations shown by 
AFM complements the DLS and DSC findings. The inhibitive effect of 
sucrose on the aggregation of IgG both alone as well as in combination with 
mannitol shown by DLS and AFM is consistent with literature. However, 
DSC disagrees with DLS in indicating failure of mannitol to reduce 
aggregation. The reason for this difference remains a topic for future research. 
This work could form the basis of a broad spectrum strategy to characterize, 
minimize and prevent aggregation in protein therapeutics through the 
screening of potential excipients. 
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Chapter 6 
The effect of sucrose and mannitol 
on the secondary structure and 
morphology of polyclonal IgG 
during cycles of lyophilization 
6.1 Introduction 
Protein products lyophilized with a suitable lyoproectants generally have fewer 
stability-related concerns and resist alterations to their structure than proteins 
lyophilized alone [12,24, 32, 242]. The probable mechanisms of prevention and 
stabilization of lyoprotectants has been described in chapter 1. However, 
lyophilization poses challenges such as low temperature (cooling); freeze-
concentration, ice-formation; and dehydration (expulsion of water molecules), 
from the abrupt alteration into the physical environment and the intensification in 
solute concentration, phase separation, and redistribution of solutes [13, 24, 242]. 
Moreover, lyophilization stresses can also enhance crystallization of the buffer 
and an initially amorphous excipient [238, 242]. The crystallization of an 
amorphous excipient can damage protein secondary structure and the desired 
physical property (cake and porous nature for better solubility and quicker 
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reconstitution) of the formulation. All these factors can contribute significantly to 
the biological inactivity of a protein [12,238,242]. 
In view of the above discussed significance of structural and physical properties 
required of a protein formulation, a study was conducted into the effect of 
sucrose and mannitol (alone and in combination) on the structural and 
morphological behaviour of a polyclonal IgG (antiglucose - 6 - phosphate 
dehydrogenise) antilxxly during multiple cycles of lyophilization. The dry 
fromulations were stored at - 4 °C for several months, prior to their structural 
and morphological analysis. Ff-IR in ATR mode was employed for the 
determination of any changes in the secondary structure [130, 200, 202]. SEM 
was introduced to provide physical insights into the multiple times lyophilized 
formulations of IgG [91,111, 187]. 
6.2 Aims and objectives 
The objectives of this study were to analyse the effect of sucrose and mannitol 
(alone and in combination in various molar ratios) on the structural and physical 
characteristics of a polyc1onal IgG antibody during multiple cycles of 
lyophilization (MCL). These strategies would provide further insight for 
optimizing the effect of the indicated sugars on the intrinsic proficiency of IgG to 
resist possible structural and physical alterations. The achievement of 
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optimization to yield desired structural and physical attributes in the studied 
protein formulation would, therefore, be another contributory step towards the 
development of screening scheme that would enable to improve an overall 
therapeutic efficiency of IgG and other such proteins. 
6.3 Materials 
D - Sucrose (99 %); D - mannitol (98 %); were obtained from Sigma Aldrich. 
All other materials which were employed were as described in the section 4.3 of 
Chapter 4. 
6.4 Sample preparation methodology 
Move to Methods [Chapter 4] 
6.4.1 Preparation of IgG formulations 
IgG was lyophilized on its own, with sucrose and mannitol alone, and in 
combination with both exactly in the same manner as described in section 5.4.4. 
6.4.2 Powdered formulations 
IgG (1.2 mM) powdered formulations of IgG were prepared with sucrose 
and mannitol exactly in the manner described in the section (5.4.5.2) 
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6.5 Methods of analysis 
6.5.1 Infra-red ATR-FTIR inspection 
The structural studies were carried out using a Nicolet Ff-IR-spectrometer in an 
identical manner as in the previous chapter 4. 
6.5.2 Scanning electron microscopic examination 
The morphological characteristics of the powdered formulations of IgG 
(lyophilized with sucrose and mannitol alone and in combination) were studied 
by SEM. The different parameters which were used in these experiments have 
been already described in Chapters 3 and 4. 
6.6 Results and Discussion 
6.6.1 Effect of sugars on secondary structure of powdered IgG 
The influence of sucrose and mannitol on the structural stability of IgG was 
probed both in their individual capacity as well as in combination. Prior to start 
of these experiments, control experiments for both sugars were performed. 
6.6.1.1 Sugar controls for Infra-red A TR - analysis 
Secondary structures in the non-lyophilized and lyophilized powders of sucrose 
and mannitol were analysed by ATR. Sucrose and mannitol displayed molecular 
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Figure 6.1 Overlaid, base line corrected ATR spectra of: non - lyophilized (blue 
trace) and lyophilized (green trace) sugars deposited on the clean surface of a glass slide 
u ing a diamond cry tal. [A] Sucro e: [B] mannitol. Spectra were recorded between 
4000 cm-I and 300 em-I. The peaks are bigger prior to lyophilization in both sugars. 
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absorptions in their respective regions [124, 129, 227]. The data is shown in 
Figure 6.1 and clearly demonstrates that the intensity of the various peaks 
decreases significantly after lyophilization both in sucrose (Figure 6.1 A) and 
mannitol (Figure 6.1 B). This is due to the weakening of the bonds in the 
lyophilized sugar samples. The other reason could have been the difference 
amount of powder in contact with ATR crystal while recording absornance 
measurements; however that is not the case over here, as the data has been 
normalized. Therefore, it would be fair to say that the intensity differences in the 
peaks observed with A TR - spectra are real. Sucrose experiences relatively more 
structural alterations than mannitol probably due to the collapse/compression of 
two pyranose rings. 
6.6.1.2 Secondary structure with sucrose and mannitol alone 
The normalized, smoothed and base line corrected ATR-spectra of the 
lyophilized powders of IgG formulated with sucrose and mannitol alone and in 
combination which were recorded by ATR - FfIR and are presented in Figures 
6.2 A [alone] and B [combination). Alike for the formulations in chapter four, 
IgG (1.2 mM) lyophilized alone and in combination with sucrose and mannitol at 
both concentrations (20 mM and 40 mM) displayed two characteristic molecular 
absorptions in the regions from (1690 - 1638 cm-I) and (1568 - 1517 em-I) 
which respectively correspond to amide bands I and II [124,129, 187,200,205]. 
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Figure 6.2 Overlaid, base line corrected and normalized FTIR-A TR spectra of: 
lyophilized IgG [formulated with sucrose and mannitol] deposited on the clean surface 
of a glas lide. [1]:- when used separately and [II] when introduced in combination [II]. 
Spectra were recorded between 1300 and 2000 cm- I . The two main peaks towards right 
under each curve corre pond to amide bands 1 and II. 
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The presence of amide 1 and II is indicative of the presence of both (l and ~ ~ -
sheet character within the lyophilized formulations. Therefore, the secondary 
structure of IgG formulated with sugars in the lyophilized formulations can be 
described as native like [205]. Several methods [such as relative peak intensity, 
ratio of areas under, shape or structural rearrangement of the different 
components within a band] can be employed to quantify the changes in the amide 
bands 1 and II of the recorded spectra of the indicated IgG samples [225J. 
However, the effect of sucrose and mannitol on the structure of IgG was 
quantified by employing the standard of calculating the ratio of the areas under 
amide bands I and II [244J. The determination of the ratio of amide bands IIII 
enabled a measurement of the ~ ~ - sheet character present in the protein and are 
demonstrated in Figures 6.3 A [alone] and B [combination]. 
Outwardly, it appears from the Figures 6.2 A [alone] and B [combination] that 
aggregation promoting effect of mannitol indicated in NT A, DLS, AFM, SEM 
findings is not due to the alterations produced in the secondary structure of IgO. 
The results presented in the Figure 6.3 [A] which gives an account of 
individualeffect, suggested no significant change in the amide IIII ratio for IgO 
lyophilized with mannitol [green bars (20 mM); light blue bars (40 mM)]. 
However, in case of IgG lyophilized with sucrose (20 mM and 40 mM), an 
increase in the ratio of amide bands (1111) suggest of the ability of sucrose to 
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maintain IgG secondary structure. However, results from the Figure 6.3 [B), 
which give an account of the combined effect, indicate some change in the amide 
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Figure 6.3 Ratio of areas under bands I and II of : lyophilized IgG formulated with 
sucro e and mannitol: - [A] Separate; and [B] in combination. The standard deviation of 
(SD - 0.07) recorded for three ets of measurements recorded for each sample. Influence 
of ucro e (40mM) ha a ignificant impact on the amide VII ratio both alone and in 
combination. 
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IIII ratio for IgG lyophilized with 20 mM sucrose and 40 mM mannitol [red bar] 
and this effect became more significant when molar concentration of sucrose and 
mannitol where switched from 1 : 2 to 2 : 1. Consequently demonstrating 
enhanced protection to IgG's secondary structure when more sucrose was used. 
The changes in the amide IIII ratio are accredited to alterations mainly in the 
secondary structure (predominant P - sheet in character). The detailed account of 
these variations was further studied by the componential analysis of an amide 
band I. This was quite intricate due to the overlapping nature of the molecular 
absorption bands pertaining to different structural components because 
instrumental resolution was not exemplary. Therefore, the spectral resolution and 
area analysis the components of the amide band I was ensured with an aid of 
CASA - XPS peak fitting software. XPS-analysis of amide I band of lyophilized 
samples of IgG (formulated with sucrose and mannitol) was carried out by fitting 
curves to the amide bands I. The relative proportion of various structural 
components of [(i) P - sheet side stretches (1617 cm- I ), (ii) predominant P -
sheet (-1640 cm-\ (iii) a - helix (1652 cm- I ), (iv) P - turns (-1670 cm- I ) and 
(v) P - sheet with anti-parallel structure (-1690 cm- I ), within amide band I can 
be found in Table 6.1 [206]. The presented band components and their 
corresponding areas serve as a method for the determination of alterations in the 
secondary structure within the amide band. I, which otherwise appear 
insignificant when only the amide IIII ratio is taken into account. From the Table 
6.1, it is clear that IgG lyophilized with both sucrose and mannitol shows 
considerable change in structural rearrangement happening amongst the 
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individual components within the amide band I. In response to this effect of 
structural rearrangement as a consequence of lyophilization, the ability of 
sucrose to resist alteration in each individual structural component was 
significantly higher than mannitol both alone and in combination. 
It can be found from the Table 6.1, that the concentration of the main p - sheet 
structural component in IgG reduced by about 27.5 % (at 20 mM) and 10.7 % (at 
40 mM) in the case of mannitol. In contrast, such reduction was only 12 % in 
IgG formulated with 20 mM sucrose. Furthermore, doubling the molar 
concentration of sucrose from 20 mM to 40 mM yielded a 7 % increase in the 
main p - sheet structural component. Similar effects can be found for the 
concentration of amino acid side chains, p - turns and p - sheet with anti parallel 
structure. The a - helical content disappeared in IgG lyophilized with sucrose 
(20 mM) and mannitol 40 mM). For a sugar alone, the least altered structural 
rearrangement of all the indicated individual components (a and P) was observed 
in IgG lyophilized with sucrose (40 mM), whereas the best protection against 
overall alteration of structural components was achieved in case of IgG 
lyophilized with sucrose and mannitol in a combination in their molar ratio of 40 
mM and 20 mM respectively [Table 6.1, Part II]. This minimization of the 
extent of structural variation within the amide band I is indicative of a decrease 
in the propensity of aggregation. 
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Table 6.1 Analysis the effect of sucrose and mannitol on different structural 
components stationed within amide band I, based on percentage and area 
Part I. Individual effect 
Amide band I Component 1 Component 2 Component 3 Component 4 Component 5 
(-1690-1600 em-I) p - sheet p - sheet (1 - helix p - turns p - sheet 
Amino-acid Main in the 
Side chains Middle Amide I 
Anti-parallel structure 
Range (-1615 -1620 em-I) (-1628 -1645 em-I) (-1650 -1658 em-I) (-1660 -1677 em-I) (-1686 -1697 em-I) 
Peak position ( - 1617 em-I) ( - 1639 em-I) ( - 1652 em-I) ( - 1670 em-1 ) ( - 1690 em-I) 
IgG (% : area) 2 : 4.1 55.37 : 110.7 10.5 : 20.1 2.02 : 4 30.5 : 6.1 
IgG+20mM 1.87 : 2.4 43.41 : 55.7 0 : 0 52.6 : 64.9 4.14 : 5.3 
Sucrose 
IgG +40mM 1.65 : 3 62.52 : 64.40 4.3 : 7 1.97 : 2.3 29.7 : 30 
Sucrose 
IgG + 20mM 12.48 : 20.4 26.64 : 943.6 16.15 : 26.4 30.28 : 49.6 14.45 : 23.6 
Mannitol 
IgG+40mM 0 : 0 44.63 : 61.6 0 : 0 33.6 : 46.4 21.73 : 30 
Mannitol 
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Table 6.1 Part II. Effect in Combination 
Amide band I Component 1 Component 2 Component 3 Component 4 Component 5 
(-1690-1600 em-I) p -sheet p - sheet a - sheet p - turns p - sheet 
Amino-acid Main in the 
Side chaills Middle Amide I Anti-parallel structure 
Range (-1615 -1620 em-I) (-1628 -1645 em-I) (-1650 -1658 em-I) (-1660 -1677 em-I) (-1686 -1697 em-I) 
Peak position ( - 1617 em-I) ( - 1639 em-I) ( - 1652 em-I) ( - 1670 em-I) (- 1690 em-I) 
IgG (% : area) 2: 4.1 55.37 : 110.7 10.5 : 20.1 2.02: 4 30.5: 61.1 
IgG+S +M 0: 0 48.7: 25.0 0: 0 30.8: 15.9 20.6: 10.5 
(20 mM + 40 mM) 
IgG+S + M 1: 3.6 57.8: 37.8 4: 6.7 6.2: 7.6 29: 20 
(40 mM + 20 mM) 
----- -- - -- - -- --
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However, irrespective of the ability of sucrose to prevent aggregation at an 
optimum concentration alone and in combination with mannitol, aggregation still 
occurs to some extent due to structural alterations such as rearrangement in the p 
- sheet structural components especially side chains, which may potentially 
weaken the protein strruture. More importantly sliding of side chains can 
aggravate both intra and inter-protein interactions by enhancing attractive 
electrostatic interactions between oppositely charged hydrophilic residues, which 
otherwise remain distant from each other. Therefore, these reasons could 
probably also explain the unfolding of Fabs or exothermic aggregation peak 
(depth of the first transition peak) for DSC analysis of IgO presented in Chapters 
4 and 5. The proportion of completely or partially unfolded molecules within the 
aggregates depends on the intensity of structural rearrangement (proportion of p 
- sheet. The presence of sucrose in lyophilized formulations in IgO both alone 
and in combination induced the least alteration in the concentration of P - sheet 
structural components. Subsequently, the degree of aggregation would be 
correspondingly reduced in the sample that has been lyophilized with an 
optimum amount of sucrose as we observed in IgG lyophilized with higher molar 
concentration of sucrose both alone and in combination. 
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6.6.2 Morphological examination 
6.6.2.1 SEM controls sucrose and mannitol 
SEM control experiments for lyophilised mannitol and sucrose are presented in 
Figure 6.4. Both sucrose and mannitol were formulated in 0.01 M PBS prior to 
lyophilization. SEM images of non-lyophilized sucrose showed the expected 
well defined cuboidal morphology. The incubation, for a period of three to four 
hours following lyophilization transforms amorphous sucrose to crystalline state 
under certain conditions (33 % relative humidity at 25°C) has been discovered in 
the previous studies [245]. In the similar studies here, micrographs obtained with 
lyophilized sucrose powder indicate the formation predominant amorphous like 
structures with less significant growth of likely crystalline structures (Figure 6.4 
middle panel). This is in contrast to that observed in mannitol, which exhibited a 
strong tendency to crystallize during lyophilization (Figure 6.4 Bottom Panel). 
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Figure 6.4 EM images of lyophilized sucrose and mannitol controls: xcept the top 
one, both can in each panel repre ent two different locations of the arne sample. 
Different can ize obtained at a magnification of 13 kY. 
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The crystals of mannitol are multi-geometric and form several crystalline 
architectures such as needles, stripes, and flowers type in appearance. Unlike, 
sucrose, mannitol appears to form flaky structures during lyophilization. The 
exclusive crystallization of mannitol [223,227,246] and partial crystal formation 
by sucrose from aqueous solution and its amorphous phase during lyophilization 
has been reported [to, 223]. This ability of sucrose to produce relatively 
abundant amorphous phase and extensive crystallization (with several types) of 
mannitol differentiated by SEM, compliments AFM results presented in Chapter 
5. 
6.6.2.2 Comparative behaviour with sucrose and mannitol 
Visually the surfaces of the formulations of IgG lyophilized with sucrose appeared 
porous, flaky and without any significant growth of crystalline material [Figure 
6.5]. Without changing the molar concentration of protein, an increase in the molar 
concentration of sucrose enhanced porosity and flakiness of the powdered 
formulation. In contrast, the effect of mannitol was quite different to that observed 
for sucrose [Figure 6.6]. The porosity and flakiness was significantly reduced with 
the abundant growth of crystalline structures in IgG lyophilized with mannitol. 
With increase in the concentration of mannitol, the visual growth in the crystalline 
material, denseness and consistent decline in the porosity is an indicative of the 
poor capability of mannitol to interact with IgG due to its susceptibility to 
crystallize. 
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Figure 6.5 SEM images of 1.2 mM IgG lyophilized with sucrose: 1 : 20 [Top panel], 
I : 40 [Middle panel] 1 : 60 [Bottom panel]; both scans in each panel represent two 
different location of the same sample. Different scan sizes obtained at a magnification 
of 13 kV. 
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Figure 6.6 SEM images of 1.2 mM IgG lyophilized with mannitol: 1 : 20 [Top 
panel], 1 : 40 [Middle panel] I : 60 [Bottom panel] ; both scans in each panel represent 
two different location of the same sample. 50 - 100 micron scans obtained at a 
magnification of 13 kV. 
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Sugar lyoprotectants in aqueous solutions interfere with the protein stability, [12, 
131,134, 221]. Generally lyoprotectants are often employed in a higher 
concentration than the therapeutic protein itself; their precipitation traits (such as 
solubility and crystallization) will therefore govern the precipitation dynamics 
and the morphology of the final dried formulation. Mannitol due to its tendency 
to crystallize (Figure 6.4) resulted in the appearance of particle families that are 
more aggregated, less porous and less flaky [Figure 6.6). Increasing the molar 
concentration of mannitol resulted in more agglomeration of the amorphous 
particles and promoted the growth of crystalline strip like features. Formulations 
containing sucrose resulted in a large number of homogenous smaller particles 
with porous surfaces (Figure 6.5). In contrast, mannitol-containing formulations 
resulted in less homogeneous particles, even at lower molar concentration (20 
mM). The lower solubility of mannitol and its propensity to form various types 
of crystal structures [as shown by AFM in Chapter 5 and Figure 6.4-bottom 
panel], probably denature the secondary structure of the IgG molecules, which 
could lead to increase in inter-protein interaction and hence aggregation. The 
diversity in the particle morphology could also be attributed to the difference in 
the extent of denaturation of the interacting protein molecules, how do to they 
interact and their orientation/alignment during their interaction, which in-turn 
could be influenced by the type of crystal formed by mannitol during 
lyophilization. On the other hand, in comparison to mannitol, the formation of 
predominantly less crystals with relatively insignificant structural diversity them, 
therefore, would serve as the likely explanation for sucrose being able to 
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potentiate the formation of relatively porous, flaky and much smaller aggregates 
of IgG. These indicated characteristics are important in order to achieve desired 
therapeutic standard. 
6.2.2.3 Influence of sucrose and mannitol in combination 
The surfaces of the formulations of IgG lyophilized with sugars in combination 
visibly demonstrate increased porosity, flakiness and smaller sized agglomerates 
without any significant growth of crystalline material [Figure 6.7]. IgG with both 
sugars gives the impression of producing much smaller agglomerated flaky 
features than when IgG was lyophilised with sucrose and mannitol individually. 
Formulations containing sucrose and mannitol in equal molar concentration 
appeared more homogeneous [Figure 6.7 top panel]. Switching of the molar 
concentration ratio of sucrose and mannitol from 1 : 2 - 2 : 1 produces an effect 
.that is completely the best in terms of porosity, flakiness, and reduced 
crystallinity, when it comes to optimization [Figure 6.7 middle panel; right 
image). In contrast, increasing the molar concentration of mannitol decreased 
porosity and promoted the growth of flaky agglomerates even in the combined 
formulations [Figure 6.7 middle panel, left image]. This indicates an inhibitory 
effect of sucrose on the crystallization of mannitol during lyophilization and this 
influence becomes clearer at higher molar concentration of sucrose [Figure 6.7 
bottom pannel). SEM images confirmed that the extensive crystallization 
propensity of mannitol (on its own) is reduced with IgG. However, sucrose once 
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Figure 6.7 SEM images of l.2mM IgG lyophilized with sucrose and mannitol in 
combination: 100 - 500 micron scans obtained at magnification between 13 kV. I : 
20 : 20 [Top panel - both can , two different locations of the same sample]; 1 : 40 : 60 
[Middle panel - left can]; 1 : 60 : 40 [Middle panel right scan]; 1 : 60 : 40 [Bottom 
panel- both can, two different location of the same sample]. 
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gain displayed a higher amorphicity with IgG and mannitol in combination. SEM 
results demonstrated an effect similar to AFM findings, and suggested greater 
defensive propensity of sucrose than mannitol on IgG during lyophilization on 
the basis of its ability to form an amorphous material with IgG, indicative of an 
intimate association between sucrose and IgG. 
6.7 Conclusions 
The present study provides a comprehensive analysis of the effect of sucrose 
and mannitol on the structural stability and morphological traits of IgG during 
lyophilization on polyc1onal IgG antibody. Sucrose showed a superior ability 
compared to mannitol in opposing alterations in the secondary structural 
components within the amide band I. The protection was best (and structural 
alterations least) in IgG lyophilized with sucrose at 40 mM. This is consistent 
with our AFM and DLS findings. This also lies in agreement with AFM results 
in chapter 5 and SEM results in this chapter, where relative increase in the size of 
aggregates and proportion of crystalline material was much larger in IgG 
lyophilized with mannitol than in IgG formulated with sucrose. Moreover, an 
increase in the magnitude of unfolding peak (depth of the first transition peak) 
during lyophilization with mannitol revealed by DSC results in Chapter 5 
complements the fact that secondary structural alterations within the components 
shown by Ff -IR destabilized the intra-protein bonded complex, and 
consequently, reduced the thermal stability of IgG. SEM findings demonstrated 
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an increase in the propensity of IgG with mannitol, to form crystalline and tightly 
packed formulation and this effect was enhanced with an increase in the 
concentration of mannitol. On the other hand, IgG formulated with sucrose 
displayed better porosity and flakiness and less crystallinity than with mannitol. 
The desired morphological characteristics enhanced in IgG when formulated 
with sucrose (40 mM) and in combination with mannitol (60 mM). 
252 
Mudasir Ahmad Lone Chapter 7 
Chapter 7 
An examination of the effect of 
multiple cycles of lyophilization on 
antigen-binding activity of IgG 
(Poly clonal) alone and with sugars 
7.1 Introduction 
With the introduction of hybridoma technology by Kohler and Milstein [247], 
and the subsequent development of monoclonal antibodies with highly specific 
interactions with antigens of interest, the target specific destruction of a disease 
became an evident reality. The antibodies have also been used as carriers for 
drugs to the site of the infection [248]. In the modem day, antibody -
therapeutics represent an important class of medicines for a number of diseases 
such as autoimmune, cardiovascular, infectious diseases, cancer and 
inflammation [249, 250]. With significant advances made in antibody based 
therapy for malignancies such as breast cancer, colorectal cancer and lymphoma 
[249, 250], there has been a growing demand to develop new and modified 
antibody therapeutics. For this reason and the potential immunogenicity caused 
by the murine antibodies when used on their own, the original murine antibody 
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(of mouse origin) has been engineered into a chimeric or humanized antibody. 
The fusing of murine variable domains (antigen binding) with constant domains 
of human antibody results into the creation of a chimeric antibody (70 % human 
and equipped with full human Fc), which has been reportedly less immunogenic 
[251]. Using CDR- grafting methods, a humanized antibody is produced when 
the hyper-variable loops in the murine antibody are completely replaced by those 
in the human antibody. Humanized antibodies have been reported to be less 
immunogenic and 85 - 90 % human [252]. Humanization means the conversion 
of non-human antibody to a human-like antibody in order to circumvent the 
human immune system. It involves either the replacement of constant regions of 
murine mAbs with those of a human mAb or modification of the protein 
sequences in the constant regions and variable framework regions of non-
humanized antibody to increase their resemblance to antibody variants occurring 
naturally in humans. This is achieved by grafting the non-humanized 
complementarity-determining regions (CDRs) onto a human antibody 
framework, resulting in more human like antibodies with reduced 
immunogenicity. Table 7.1 shows some of the mAbs under the final stages of 
clinical approval, whereas Table 7.2 presents a list of murine, chimeric and 
humanized monoclonal antibodies already approved by FDA for therapeutic use 
[249, 250, 253]. 
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Table 7.1 Monoclonal antibodies in late stages of clinical trials [249] 
Descriptron Target Indication Sponsor 
Ch14.18 chimeric mAb GD2 Neuroblastoma. Used in combination NCI 
with chemotherapy radiotherapy and 
colony-stimulating factors 
Rencarex (WX-9250; G250 antigen Nonmetastatlc kidney cancer. Used Wilex 
cG250> chimeric mAb after surgery 
MDX-OIO CTLA-4 Melanoma. Used alone and in combl- Medarex 
humanized mAb nation with gplOO peptide vaccine 
Panitumumab (ABX-EGF) EGFR Non- small cell lung cancer Abgenixl 
human mAb Immunex 
Remitogen (HulDIO) HCclass II Non-Hodgkin lymphoma Protein Design 
humanized mAb labs 
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Table 7.2 Therapeutic Monoclonal Antibodies Approved For Therapeutic Use [250] 
Generic name Trade name Antibody fonnat Antigen Approved Indication IlFDA llEMEA 
approval approval 
Muromomab Orthoclone Murine, IgG2a C03 Allograft retectlon In allogeneic renal 86/06/19 NA 
transpiantaUon 
Abchdmab1 ReoPro Chimeric, IgG 1 GPilb/llla r Maintenance of coronary patency 94/12/22 NA 
Rltuxlmabl Mabthera Chlmenc, IgG 1 C020 Co20-posiUve 8-cell non-Hodgkln's lymphoma 97/11/26 98/06/02 
Dacllzumab Zenapax Humanized, IgG 1 C025 (112r) Allograft refection 97/12/10 99102126 
Basllhdmab Simulect Chimeric, IgG 1 Co25 (112r) Allograft retecUOn 98/05/12 98110109 
PaiMzumab Synagls Humanized, IgG 1 Protein F Respiratory syncytial virus (RSV Inhibitor) In 98106119 99/08/13 
children 
Inflhdmab Remlcade Chlmenc, IgG 1 TNFa Crohn's disease and rheumatoid arthritis 98/08/24 99108113 
Trastuzumab Herc.eptln Humanized, IgG 1 HER2/Neu Metastatic breast cancer 98109/25 00/08128 
Etanerc.ept) Enbrel huFcy1ITNFr TNFa and ~ ~ Autoimmune diseases such as ankyloslng 98111/02 00/02/03 
spondylitis 
Gemtuzumab4 Mylotarg Humanized, IgG4 C033 Co33-poslUve acute myeloid leukemia 00/05/17 NA 
Alemtuzumai)S Mabcampath Humanized, IgG 1 C052 8-cell chronic lymphocytic leukemia 01/05/07 01107106 
Ibrltomomab6 Zevalln'lOy Mouse,lgGl C020 8-cell non-Hodgkin's lymphoma 02/02/19 04/01116 
Adallmumab1 Trudexa Human, !gG 1 (PO) TNFa Crohn's disease and rheumatoid arthritis 02/12/31 03/09101 
AlefaceptJ Amevtve huFcy1/UA-3 CO2 Chronic plaque psoriasis 03/01/30 NA 
Omallzumab Xolalr Humanized, IgG 1 IgE Treatment of asthma 03/06/20 05110125 
Tosltumomabu Bexxar 1111 Murine, IgG2a C020 C020-posiUve 8-cell non-Hodgkin's lymphoma 03/06/27 NA 
Efallzumab RaptJva Humanized, IgG 1 COlla Moderate to severe plaque psortaSis 03110/27 04/09120 
Cetuxlmab Erbltux Chimeric, IgG 1 EGFR Metastatic colorectal and head and neck 04/02112 04/06129 
carcinoma 
Bevaclzumab AvasUn Humanized, IgG 1 VEGF-A MetastatIC colorectal and non-small cell lung 04/02126 05/01/12 
carcinoma 
Natahzumab9 Tysabrt Humanized, IgG4 Integrin-a4 Multiple sclerosis 04/11/23 06/06/27 
Ranlblzumab lucentls Humanized, IgG 1 VEGF-A Wet-type age-related macular degeneraUon 06/06/30 07/01122 
Panltumumab'o VectJbls Human, !gG2 EGFR Metastatic colorectal carcinoma 06/09/27 07112119 
Ecullzumab'1 SoIlris HumanlZed,lgG214 C5 Paroxysmal nocturnal haemogloblnurta 07/03/16 07106/20 
CertoIIzumab'1 Clrnzla Humanized, IgG 1 TNFa CrohI"I's disease 08/04118 NA 
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The antibodies or fragments approved for therapeutic use (Table 7.1) like other 
protein based formulations are generally stored in a dry form (lyophilized) owing 
to their propensity to aggregate in solution as discussed in Chapter 1. Therefore, 
from a pharmaceutical point of view, amongst the several characteristics to be 
examined, the capability to bind an antigen or the activity of the therapeutic 
antibodies after lyophilization and reconstitution is clearly a significant 
parameter that needs to be explored. This is because specific recognition at a 
molecular level is the fundamental requirement for an active therapeutic [254]. 
Such molecular recognition is governed by the specific interaction of multiple 
non-covalent bonds such as electrostatic, electro-dynamic (van der Waals), 
hydrogen bonds or hydrophobic interactions. 
7.1.1 Mechanisms of action of therapeutic antibodies 
A brief description of the five reported mechanisms (see Figure 7.1) of antibody-
antigen interaction; from pathogenic point of view are provided: 
I. Ligand blockade 
This mechanism involves blocking of the binding site of the ligand (antigen) and 
therefore prevents activation of cognate receptors of ligands. The blocking could 
be facilitated either by whole therapeutic antibody (lgG) molecule or by an 
antibody fragment or receptor immunoadhesins. 
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T F 
TherapeutIc antibody 
Fab fra ment 
Chapter 7 
Ligand blockade 
Receptor blockade 
Receptor down regulation 
Depletion 
Signalling induction 
Figure 7.1 Five reported mechanisms of therapeutic antibody-antigen interaction 
are illustrated schematically. TNF : - tumour necrosi factor; TNFRI : - tumour 
necro is receptor I; TCR : - T cell receptor; MAC: - membrane-attack complex [255] . 
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II. Receptor blockade 
Ligand receptor interaction can also be prevented by antibodies by positioning 
themselves into the cognate receptors which results in the inhibition of receptor 
activation and impairs functioning. 
III. Receptor down regulation 
In this mode of operation, the antibodies after binding to cellular surfaces get 
internalized and down regulate to inhibit the activation of cell surface receptors 
of the ligand. 
IV. Depletion 
This involves breakdown of antigen-bearing cells via complement-mediated lysis 
and opsonization, as well as Fc receptor for IgG (FcyR) - mediated clearance. 
V. Signalling induction 
In this mode of action, therapeutic antibodies induce active signals that affect 
cellular life. 
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7.1.2 Overview of methods for studying antibody-antigen binding 
Over the last couple of decades, the development of various assays (such as an 
ELISA, RIA) [254] and several physical detection methods such as AFM [64, 
132, 256], SPR [257] have been successfully employed for the measurement 
antigen-antibody interactions. However, each indicated method has its own 
complexities. ELISA has been widely employed for the measurement antibody-
antigen interactions such as anti-cardiolipin antibodies [258], anti-phospholipid 
antibodies [259], thrombocytopenic purpura [260], thrombocytopenia, [261], and 
recently anti-tumor necrosis factor antibodies [262]. ELISA involves 
immobilization of one of the interacting partners, usually an antigen on the 
surface of a micro-plate, and then compounded with an antibody linked to an 
enzyme (direct approach) [263]. However, if the primary antibody is not linked 
to an enzyme, then antigen is first complexed with primary antibody (without 
any linked enzyme) followed by detection with a secondary antibody linked to an 
enzyme (indirect approach). The detection is achieved by measuring the 
conjugated enzyme activity via incubation with suitable substrate to produce a 
signal [263]. Both assays have their own merits and potential difficulties [263]. 
AFM involves the direct measurement of the intermolecular interaction by 
suitable functionalization of the interacting agencies. The utilization of AFM [64, 
256, 264, 265], shows such measurements in the piconewton range under 
physiological conditions. However, direct force measurement of inter-molecular 
interactions by AFM becomes intricate due to several factors. For instance the 
complicated tertiary structures of both antibody and antigen require robust 
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attachment to the interacting surfaces (AFM tip and substrate) for accurate force 
measurements. Furthermore, such interactions are influenced by conformational 
state, environment, and steric hindrance offered by the involved molecules. The 
other drawback emanates from the potential non-specific interactions which may 
occur between the surfaces [64,256,264,265]. 
In the 1990s, the emergence of biomolecular interaction analysis (BIA) or 
surface plasmon resonance (SPR) based new biosensor technology significantly 
improved the biophysical measurement of antigen-antibody binding interactions 
at an interface [266, 267,268, 269, 270, 271, 272]. SPR enables these 
measurements as a function of time. The binding is marked by an increase in 
refractive index when one of the interacting associates, branded as the analyte 
(antigen or antibody), interacts to a ligand immobilized (antigen or antibody) on 
the surface of the bio-sensor chip [273]. Unlike ELISA, SPR does not require 
any labelling of the interacting partners, and therefore, eliminates binding 
artefacts due to the label [274]. 
Over the last couple of decades there has been a significant amount of increase in 
research concentrated on addressing the role of lyophilization induced 
aggregation in affecting the activity of bio-pharmaceuticals (protein therapeutic) 
[13, 164]. The convenience of methods to measure the activity of protein 
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therapeutic or markers with high sensitivity and specificity is critically 
significant. Among several potential methods discussed above (ELISA, AFM, 
SPR), this work employs ELISA. 
7.1.3. ELISA, its principle and formats 
ELISA is the most extensively employed and amongst the best validated methods 
for testing the activity of therapeutic proteins [275]. 
The basic general principle behind an ELISA is that it involves the 
immobilization of one of the interacting partners (either an antigen or an 
antibody) on the surface of polyvinyl chloride (PVC) micro-plate, followed by 
washing of the coated surface to remove any unbound molecules. The PVC 
surface immobilized (coated) with an antigen (for consideration) is then 
incubated with an antibody which is linked to an enzyme that produces 
fluoresces upon the addition of a suitable substrate (due to oxidation). The 
intensity with which the colour is produced is related to the amount of 
antigen/antigen with binding activity (functionality) [263]. 
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Substrate 
Direct ELISA Indirect ELISA Capture ELISA 
Figure 7.2 Schematic representations of the three methods for performing an 
ELISA experiment: There is a difference in the number and in the arrangement of 
interacting partners (antigen and antibodies) in all three formats. The method of choice 
depends on the nature of the interacting partners involved. Direct approach is considered 
ideal when primary antibody i linked to an enzyme or could be linked to an enzyme. 
Indirect involves one step more in the middle, that is the addition of secondary antibody 
which is enzyme linked. Capture ELISA is an indirect ELISA performed on the capture 
antibody which is immobilized on the PVC microwell surface first [263, 276]. 
ELISA can be performed in at least three well established formats highlighted in 
Figure 7.2 [263, 275]. In this study, we report the measurement of the antigenic 
binding activity of multiple times (1 - 7) lyophilized IgG antibody using an 
indirect ELISA approach pre ented in Figure 7.2. We have also attempted to 
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probe into the effect of sucrose and mannitol (alone and in combination) on the 
antigen binding capability of IgG (antiglucose - 6 - phosphate dehydrogenase). 
7.2 Aims and objectives 
The objectives of this study were to study the effect of repeated lyophilization 
on, the protective effect of sucrose and mannitol (alone and in combination in 
various molar ratios during lyophilization) on the antigen binding capability of a 
polyclonal IgG. This information would assist in the optimization of the 
standard conditions required to minimise aggregation in protein based bio-
pharmaceuticals. 
7.3 Materials 
Primary antibody, secondary antibody, antigen, substrates, buffers, sugars which 
and other materials which were used in this study have been reported in the 
section 2.1 of Chapter 2. 
7.4 Methods 
7.4.1 Lyophilization of IgG alone and with sugars 
This has been already described in section 2.1.1.2 of Chapter 2. 
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7.4.2 Preparation of primary antibody solution 
The multiple times lyophilized IgG (0 - 7) and IgG lyophilized with sugars 
(sucrose, mannitol, trehalose, and sorbitol) alone and in combination were 
diluted to 1 : 1000 in blocking buffer (1 % BSA v/v in PBS). 
7.4.3 Preparation of secondary antibody solution 
The HRP-linked anti-rabbit IgG antibody solution was diluted to 1 : 2000 in 
blocking buffer. 
7.4.4 Preparation of antigenic solution 
The lyophilized powder of G-6-P-DH antigen was reconstituted in 5 roM sodium 
citrate as per manufacturer's instructions and dilutions were made to a range of 
concentrations 50 ng/ml, 500 ng/mI, 1 ~ g / m l , , 5 ~ g / m l , , 7 ~ g / m l , , 10 ~ g / m l , , and 15 
~ g / m l . .
7.4.5 Preparation of butTer solutions 
- Wash buffer (Tween 20) 
- Blocking buffer (1 % BSA v/v in PBS) 
- TMB subsrate (1 tablet in 10 mL of O.IM sodium acetate + 3 ~ L L of H20 2• 
- OPD substrate (1 tablet in 10 mL of filtered deionized water) 
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4.6 Preparation of plates ELISA plates 
The ELISA plates were prepared using an indirect ELISA approach (Figure 7.3). 
Step 1 
Step 2 
Step 3 
Step 4 
Step 5 
Step 6 
Step 7 
Coating of ELISA plate with an antigen 
Washing with Tween 20, 0.05 % vlvin PBS 
Blocking of wells with 1 % BSA wlv in 
PBS (Blocking Buffer) 
Incubation of wells with primary antibody 
(AG - 6 - PDH antibody) 
Incubation of wells with secondary antibody 
(anti - rabbit IgG linked to (HRP) 
Incubation with TMB substrate 
The completion of reaction with 2.5 M 
sulphuric acid gives plate ready for analysis 
Figure 7.3 The chronology of the steps involved in the preparation of an ELISA 
plate via an indirect approach. 
The most challenging aspect for generating robust immunoassays is the design of 
experiments for the optimization ligand - receptor interactions. The identification 
of critical factors such as right concentration of antigen, primary and secondary 
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antibodies, incubation periods, use of appropriate washinglblocking buffers and 
their impact on interactions with a minimal number of experiments is crucial for 
the optimization of binding interactions between an antigen and detection antibo 
dy. For an indirect ELISA assay, after conducting a series of experiments, we 
successfully optimized incubation periods for each step and the intra-plate factors 
such as concentration of antigen for plate well coating, detection antibody, and 
HRP-linked anti-rabbit IgG concentrations. All this effort involved ensured 
desirable conditions for improving specific binding events. The optimization of 
assays was validated by recording less than 1 % error in the measurements after 
repeating the experiments three times. 
The ELISA plates were prepared using an in direct ELISA approach. The 
following text describes the chronology of the steps involved in Figure 7.2 
I. Antigen [(glucose-6-phosphate dehydrogenase from baker's yeast (S. 
cerevisiae)] was coated on 96 - well polystyrene ELISA plates 
(Immuno 96 MicroWell™) and incubated overnight at 4 0c. This was 
executed in order to ensure that antigen covered the surfaces of the 
multiwell plate. 
II. In the subsequent day, the indicated sample solution was removed and 
the plate was washed three times with the wash buffer composed of 
Tween 20, 0.05 % v/v in PBS. 
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III. The next step involved the blocking of wells by putting in 250 III of 1 
% BSA w/v in PBS (blocking buffer) for an hour at room 
temperature. The removal of blocking buffer was ensured by washing 
the wells three times as described earlier. 
IV. The individual wells of the plate were mounted with 125 III of IgG 
[lyophilized alone (1 - 7) and with sugars (sucrose/mannitol or both, 
cycle 1) diluted 1 : 2000] in blocking buffer. The plate was subjected 
to incubation for couple of hours at room temperature. The removal 
of IgG solution from the plate wells was once again ensured by 
washing the wells three times with washing buffer as before. 
V. The individual wells of the plate were mounted with 125 III of anti-
rabbit IgG linked to horseradish peroxidase (HRP); diluted 1 : 2000 in 
blocking buffer. The plate was subjected to incubation for couple of 
hours at room temperature. The removal of anti - rabbit IgG - HRP 
solution from the plate wells was once again ensured by washing the 
wells three times with washing buffer as before. 
VI. The next stage of the reaction involved the addition of TMB substrate 
(loo Ill) into each well for an approximate incubation period of 10 
minutes. 
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VII. Finally the addition of 20 ~ l l of 2.5 M sulphuric acid enabled the 
completion of the reaction process for the preparation of required 
plates, which were readily introduced into the Dynex microplate 
reader for measurement of absorbance (measured at 450 nm). 
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I. 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.Sf.lg/ml 0.Sf.lg/ml If.lg/ml If.lglml Sf.lglml Sf.lg/ml 7f.lglml 7f.lg/ml lOf.lg/ml lOf.lg/n1l lSf.lglml lSf.lg/ml 
B 0.Sf.lg/ml 0.Sf.lg/ml If.lg/ml If.lglml Sf.lg/ml Sf.lg/ml 7f.lglml 7f.lg/ml lOf.lg/ml lOf.lg/ml lSf.lg/ml lSf.lg/ml 
C 0.Sf.lg/ml O.Sf.lglml If.lg/ml If.lg/ml Sf.lg/m1 Sf.lg/ml 7f.lg/ml 7f.lg/ml lOf.lg/ml lOf.lg/ml lSf.lg/ml lSf.lg/m1 
D 0.Sf.lg/ml 0.Sf.lg/ml If.lglml If.lglml Sf.lg/ml Sf.lglml 7f.lg/ml 7f.lg/ml 10f.lg/ml lOf.lg/ml lSf.lg/m1 lSf.lg/ml 
E 0.Sf.lg/ml 0.Sf.lg/m1 If.lg/ml If.lg/ml Sf.lglml Sf.lg/ml 7f.lg/ml 7f.lg/ml 10f.lg/m1 lOf.lg/ml lSf.lg/ml lSf.lg/ml 
F 0.5 f.l glml O.Sf.lglml If.lg/ml If.lg/ml Sf.lglml Sf.lglml 7f.lg/ml 7f.lg/ml lOf.lg/ml 10f.lglml lSf.lg/ml lSf.lg/ml 
G O.Sf.lglml O.Sf.lglml If.lg/ml If.lg/ml Sf.lg/ml Sf.lg/ml 7f.lglml 7f.lg/ml lOf.lg/ml 10f.lglml lSf.lg/ml lSf.lg/ml 
H O.Sf.lglml 0.Sf.lg/ml If.lglml If.lg/ml Sf.lg/ml Sf.lglml 7f.lg/ml 7f.lg/ml lOf.lg/ml 10f.lglml lSf.lg/ml lSf.lg/ml 
II. 1 2 3 4 5 6 7 8 9 10 11 12 
A Cycle 0 O.Sf.lglml Cycle 0 If.lg/ml Cycle 0 Sf.lg/m1 Cycle 0 7f.lg/ml Cycle 0 lOf.lg/ml Cycle 0 ISf.lg/ml 
B Cycle 1 20mMS Cycle 1 20mMS Cycle 1 20mMS Cycle 1 20mMS Cycle 1 20mMS Cycle 1 20mMS 
C Cycle 2 40mMS Cycle 2 40mMS Cycle 2 40mMS Cycle 2 40mMS Cycle 2 40mMS Cycle 2 40mMS 
D Cycle 3 60mMS Cycle 3 60mMS Cycle 3 60mMS Cycle 3 60mMS Cycle 3 60mMS Cycle 3 60mMS 
E Cycle 4 20mMM Cycle 4 20mMM Cycle 4 20mMM Cycle 4 20mMM Cycle 4 20mMM Cycle 4 20mMM 
F CycleS 40mMM CycleS 40mMM CycleS 40mMM CycleS 40mMM CycleS 40mMM CycleS 40mMM 
G Cycle 6 60mMM Cycle 6 60mMM Cycle 6 60mMM Cycle 6 60mMM Cycle 6 60mMM Cycle 6 60mMM 
H Cycle 7 S+M(l:l) Cycle 7 S+M(l: I) Cycle 7 S+M(1:l) Cycle 7 S+M(1:l) Cycle 7 S+M(l:I) Cycle 7 S+M(l:l) 
Figure 7.4 Plate layout for an indirect ELISA testing of samples. Each sample of IgG, was tested against at least six antigenic concentrations simultaneously 
within a plate. I. Plate maps for wells coated with relative antigenic concentrations from (0.5 f.lglrnl to 15 !J,glrnl) for testing different samples of IgG. II. Shows 
scheme of testing multiple times (0 - 7) lyophilized IgG samples, and one cycled IgG containing sucrose and mannitol (alone and in combination). 
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III. 1 2 3 4 5 6 7 8 9 10 11 12 
A HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
B HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
C HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
D HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
E HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
F HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
G HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
H HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG HRP-IgG 
IV. 1 2 3 4 5 6 7 8 9 10 11 12 
A TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
B TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
C TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
D TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
E TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
F TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
G TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD 
H TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD TMB/OPD I 
Figure 7.4 Part In. Shows scheme of adding of J 25 flL of ( I in 2000) HRP-linked secondary antibody to each antibody. IV. Displays addition of substrate 120 flL 
to each well of the plate. 
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-- . - - - -
v. 1 2 3 4 5 6 7 8 9 10 11 12 
A 2.5M H2SO .. 2.5M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 2_'iM H2SO .. 2.5 M H2SO .. 25 M H2SO .. 25 M H2SO .. 
8 2.5M H2SO .. 2.5M H2SO .. 25M H2SO .. 2.5M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 25 M H2SO .. 2.5 M H2SO4 2.5M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 
C 2.5M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 25 M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 25M H2SO .. 25 M H2SO .. 2.5 M H2SO .. 2.5M H2SO .. 
I, D 2.5M H2SO .. 2.5M H2SO .. 25M H2SO .. 2.5M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 2.5M H2SO4 2-'i M H2SO4 25M H2SO .. 2.5 M H2SO4 2.5 M H2SO .. 2.5 M H2SO. 
E 25M H2SO .. 2.5M H2SO .. 2.5M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 25 M H2SO4 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 25M H2SO .. 2.S M H2SO .. 2.5 M H2SO .. 
F 2.5M H2SO .. 2.5M H2SO. 2.5M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 25M H2SO .. 25 M H2SO. 2.5M H2SO .. 2.SM H2SO .. 2.S M H2SO .. 2.5 M H2SO .. 
G 25M H2SO .. 2.5M H2SO .. 2.5M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 25 M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5M H2SO .. 2.5 M H2SO. 2.5 M H2SO .. 
, 8 2.5M H2SO .. 2.5M H2SO .. 2.5M H2SO .. 25M H2SO .. 25M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 2.5 M H2SO .. 
- -- - ----
Figure 7.4 Part V. Demonstrates liberation of yellow colour upon the addition 20 f-tL of 2.5 M H2S04 to each well of the plate. The more intense the colour 
indicates more strong binding to an antigen . 
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7.5 Measurements 
The recorded absorbance measurements using Dynex plate reader were plotted 
against concentrations for each sample type of IgG. The activity of IgG in a given 
sample was determined by plotting the absorbance readings against antigenic 
concentrations. A series of ELISA experiments were conducted on successively 
increasingly diluted solutions of each individual IgO sample at known 
concentrations. Same procedure was adopted for each sample of IgO 
lyophilized multiple times (0 - 7), IgO with sucrose and mannitol separately 
and in combination. The only change that was to be made was at step 4 by 
changing the IgG sample formulated under specific conditions such as 
number of cycles that the primary antibody has been exposed to and the type 
/quantity of sugar/s that was used during lyophilization. 
The same procedure was adopted for each sample of IgG lyophilized 
multiple times (0 - 7), IgG with sucrose and mannitol separately and in 
combination. The only change that was made was at step 4 by changing the 
IgO sample formulated under specific conditions such as number of cycles 
that the primary antibody has been exposed to and the type of sugar/s that 
was used during lyophilization. 
273 
Mudasir Ahmad Lone Chapter 7 
7.6 Results and Discussion 
7.6.1 Antigen binding propensity of multiple times lyophilized IgG 
Indirect ELISA approach (Figures 7.2, 7.3) was employed to detect antigen 
binding propensity of a range of IgG samples which were subsequently exposed 
to multiple times lyophilzation (0 - 7) on its own (Figure 2.2 Chapter 2). 
The data for antigen-binding propensity for multiple times lyophilized IgG 
samples against six different antigenic concentrations are summarized in Figure 
7.5. There occurred a significant decrease in the binding strength of IgG ( - 60 
%) after cycle one onwards up to cycle seven. For one and two times lyophilized 
IgGs, among these six antigenic concentrations used, the binding activity 
displayed by IgG was the highest, ( - 80 %) at 15 Jlglml and lowest ( - 62 %) at 
0.5 Jlg/rnl. However, over all the lowest activity ( - 7 %) was exhibited by IgG 
exposed to seven consecutive cycles of lyophilization. In all samples, the higher-
antigen concentration (15 Jlg/ml) ELISA results were superior to any lower 
antigen concentration used. This was confirmed by a ( - 43 %) increase in the 
activity response in IgG exposed to two cycles of lyophilization when antigen 
concentration was lifted from 0.5 - 15 Jlg/ml. All other IgG samples from cycle 
two onwards were poorly active and showed no response to an increase in the 
antigen concentration. 
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Figure 7.5 Indirect ELISA assay of multiple times lyophilized IgG antibody obtained 
at ix different antigenic (G - 6 - PDH) concentrations indicated. IgG showed significant 
dec rea e in the antigen binding propensity with multiple cycles of lyophilization after 
cycle 2. The binding activity lifted with antigenic concentration in Cycle 2. 
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7.6.2 Diverse activity response of IgG lyophilized with individual sugars 
IgG samples lyophilized separately with sucrose and mannitol at three different 
molar concentrations (20 mM, 40 mM and 60 mM) were ELISA tested and the 
activity response of IgG lyophilized with sucrose were compared to IgG 
formulated with mannitol at six different antigenic conentrations (Figure 7.5). 
The responsiveness of IgG lyophilized with sucrose against each antigenic 
concentration was higher than IgG lyophilized with mannitol at each molar 
concentration of sugar (Figure 7.5). IgG containing sucrose demonstrated a ( - 5 
- 12 %) increase in the activity response in comparison to manntol against all six 
antigenic concentrations (Figure 7.5 A and B). However, it was interesting to 
observe an activity response of IgG in 40 mM mannitol identical to that displayed 
by IgG in 20 mM sucrose. With the exception two antigenic concentrations (10 
~ g l m l l and 15 ~ g / m l ) , , the behaviour of IgG in 60 mM sucrose and 60 mM 
mannitol deomstrated a similar response. IgG lyophilized with sucrose (20 mM) 
displayed better activity against most of the antigenic concentrations used. It 
should also be noted that doubling (Figure 7.6 B) the molar concentration of 
either sucrose or mannitol did not significantly alter their antigen binding 
propensity from those displayed in (Figure 7.6 A). The reason probably is the 
same quantity of monomeric protein being available for binding in the 
formulations with higher molar concentration of sucrose. However, decrease in 
the IgG activity was observed after the molar concentration of sugars was tripled 
(Figure 7.6 C), especially at the 15 ~ g / m l , , the activity of the IgG formulated in 
60mM sucrose was reduced by 10 % when compared to 20 mM sucrose. 
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Figure 7.6 Indirect ELISA testing of IgG lyophilized with sucrose and mannitol separately at 
six different antigenic concentration indicated an increase in the antigen binding activity (ABA) 
with the concentration of antigen u ed. The effect of the sugars presented in [A] , [B] , and [C], 
showed that IgG formulated in sucro e [Blue ba rs] displayed relatively better antigen binding 
activity than IgG containing mannitol [Red ba rs). Using fairly large concentration of the both 
ugar excipient brought a dip in the activity of IgG [A - B > C] and thi dip in the activity was 
more pronounced in IgG lyophilized with mannitol [C-Red bars). 1.2mM IgG lyophilized in 
20mM ucrose [A-Blue Bars] exhibited best antigen binding activity among IgG lyophilized with 
ugars . 
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In contrast, at 15 ~ g l m l , , the activity of IgG lyophilized with 60 mM mannitol 
which increased by 6 % at 40 mM, was back to its activity at 20 mM. From the 
IgG antibody response patterns, we suggest that such diverse activity of IgG 
lyophilized with sucrose and mannitol against six antigenic concentrations is due 
to the paucity of monomeric IgG available after the onset or progression of IgG 
aggregation, which in tum is differently influenced by sucrose and mannitol 
during lyophilization (see Chapter 5). 
7.6.3 Effect of the sugars in combination on IgG activity response 
Since the activity levels of IgG lyophilized separately with sucrose or mannitol 
varied considerably, and was best for IgG lyophilized with 20mM sucrose. 
Therefore, in the quest of enhancing further, the activity response of IgG, 
mannitol in two different molar concentrations (20 mM and 40 mM) was added to 
IgG containing 20 mM sucrose. The activity responses of IgG were compared 
against set pattern of six antigenic. concentrations as shown in Figure 7.7. The 
first combination containing 20 mM mannitol (Figure 7.7 [A]-Blue bars), showed 
relatively higher antigen binding propensity (6 %, 11 %, 11 %, 16 %, 16 %, and 
32 %) against all six antigenic concentrations (0.5 ~ g l m l , , 1 ~ g l m l , , 5 ~ g / m l , , 7 
~ g l m l , , 10 ~ g l m l l and 15 ~ g l m l ) ) used, than the corresponding formulation 
containing 40 mM mannitol (Figure 7.7 [A] - Red bars). The antigen binding 
propensity increased with antigenic concentration. However, unexpectedly, the 
activity response of IgG containing 40 mM Mannitol showed rio improvement in 
antigenic concentration from 5 - 15 ~ g l m l l (Figure 7.7 [A]-Red-bars). 
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Figure 7.7 Indirect ELISA testing of IgG lyophilized with sucrose a nd mannitol in 
combination indicated increase in the antigen binding activity (ABA) with the increase in the 
concentration of the antigen used. The presence of 20mM mannitol in 1.2 mM IgG containing 20 
mM sucrose (Blue bars), demonstrated a significant increase in the antigen binding activity than 
the corresponding IgG formulation with 40 mM mannitol (Red bars). The doubling of the molar 
concentration of sucrose from 20 mM to 40 mM in the first combined formulation caused a 
decrease in the antigen binding activity of IgG (Green bars). The data obtained for IgG with 
threefold increase in the molar concentration of both sucrose and mannitol showed no strong 
influence in enhancing the antigen binding activity of IgG (Purple bars) when compared to other 
examined formulations ofigG containing single or two excipients together. 
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Following on from the observation that in combination IgG lyophilized with 20 
mM sucrose and 20 mM mannitol showed considerable increase in the antigen 
binding activity a second set of combination experiments with increased molar 
concentration of sucrose (Figure 7.7 [B) - Green bars), and sucrose and mannitol 
(Figure 7.7 - [B) - Purple bars) were carried out. The activity of IgG in the former 
(Green bars) was relatively less than in the latter (Purple bars). However, the 
results of both these formulations showed decrease in the activity response when 
compared to the first combined formulation itself (Figure 7.7 [A] - Blue bars). 
For an example: at the antigenic concentration of 15 ~ g / m l , , the decrease in the 
antigen binding activity after doubling the molar concentration of sucrose was -
40 %, whereas 38 % decrease took place when the molar concentration of both 
sugars was tripled to that in the first combined formulation. The increase in the 
molar concentration of sugars reduced the antigen binding response of IgG both 
alone and in combination. 
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7.7 Discussion 
Lyophilization has been reported to cause inactivity of proteins [277]. With the 
understanding that therapeutic proteins have a critical role in antigen binding 
during pathogenesis, the effect of multiple lyophilizations alone and in 
conjugation with sugars on the strength of IgG to bind to an antigen was 
examined. 
The present results clearly demonstrated that multiple lyophilizations makes IgG 
highly susceptible to inactivity compared to one or two lyophilization steps. The 
significant decrease in the antigen binding strength could be attributed to the 
amount and nature of IgG monomers present in the protein solution (Primary 
antibody). One would expect a decrease in the antigen binding activity under 
following circumstances: (i) a lack of sufficient structurally unaltered monomeric 
IgG in a free state (non - aggregated), (ii) IgG monomers available but with 
altered secondary structure, (iii) IgG monomers aggregated (structurally 
unaltered), (iv) IgG monomers aggregated (structurally altered) and (v) fully 
aggregated. The stress created by lyophilization can induce all of the above 
indicated changes at the same point of time and therefore can reduce the activity 
of protein [25, 26, 29]. In case, of the (ii) factor, the decrease in the antigen 
binding activity reveals weakened bonded network within the antigen binding 
fragments (Fabs) of the antibody. This could be also established from the findings 
in the earlier chapter 4, where we discovered that multiple lyophilization caused 
decrease in the proportion of monomeric IgG, an increase in the particle size, 
281 
Mudasir Ahmad Lone Chapter' 
growth in the crystalline features, increase in the concentration of P - sheet main 
component coupled with alterations in other P - sheet secondary structural 
components within amide band I and intensification in the extent of thermal 
unfolding. However, one could not find any defnite association or relationship 
amongst the indicated factors and their influence on antigen binding activity other 
than the P - sheet structural changes. It is because the structures of the 
hypervariable regions (CDRs) of the variable domains of light and heavy chains 
of the antibody molecule found in the loops are based on p - sheet secondary 
structure. These loops, infact are the portions that specifically bind the antigen. 
Therefore, decrease in the antigen binding affinity during multiple cycles of 
lyophilization could be attributed to the changes in p - sheet structure of the loops 
that hold hypervariable regions. The relatively increased activity response 
demonstrated by JgG lyophilized with sucrose suggests more structural stability 
in the hypervariable regions compared to that of IgG lyophilized with mannitol 
[278]. The finding that mannitol was less effective probably reflects its intrinsic 
inability to form sufficient amorphous phase and susceptibility to crystallize 
during lyophilization. The improvements in the antigen binding propensity noted 
upon the addition of mannitol to sucrose, suggests the importance of the role of 
mannitol in stabilizing lyophilized cake structure of the protein formulation in the 
medium of sucrose. In the present experiments, there was no evidence that 
increasing the molar concentration of sucrose both alone or in combination 
improved the IgG activity. This disagrees with findings in the other chapters and 
must be noted. 
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7.7 Conclusions 
The identification of critical factors in maintaining the protein binding activity 
and their optimization is highly significant for improving the efficiency of 
therapeutic proteins. For the same quantity of antibody, the antigen binding 
propensity was shown to be highly dependent upon the concentration of antigen 
coated to the well. IgG activity significantly decreased with multiple 
lyophilization after cycle two onwards. In comparison to mannitol, the sucrose 
had a stronger and positive influence on the antigen binding activity of IgG when 
the sugars were used separately. However, in combination, the addition of 
mannitol significantly improved the binding strength of IgG. Individually, the 
activity response of IgG in 40 mM mannitol was similar to that displayed by IgG 
in 20mM sucrose. However, adding more sugar (more than double) to the same 
quantity of IgG in the formulation does not improve the antigen binding activity. 
The future interest, therefore, will be to investigate the possible immunological 
role of IgG antibodies with other sugars and other higher antigen concentrations 
to establish a robust relationship between the amount of sugars and antigens 
involved. 
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Chapter 8 
Summary and potential for 
further improvement in future 
investigations 
8.1 Framework of the investigations conducted in this project 
A general approach of the investigations conducted in this project is presented in 
Figure 8.1. In the preliminary investigations, the effect of lyophilization on the 
particle size and morphology of the ferritin and IgG, both in air and liquid, were 
characterized. The second phase of experiments investigated the influence of 
multiple cycles (0-7) of lyophilization on an antiglucose-6-phosphate 
dehydrogenase antibody (IgG) without excipients. The penultimate set of 
experiments probed the impact of excipients (sucrose and mannitol alone, and in 
combination) on aggregation behaviour of IgG during lyophilization. The 
parameters examined were particle size, morphology, secondary structure, thermal 
stability, effect of humidity (data not included) and antigenic - binding activity. 
Liquid formulations were analyzed by dynamic light scattering (DLS) and atomic 
force microscopy. 
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I. Screening of the effect of lyophilization on ferritin 
aggregation in air and in liquid. 
Particle size measurements (AFM), Morphology (SEM) 
II. Screening of the effect of lyophilization on the IgG 
aggregation in air and in liquid. 
Particle size measurements (AFM), Morphology (SEM) 
III. Screeening of the effect of multiple lyophilizations on 
the aggregation of IgG in liquid and solid state. 
Particle size measurement (DLS and NTA); Morphology (SEM and 
AFM); Secondary structure (ATR-FT-IR); Thermal Stability (DSC); 
Antigen binding activity (ELISA) 
IV. Screeening of the effect of multiple lyophilizations on 
the aggregation of IgG with excipients in liquid and 
solid state. 
Particle size measurement (DLS); Morphology (SEM and AFM); 
Secondary structure (ATR-FT-IR); Thermal Stability (DSC); 
Antigen binding activity (ELISA) 
Figure 8.1 Schematic overview of the experiments perfonned in this project. 
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(AFM) for particle size characterization. AFM and SEM were employed to 
identify and characterize different components in the powdered lyophilized 
formulations. Differential scanning calorimetry (DSC) and ATR -Fourier 
transform infrared (FfIR) spectroscopy were also used to classify any thermal 
and structural alterations. Antigen binding activity was investigated by an 
indirect ELISA method. The investigations were aimed to provide an insight in 
order to develop a broad spectrum novel screening standard for the detection, 
quantifications and control of aggregation in IgG and other such therapeutic 
proteins. 
8.1.1 Nanoscale characterization of lyophilized ferritin and IgG 
8.1.1.1 Characterization with AFM only 
The nanoscale characterization of the effect of lyophilization on ferritin, both in 
air and liquid was scrutinized in Chapter 3 and Chapter 4 (beginning) 
respectively. The real time imaging of the samples was performed using AFM in 
tapping mode and particle size measurements were carried out by SPIP image 
analysis software. 
In case of both Ferritin and IgG, molecules were randomly arranged onto the 
hydrophilic surface of mica. In air, arrangement of the deposits of ferritin and 
IgG molecules onto mica surface was denser than in liquid, both before and after 
lyophilization. IgG on exposure to air, aggregated heavily compared to ferritin. 
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Overall, both in air and liquid, there occured a decrease in the proportion of 
monomers (for both ferritin and IgG) and smaller multimeric forms, where as 
higher multimers and larger aggregates showed an increase after lyophilization. 
In air, however, the decrease in the proportion of monomeric features was 
relatively more for both ferritin and IgG. Morphologies of the lyophilized ferritin 
using SEM revealed aggregation with visible crystalline surfaces. SEM 
micrographs gave an impression of decrease in the porosity of ferritin after 
lyophilization. 
8.1.2 Multiple times lyophilized IgG without excipients 
8.1.2.1 Characterization with DLS, AFM, DSC, SEM and A TR 
The influence of multiple lyophilizations on IgG without excipients was studied 
in Chapter 4. The reason behind not using excipients was to investigate the 
inherent strength of IgG to resist the effect of stress produced by multiple 
lyophilizations. The size distributions, morphology, structural and thermal 
stability were the parameters examined. [gO lyophilized on its own was able to 
offer certain resistance against aggregation, however, this resistance is not 
sufficient to overcome the stresses inflicted during multiple cycles of 
lyophilization. The propensity of [gO particles to aggregate (increase in size) 
enhanced during multiple cycles of lyophilization was shown by DLS and 
NT A. This was complimented by AFM which confirmed an increase in the 
average size of the globular features embedded in amorphous regions. 
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Moreover, these findings were further endorsed by the complimentray results 
from both A TR and DSC measurements. The fomer demonstrated structural 
alteractions accompanied by significant increase in the p - sheet character 
(structural rearrangement), whereas latter revealed an increase in the thermal 
unfolding propensity of IgG. This piece of work laid an insight into the 
inherent ability of IgG to defy aggregation. Moreover, this strategy became 
essential for comparative analysis when the effect of the excipients on IgG 
during successive lyophilization was investigated in Chapter 5. 
S.I.3 IgG lyophilized with excipients 
S.I.3.1 Characterization with DLS, AFM and DSC 
The influence of excipients (sucrose and mannitol) on IgG particle size with 
DLS, nanoscale characterization of different components and thermal stability 
with DSC was probed in Chapter 5. The tendency of IgG formulated with 
sucrose or mannitol, alone and in combination to aggregate also increased 
with multiple cycles of lyophilizations. However, the presence of sugars in 
the protein formulations lowered the temptation of aggregation. Sucrose 
displayed profound inhibitive effect on the aggregation of IgG both alone as 
well as in combination with mannitol (Chapter 5, DLS results). The best 
protection was achieved in combination when 1 mg/ml of IgG was formulated 
with 3.6 mM sucrose and 3.6 mM mannitol. AFM images of lyophilized 
formulations revealed globular protein-like features of variable size. However, 
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the mean size of the agglomerates increased significantly with successive 
lyophilization. The increase in the mean size of the globular IgO and their 
association with amorphous regions in the powdered formulations indicated 
by AFM complements the DLS and DSC findings. Samples of IgO formulated 
with mannitol showed more protein aggregation and had more crystalline 
features. DSC confirmed that the propensity of the unfolding of IgO increased 
during multiple cycles of lyophilization. However, the denaturation temperature 
(Tm) of IgO [Fab fragments] - 58°C remained unchanged. The unfolding of the 
Fc domain of IgO occurred at lower temperatures following multiple cycles of 
lyophilization. Sucrose at higher molar concentration provided protection against 
thermal denaturation, both alone and in combination with mannitol. 
The inhibitive effect of sucrose on the aggregation of IgO both alone as well 
as in combination with mannitol shown by DLS and AFM is consistent with 
literature. However, DSC disagrees with DLS in indicating failure of 
mannitol to reduce aggregation. The reason for this difference remains a topic 
for future research. 
8.1.3.2 Characterization with SEM and FT-IR 
The Chapter 6, studies structural and morphological characteristics of a polyclonal 
IgG formulated with sucrose and mannitol, both alone and in combination during 
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successive cycles of lyophilization. IgG formulated with sucrose displayed efficient 
secondary structures with lesser alterations in the secondary structural 
components stationed within amide band I. The alterations were least in IgG 
lyophilized with sucrose at 40 mM, therefore, validates our AFM, DLS findings, 
presented in Chapter 5. Mannitol pronounced aggregation, produced several 
types of crystalline features, decreased porosity (solubility) when used alone was 
confirmed by SEM and therefore, compliments AFM results. The magnitude of 
unfolding (Fabs) increased with mannitol shown by DSC is complementary to 
A TR which indicated significant in the main ~ ~ - sheet structural component. In 
contrast, sucrose in IgG formulations showed comparatively enhanced porosity 
and flakiness with few crystalline faces. This effect pronounced at higher molar 
concentration of sucrose in IgG formulations both alone and in combination with 
mannitol. This work could form the basis of a broad spectrum strategy to 
characterize, minimize and prevent aggregation in protein therapeutics 
through the screening of potential excipients. 
8.1.4 Antigen-binding activity of IgG 
In Chapter 7, the antigen-binding activity of polyclonal IgG lyophilized on its own 
multiple times and once with excipients [sucrose and mannitol, both alone and in 
combination] against six different antigenic (G - 6 - PDH) concentrations (from 0.5 
- 15 Ilg/ml) was explored using an indirect ELISA approach. A HRP -linked anti-
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rabbit IgG was used as secondary antibody for detection against TMB/OPD 
substrates. 
8.1.4.1 Antigen-binding activity of lyophilized IgG (on its own) 
The antigen binding propensity of IgG increased with an increase in the 
concentration of antigen coated to the wells, both in case of multiple times 
lyophilized IgG (on its own) and 19O lyophilized once with sucrose and mannitol 
(alone and in combination). There occurred a significant decrease (- 60 %) in the 
binding activity against each antigenic concentration used in case of IgO exposed to 
multiple cycles of lyophilization. The antigen binding propensity was retained only 
upto cycle one. Although in cycle two, an increase in the activity response at higher 
antigenic concentration was obsereved. However, cycle two onwards up to cycle 7, 
there occured a significant decrease in the activity of IgO against each antigenic 
concentration used and this decrease was identical from cycle 5 - cycle 7. 
8.1.4.2 Activity of IgG with sugar excipients 
The antigen binding propensity of IgO with sucrose was relatively higher than in 
mannitol at each molar concentration used, both alone and in combination. 
However, there occurred a decrease in the antigen binding activity when the molar 
concentration of either sugar was increased. This was confmned by a 20 % decrease 
in the activity of IgG, when the molar concentration of sucrose was doubled in 1.2 
mM IgG lyophilized with sucrose (20 mM) alone. Similar results were obtained 
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after doubling the molar concentration of mannitol in fonnulations containing single 
excipient. IgG lyophilized with 20 mM mannitol demonstrated best activity from the 
IgG lyophilized with single excipient. The presence of appropriate quanitity of 
mannitol significantly enhanced activity response of IgG in fonnulations containing 
sucrose. Upon the addition of 20 mM mannitol, this was best demonstrated by 
observing a significant improvement in the activity (20 %) of the best fonnulation 
containing single excipient (1.2 mM IgG lyophilized with 20 mM sucrose). 
However, any increase (beyond 1 : 40) in the molar concentration of either sugar 
(sucrose or mannitol) in the fonnulations containing single excipient or double 
excipients reduced the activity of IgG. This decrease in the activity response could 
be attributed to the presence of two many sugar molecules occupying the linear or 
three-dimensional antigenic conformation of the binding site (a unique site 
formed by the interaction of two native protein loops or subunits). This results in 
the deficit of freely available epitope (binding site of an antigen). The binding site 
is usually one to six monosaccharides or 5 - 8 amino acid residues on the surface 
of the antigen. Generally, variety of binding sites is possible on the surface of 
antigen, with each potential binding site having its own structure designed as a 
consequence of covalent and non-covalent interactions such as ionic bonds, 
hydrophilic and hydrophobic interactions. If either the ligand or the receptor 
binding site is not in an ideal state due to deposition of two many sugar 
molecules, or through fixation, the epitope may be malformed to a certain degree 
and this may affect its ability to interact with an antibody. Therefore, for a 
competent interaction to facilitate between an antigen and the antibody, the 
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binding site must be fully free and not crowded with two much sugar. This 
suggests the necessity to optimize the molar concentration of sugar for efficient 
binding which we were able to achieve in case of IgG lyophilized with 20 mM 
sucrose in individual formulations. This suggested molar concentration of sugar 
excipients (no matter how good they are) only upto a certain critical limit in enable 
IgG during lyophilization to maintain the population of its active monomers that 
could readily bind to an antigen. 
8.1.5 Impact of this research work 
The investigations which were carried out in this project established that multiple 
lyophilization is not a right approach to stabilize proteins. It is not ideal to expect 
the maintenance of all the necessary therapeutic characteristics in a protein 
formulation (such as an IgG) even up to the cycle 1. Multiple lyophilizations have 
a negative impact on the thermal stability, antigen binding activity, porosity and 
amorphicity. These studies established the influence of sucrose and mannitol 
(alone and in combination in different molar ratios) on the proteins during 
lyophilization. The achievement of desired characteristic in a protein therapeutic 
requires several additives in combination, even if one of the additives provides 
most of the wanted benefits when used alone. The reduction in aggregation, 
resistance in the thermal unfolding, and decrease in the alterations in the 
secondary structural components with an increase in the molar concentration of 
the sugar equal or more than optimum may reduce antigen binding propensity 
which is very much vital from a therapeutic point of consideration. Therefore, 
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from the conducted studies, it is understood, that the protein must be retained not 
only in its native-like state, but also in a native like environment with an optimum 
protection provided by suitable sugars during lyophilization in order to ensure 
that the protein that was protected becomes fully functional to deliver 
therapeutically a desired performance. This study standardized characterization 
approaches for stabilizing IgG alone and with sucrose and mannitol (alone and in 
combination). The benchmark provided by this work would serve as a precursor 
for developing a novel screening standard for optimizing and improving the 
therapeutic efficiency of other proteins besides furnishing a detailed account of 
the disparity in correlating the data from multiple novel techniques. The findings 
of our work can be directly translated to biotech and biopharm industries for the 
enhancement of protein based therapeutics. 
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Appendix 1 
Materials 
Materials Batch No. 
Horse spleen ferritin F4503 
A-G-6-PDH IgG antibody A9521 
G-6-PDH antigen (S. cerevisiae) G6378 
HRP-linked anti-rabbit IgG ABE2047 
D-sucrose (99%) 
D-mannitol (98%) 037K0208 
D-sorbitol (98%) 047K0025 
D-( + )-trehalose dehydrate (95%) 90208 
PBS tablets P4417 
DNPS (K= 0.06-0.6N/m; 
TM in Liquid, CM in air) 
SNL (K= ); RTESPA (20-80N/m) 
Mica 1, (3"x 1") G250-1 
TWEEN 20 washing solution 167008 
Polypropylene plates 
(lmmuno 96 MicroWell™) 167008 
12.5-mm aluminum 
pin stubs G301 
TlI0404 (lid) 
DSC Lids and Pans TI10516 (pan) 
Tetramethyl benzidine (TMB) 
substrate T5525 
Tween 20 
Bovine serum albumin (BSA) 
Sterile 0.2 IJm Ministart filters 16532 
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Supplier 
Sigma Aldrich 
Sigma Aldrich 
Sigma Aldrich 
Bioscience UK Ltd 
S!.Kma Aldrich 
Sigma Aldrich 
Sigma Aldrich 
Fluka 
.-
Sigma Aldrich 
Veeco CA 
Agar Scientific 
Thermo Scientific 
Thermo Scientific 
Agar Scientific 
TA hermetic 
Sigma Aldrich 
S!&.ma Aldrich 
Sigma Aldrich 
Anachem 
Mudasir Ahmad Lone Appendices 
Sodium citrate-dihydrate (99%) 6132 - 04-03 Sigma Adrich 
Silica Gel SI0761/53 Fischer Chemical 
Lens Cleaning Tissue 2105841 Whatman 
OPD substrate P9187 Sigma Aldrich 
ELISA plates (Nunc) 167008 ThermoScientific 
A. 1.1 List of materials used in this project. 
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Appendix 2 
Novel Techniques 
Name of the Techniques 
Atomic Force Microscopy (AFM) 
Dynamic Light Scattering (DLS) 
Nanoparticle Tracking by Nanosight (NT A) 
Differential Scanning Calorimetry (DSC) 
Fourier-transform Infra-red Spectroscopy (Ff-IR) 
Scanning Electron Microscopy (SEM) 
Polarization Microscopy (PM) 
Surface Plasmon Resonance (SPR) 
Enzyme Linked Immunosorbant Assay (ELISA) 
Analytical Ultra-Centrifugation (AUC) 
Size Exclusion Chromatography (SEC) 
Ultra-Violet Absorption Spectrometry (UV) 
Lyophilization 
A.2.1 List of novel techniques. 
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Appendix 3 
AFM size measurements of ferritin aggregates 
Area Leogth 
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80 20 
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'=t = 
= 60 '=t 60 ... C c 0 ~ ~ 40 Col 40 J. J. 0 0 p.. 20 p.. 20 
0 0 
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Size (om) Size (om3) 
A.3.t AFM measured a g g r e g a ~ i o n n profiles of ferritin in air (Cycle 0) 
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A.3.2 AFM measured aggregation profiles of ferritin in liquid (Cycle 0) 
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A.3.3 AFM measured aggregation profiles of ferritin in liquid (Cycle 1) 
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Appendix 4 
Results from lyophilization of IgG 
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A.4.1 AFM measured aggregation profiles of IgG (0.75 !1g1m1, Cycle 0) 
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A. 4.2 AFM measured aggregation profiles of IgG (0.75 I-lglml, Cycle 1) 
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A.4.3 AFM measured aggregation profiles of IgG (1 ,..,g/ml, Cycle 0). 
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A.4.4 AFM measured aggregation profiles of IgG (1 J,lglml, Cycle 1) 
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A.4.S Aggregation profiles of multiple times (0 - 7) lyophilized IgG formulations 
obtained by NTA at room temperature after doubling the concentration of the 
suspended protein from 0.25 - 0.5 mglml. 
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Intensity Distribution 
at 0.5mglml 
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A.4.6 Overlaid aggregation profiles of multiple times (0 - 7) lyophilized IgG 
formulations obtained by DLS at room temperature at two different concentrations 
(0.125 and 0.5 mg/ml) of the protein solution. 
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A.4.7 SEM image of IgG (zero - cycled) indicating porous and flaky nature of the 
antibody formulation which are important for quick solubility. Each can is 50 
micron obtained at low magnification (10 kV). 
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A.4.8 3 - D AFM images of zero - cycled IgG in PBS (0.01 M PBS), indicating 
formation of a range of aggregates. Each scan is one micron obtained at scan speed 
of 2 Hz. Images taken from different locations of the same sample. Z - scales are 
3.9 om - 12 om. 
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A.4.9 3-D AFM images of one cycled IgG PBS (0.01 M PBS), indicating formation 
of a range of aggregates. Each scan is one micron obtained at scan speed of 2 Hz 
from different locations of the same sample. Z - scales are 4 - 12 nm. 
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Cycle! Cycle 2 
Cycle 3 Cycle 4 
CycleS Cycle 6 
A.4.10 3 - D AFM images of multiple times lyophilized IgG indicating formation of 
a range of aggregates. Size of aggregates appears to increase after mUltiple 
lyophilization. Each scan is one micron obtained at scan speed of 2 Hz. Z - scales 
are 66 om, 82 om, 138 om, 171 om, 180 om and 222 nm for 1, 2, 3, 4, 5 and 6 times 
lyophilized IgG respectively. 
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A.4.11 Second set: - SEM images of multiple times lyophilized IgG indicating 
formation of a range of aggregates. Size of aggregates and crystalline content 
appears to increase, whereas porosity and flakiness decreased after mUltiple 
lyophilization. 
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A.4.12 Overlaid ATR-IR spectra of multiple times lyophilized IgG:- Raw data[A]: 
Baseline corrected data [B]. Amide I and II appear in all samples; indicating 
secondary structure does not completely collapse during multiple lyophilization. 
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A.4.12 [C] Overlaid normalized ATR - IR spectra of multiple time lyophilized 
IgG. 
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Analysis of different concentrations of the main p - sheet within the 
component 2 of amide I in multiple times lyophilized IgG. 
Component 2 In the middle of Amide band I 
R a n ~ e e (-1628 -164S cm"l) 
Peak position (-1639 cm"l) 
Cycle 1 (% :area) 55.37: 110.7 
Cycle 2 (% :area) 52 : 90.07 
Cycle 3 
(%) -1626: 20.10; -1636 : 10.24; -1649 : 26.20 ----- (52.71) 
Area -1626: 62.40; -1636 :32.lO; -1649: 80.00 ----- (175.5) 
Cycle 4 
(%) -1633: 26.25; -1641 : 26.45, ----- (52.70) 
Area -1633: 63.60; -1641 : 64.00, ----- (127.4) 
CycleS 
(%) -1625: 18.03; -1636: lO.56; -1649: 31.08 ----- (59.57) 
Area -1625: 56.50; -1636 :33.lO; -1649: 97.30 ----- (177.5) 
Cycle 6 (% :area) 46.95; 69.1 
Cycle' 
(%) -1637: 2.25; -1638 : 36.50 ----- (38.75) 
Area -1637: 4.01; -1638: 69.40 ----- (73.40) 
A.4.13 The different concentrations within main p - sheet component realized by 
IgG, under the influence of multiple cycles of lyophilization. 
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A.4.14 Aggregation behaviour of zero and seven times lyophilized IgG over time at 
three different concentrations. [A, B, C] and [C, D, E] respectively represents average 
of the data from ten and thirty DLS acquisitions. Aggregation decrea es with time at 
higher concentration, whereas at lower concentrations, significant change after multiple 
Iyophilizations. 
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Appendix 5 
Lyophilization of IgG with Sugars 
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A.S.I DLS control experiments for sugars alone and in combination. Size of sucro e 
equivalent to 1 nm was detected by DLS; however, no aggregation was detected 
irre pective of increa e in the molar concentration of sugars. 
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A.S.2 [A - B], [C - D], and [E - F] respectively represent the AFM images 
(topography and phase) of once lyophilized: IgG + Sucrose ( I : 2, w/w), IgG + Mannitol 
(I : 2, w/w), IgG + Sucro e + Mannitol (l : 2: 2, w/w/w). Each scan is one micron. All 
images have height (Z - scale) of 100 nm and a pha e angle of 160°. 
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Appendix 6 
Secondary structure of IgG with Sugars 
Analysis of different concentrations of main p - sheet within the component 
2 of the amide I under the influence of sugar excipients individually. 
Component 2 In the middle of Amide band I 
Ran2e (-1628 -1645 cm'l) 
Peak position (-1639cm,l) 
Formulation Concentrations 
IgG + 40 mM Sucrose 
(%) -1624: 10.42; -1636: 1.5; -1646: 50.52 ----- (62.52) 
Area -1624: 12.30; -1636 : 1.7; -1646 : 50.40 ----- (64.40) 
Analysis of different concentrations of p - turns within the component 3 of 
amide band I under the influence of sugar excipients individually. 
Component 3 in Amide band I 
Ran2e (-1660 -1677 cm'l) 
Peak lJosition (- 1670 cm'l) 
Formulation Concentrations 
IgG + 20 mM Sucrose 
(%) -1665.97: 29.4; -1665.49: 21.2 ---- (52.6) 
Area -1665.97: 37.7 ; -1665.49: 27.2 ---- (64.9) 
A.6.1 Influence of sucrose on the different p - sheet concentrations in components 
2 and 3 within the amide band I. 
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Analysis of different concentrations of main p - sheet within component 
2 of the amide I under the influence of sugar excipients in combination 
Component 2 In the middle of Amide band I 
RanKe (-1628 -1645 em-I) 
Peak position (-1639 cm"l) 
Formulation (I) 
Concentrations 
IgG + 20 mM Sucrose + 
40 mM Mannitol 
(%) -1624: 11.09; -1642: 37.6 ----- (48.7) 
Area -1624: 5.70; -1642: 19.3 ----- (25.0) 
IgG + 40 mM Sucrose + Concentrations 
20 mM Mannitol 
(%) -1633: 25.56; -1643: 32.24-···· (57.8) 
Area -1633: 16.80; -1643: 21.1 ••••• (37.9) 
Analysis of different concentrations of p.turns within the component 3 
of amide band I under the influence of sugar excipients in combination 
Component 3 within amide band I 
RanKe (-1660 -1677 em-I) 
Peak position (- 1670 em-I) 
IgG + 20 mM Sucrose + Concentrations 
40 mM Mannitol 
(%) -1673.66: 11.5; -1660.40: 19.3 ---- (30.8) 
Area -1673.66: 5.9; -1660.40: 9.9 ---- (15.9) 
A.6.2. Influence of sucrose and mannitol together on p·sheet concentrations in 
components 2 and 3 of the amide band I. 
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